<SEC-DOCUMENT>0001104659-21-023984.txt : 20210216
<SEC-HEADER>0001104659-21-023984.hdr.sgml : 20210216
<ACCEPTANCE-DATETIME>20210216161115
ACCESSION NUMBER:		0001104659-21-023984
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210216
FILED AS OF DATE:		20210216
DATE AS OF CHANGE:		20210216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GLOBUS MARITIME LTD
		CENTRAL INDEX KEY:			0001499780
		STANDARD INDUSTRIAL CLASSIFICATION:	DEEP SEA FOREIGN TRANSPORTATION OF FREIGHT [4412]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			1T

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34985
		FILM NUMBER:		21638427

	BUSINESS ADDRESS:	
		STREET 1:		128 VOULIAGMENIS AVENUE 3RD FL
		STREET 2:		166 74 GLYFADA
		CITY:			ATHENS GREECE
		STATE:			J3
		ZIP:			00000
		BUSINESS PHONE:		30 210 960 8300

	MAIL ADDRESS:	
		STREET 1:		128 VOULIAGMENIS AVENUE 3RD FL
		STREET 2:		166 74 GLYFADA
		CITY:			ATHENS GREECE
		STATE:			J3
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm216516d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR<BR>
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of February&nbsp;2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number: 001-34985</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Globus
Maritime Limited</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B></B></FONT>(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>128 Vouliagmenis Avenue, 3rd Floor, Glyfada,
Attica, Greece, 166 74<BR>
</B>(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form&nbsp;20-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K
in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K
in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION CONTAINED IN THIS FORM&nbsp;6-K
REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&nbsp;12,
2021, Globus Maritime Limited (the &ldquo;Company&rdquo; or &ldquo;we&rdquo; or &ldquo;our&rdquo;) entered into a securities purchase
agreement with certain unaffiliated institutional investors to issue in a registered direct offering (the &ldquo;Offering&rdquo;)
to issue (a)&nbsp;3,850,000 of its common shares, par value $0.004 per share (the &ldquo;Common Shares&rdquo;), (b)&nbsp;pre-funded
warrants to purchase 950,000 Common Shares (&ldquo;Pre-Funded Warrants&rdquo;), and (c)&nbsp;commons share purchase warrants (&ldquo;Purchase
Warrants&rdquo;) to purchase 4,800,000 Common Shares with an exercise price of $6.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary
of certain terms and provisions of the Purchase Warrants, and is not complete and is subject to, and qualified in its entirety
by the provisions of the form of Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercisability.</I>
The Purchase Warrants will have a term of 5.5 years. The Purchase Warrants will be exercisable, at the option of each holder, in
whole or in part by delivering to us a duly executed exercise notice with payment in full in immediately available funds for the
number of common shares purchased upon such exercise. If a registration statement registering the issuance of the Common Shares
underlying the Purchase Warrants under the Securities Act of 1933 is not effective or available, the holder may, in its sole discretion,
elect to exercise the Purchase Warrants through a cashless exercise, in which case the holder would receive upon such exercise
the net number of common shares determined according to the formula set forth in the Purchase Warrants. If we do not issue the
shares in a timely fashion, the Purchase Warrants contain certain damages provisions. No fractional common shares will be issued
in connection with the exercise of a Purchase Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Limitation</I>.
A holder will not have the right to exercise any portion of the Purchase Warrants if the holder (together with its affiliates)
would beneficially own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of our Common Shares outstanding
immediately after giving effect to the exercise, as such percentage of beneficial ownership is determined in accordance with the
terms of the Purchase Warrants. However, any holder may increase or decrease such percentage, but not in excess of 9.99%, provided
that any increase will not be effective until the 61st day after such election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Price.</I>&nbsp;The
exercise price per whole common share purchasable upon exercise of the Purchase Warrants is $6.25 per share. The exercise price
of the Purchase Warrants and number of common shares issuable upon exercise of the Purchase Warrants is subject to appropriate
adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar
events affecting our common shares. The exercise price of the Purchase Warrants is also subject to adjustment upon any distributions
of assets, including cash, stock or other property to our shareholders. <FONT STYLE="background-color: white">The holders of </FONT>Purchase
Warrants <FONT STYLE="background-color: white">also will have the right to participate on an&nbsp;as-exercised basis in certain
rights offerings to our common shareholders.</FONT> The exercise price may also be reduced to any amount and for any period of
time deemed appropriate at the sole discretion of our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exchange Listing.</I>
There is no established trading market for the Purchase Warrants and we do not expect a market to develop. In addition, we do not
intend to apply for the listing of the Purchase Warrants on any national securities exchange or other trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Fundamental Transactions.</I>
If a fundamental transaction occurs, then the successor entity will succeed to, and be substituted for us, and may exercise every
right and power that we may exercise and will assume all of our obligations under the Purchase Warrants with the same effect as
if such successor entity had been named in the Purchase Warrant itself. If holders of our common shares are given a choice as to
the securities, cash or property to be received in a fundamental transaction, then the holder shall be given the same choice as
to the consideration it receives upon any exercise of the Purchase Warrants following such fundamental transaction. In addition,
we or the successor entity, at the request of Purchase Warrant holders, will be obligated to purchase any unexercised portion of
the Purchase Warrants in accordance with the terms of such Purchase Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Rights as a Shareholder.</I>
Except as otherwise provided in the Purchase Warrants or by virtue of such holder&rsquo;s ownership of our common shares, the holder
of Purchase Warrants will not have the rights or privileges of a holder of our common shares, including any voting rights, until
the holder exercises the Purchase Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Transferability.</I>&nbsp;Subject
to applicable laws, the Purchase Warrants may be offered for sale, sold, transferred or assigned without our consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Governing Law</I>.
The Purchase Warrants are governed by New York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following summary
of certain terms and provisions of the Pre-Funded Warrants is not complete and is subject to, and qualified in its entirety by
the provisions of the form of Pre-Funded Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercisability.</I>
The Pre-Funded Warrants are exercisable at any time after their original issuance until exercised in full. The Pre-Funded Warrants
will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice with
payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration
statement registering the issuance of the Common Shares underlying the Pre-Funded Warrants under the Securities Act of 1933 is
not effective or available, the holder may, in its sole discretion, elect to exercise the Pre-Funded Warrant through a cashless
exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the
formula set forth in the Pre-Funded Warrant. If we do not issue the shares in a timely fashion, the Pre-Funded Warrant contains
certain damages provisions. No fractional common shares will be issued in connection with the exercise of a Pre-Funded Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Limitation</I>.
A holder will not have the right to exercise any portion of the Pre-Funded Warrants if the holder (together with its affiliates)
would beneficially own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of our Common Shares outstanding
immediately after giving effect to the exercise, as such percentage of beneficial ownership is determined in accordance with the
terms of the Pre-Funded Warrants. However, any holder may increase or decrease such percentage, but not in excess of 9.99%, provided
that any increase will not be effective until the 61st day after such election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Price.</I>&nbsp;The
exercise price for the Pre-Funded Warrants is $0.01 per share and the exercise price and number of common shares issuable upon
exercise of our Pre-Funded Warrants will adjust in the event of certain stock dividends and distributions, stock splits, stock
combinations, reclassifications or similar events affecting our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exchange Listing.</I>
There is no established trading market for the Pre-Funded Warrants and we do not expect a market to develop. In addition, we do
not intend to apply for the listing of the Pre-Funded Warrants on any national securities exchange or other trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Fundamental Transactions.</I>
If a fundamental transaction occurs, then the successor entity will succeed to, and be substituted for us, and may exercise every
right and power that we may exercise and will assume all of our obligations under the Pre-Funded Warrants with the same effect
as if such successor entity had been named in the Pre-Funded Warrants itself. If holders of our common shares are given a choice
as to the securities, cash or property to be received in a fundamental transaction, then the holder shall be given the same choice
as to the consideration it receives upon any exercise of the Pre-Funded Warrants following such fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Rights as a Shareholder.</I>
Except as otherwise provided in the Pre-Funded Warrants or by virtue of such holder&rsquo;s ownership of our common shares, the
holder of Pre-Funded Warrants will not have the rights or privileges of a holder of our common shares, including any voting rights,
until the holder exercises the Pre-Funded Warrants. Holders of Pre-Funded Warrants have the right to participate in dividends and
certain distributions as specified in the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Transferability.</I>&nbsp;Subject
to applicable laws, the Pre-Funded Warrants may be offered for sale, sold, transferred or assigned without our consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Governing Law</I>.
The Pre-Funded Warrants are governed by New York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex4-1.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;4.1 is a copy of the Placement Agency Agreement dated February&nbsp;12, 2021 between the Company and Maxim Group LLC, as sole placement agent.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex4-2.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;4.2 is a copy of the form of Securities Purchase Agreement, dated February&nbsp;12, 2021.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex4-3.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;4.3 is a copy of the form of the Common Share Purchase Warrant, to be issued to the purchasers under the Securities Purchase Agreement.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex4-4.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;4.4 is a copy of the form of the Pre-Funded Warrant, to be issued to the purchasers under the Securities Purchase Agreement.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex5-1.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;5.1 is the opinion of Watson Farley&nbsp;&amp; Williams LLP relating to the legality and validity of the Common Shares.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex8-1.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;8.1 is the opinion of Watson Farley&nbsp;&amp; Williams LLP relating to certain tax matters.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex99-2.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form 6-K as Exhibit 99.2 are updated risk factors the Company included in the prospectus supplement pursuant to which the Offering was made.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><A HREF="tm216516d1_ex99-1.htm" STYLE="-sec-extract: exhibit">Attached to this report on Form&nbsp;6-K as Exhibit&nbsp;99.1 is a copy of the press release of the Company dated February&nbsp;12, 2021 titled &ldquo;Globus Maritime Limited Announces Pricing of $30.0 Million Registered Direct Offering.&rdquo;</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS REPORT ON FORM&nbsp;6-K IS HEREBY
INCORPORATED BY REFERENCE INTO THE COMPANY&rsquo;S REGISTRATION STATEMENTS: (A)&nbsp;ON <A HREF="http://www.sec.gov/Archives/edgar/data/1499780/000110465920085977/tm2024934d1_f3.htm" STYLE="-sec-extract: exhibit">FORM&nbsp;F-3
(FILE NO.&nbsp;333-240042)</A>, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 23, 2020 AND DECLARED EFFECTIVE AUGUST
6, 2020 (B)&nbsp;ON <A HREF="http://www.sec.gov/Archives/edgar/data/1499780/000110465920089124/tm2024934d3_posam.htm" STYLE="-sec-extract: exhibit">FORM&nbsp;F-3
(FILE NO.&nbsp;333-239250)</A>, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 31, 2020 AND DECLARED EFFECTIVE AUGUST
6, 2020, AND (C)&nbsp;ON <A HREF="http://www.sec.gov/Archives/edgar/data/1499780/000110465920089138/tm2024934-2_f3.htm" STYLE="-sec-extract: exhibit">FORM&nbsp;F-3 (FILE NO.&nbsp;333-240265)</A>, FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JULY 31,
2020 AND DECLARED EFFECTIVE ON AUGUST 12, 2020.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: February&nbsp;16, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>GLOBUS MARITIME LIMITED</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Athanasios Feidakis</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Athanasios Feidakis</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>President, Chief Executive Officer and Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>tm216516d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLACEMENT AGENCY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">February&nbsp;12, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white">Globus
Maritime Limited</FONT><BR>
128 Vouliagmenis Avenue, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">166 74 Glyfada<BR>
Athens, Greece<BR>
Attention: Athanasios Feidakis, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr.&nbsp;Feidakis:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This agreement (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement between Maxim Group LLC (the &ldquo;<B>Placement Agent</B>&rdquo;) and <FONT STYLE="background-color: white">Globus
Maritime Limited</FONT>, a Republic of the Marshall Islands corporation (the &ldquo;<B>Company</B>&rdquo;), pursuant to which the
Placement Agent shall serve as the exclusive placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis,
in connection with the proposed placement (the &ldquo;<B>Placement</B>&rdquo;) of registered common shares (the &ldquo;<B>Shares</B>&rdquo;)
of the Company, par value $0.004 per share (the &ldquo;<B>Common Stock&rdquo;)</B>, pre-funded warrants to purchase Common Shares
(collectively, the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;) and Warrants (collectively, the &ldquo;<B>Warrants</B>&rdquo;) to
purchase shares of Common Stock (the shares of Common Stock underlying the Pre-Funded Warrants and the Warrants, collectively with
the Pre-Funded Warrants, the Warrants and the Shares, the &ldquo;<B>Securities</B>&rdquo;). The terms of the Placement and the
Securities shall be mutually agreed upon by the Company and the purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively,
the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein constitutes that the Placement Agent would have the power or authority
to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement
and the documents executed and delivered by the Company and the Purchasers in connection with the Placement, including but not
limited to the Purchase Agreement (as defined below), the form of the Pre-Funded Warrants and the form of the Warrants shall be
collectively referred to herein as the &ldquo;<B>Transaction Documents</B>.&rdquo; The date of the closing of the Placement shall
be referred to herein as the &ldquo;<B>Closing Date</B>.&rdquo; The Company expressly acknowledges and agrees that the Placement
Agent&rsquo;s obligations hereunder are on a reasonable best efforts basis only and that the execution of this Agreement does not
constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement of the Securities
or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf of the Company.
With the prior written consent of the Company, the Placement Agent may retain other brokers or dealers to act as sub-agents or
selected-dealers on its behalf in connection with the Placement. The sale of the Securities to any Purchaser will be evidenced
by a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between the Company and such Purchaser in a form
reasonably acceptable to the Company and the Placement Agent. Capitalized terms that are not otherwise defined herein have the
meanings given to such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company
will be available to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;1.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>REPRESENTATIONS
AND WARRANTIES OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">A.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
of the Company</U>. Each of the representations and warranties (together with any related disclosure schedules thereto) and covenants
made by the Company to the Purchasers in the Purchase Agreement in connection with the Placement is hereby incorporated herein
by reference into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing
Date, hereby made to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company has prepared and filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration
statement on Form&nbsp;F-3 (Registration No.&nbsp;333-240265), and amendments thereto, and related preliminary prospectuses, for
the registration under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), of the Securities which
registration statement, as so amended (including post-effective amendments, if any) became effective on August&nbsp;12, 2020. At
the time of such filing, the Company met the requirements of Form&nbsp;F-3 under the Securities Act. Such registration statement
meets the requirements set forth in Rule&nbsp;415(a)(1)(x)&nbsp;under the Securities Act and complies with said Rule. The Company
will file with the Commission pursuant to Rule&nbsp;424(b)&nbsp;under the Securities Act, and the rules&nbsp;and regulations (the
 &ldquo;<B>Rules&nbsp;and Regulations</B>&rdquo;) of the Commission promulgated thereunder, a supplement to the form of prospectus
included in such registration statement relating to the placement of the Securities and the plan of distribution thereof and has
advised the Placement Agent of all further information (financial and other) with respect to the Company required to be set forth
therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter
called the &ldquo;<B>Registration Statement</B>&rdquo;; such prospectus in the form in which it appears in the Registration Statement
is hereinafter called the &ldquo;<B>Base Prospectus</B>&rdquo;; and the supplemented form of prospectus, in the form in which it
will be filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;(including the Base Prospectus as so supplemented) is hereinafter
called the &ldquo;<B>Prospectus Supplement</B>.&rdquo; Any reference in this Agreement to the Registration Statement, the Base
Prospectus or the Prospectus Supplement shall be deemed to refer to and include the documents incorporated by reference therein
(the &ldquo;<B>Incorporated Documents</B>&rdquo;) pursuant to Item 6 of Form&nbsp;F-3 which were filed under the Exchange Act on
or before the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be;
and any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with
respect to the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include
the filing of any document under the Exchange Act after the date of this Agreement, or the issue date of the Base Prospectus or
the Prospectus Supplement, as the case may be, deemed to be incorporated therein by reference. All references in this Agreement
to financial statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo;
 &ldquo;referenced,&rdquo; &ldquo;set forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus or
the Prospectus Supplement (and all other references of like import) shall be deemed to mean and include all such financial statements
and schedules and other information which is or is deemed to be incorporated by reference in the Registration Statement, the Base
Prospectus or the Prospectus Supplement, as the case may be. No stop order suspending the effectiveness of the Registration Statement
or the use of the Base Prospectus or the Prospectus Supplement has been issued, and no proceeding for any such purpose is pending
or has been initiated or, to the Company&rsquo;s knowledge, is threatened by the Commission. For purposes of this Agreement, &ldquo;<B>free
writing prospectus</B>&rdquo; has the meaning set forth in Rule&nbsp;405 under the Securities Act and the &ldquo;<B>Time of Sale
Prospectus</B>&rdquo; means the preliminary prospectus, if any, together with the free writing prospectuses, if any, used in connection
with the Placement, including any documents incorporated by reference therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required
by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective,
complied in all material respects with the Securities Act and the Exchange Act and the applicable Rules&nbsp;and Regulations and
did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading. The Base Prospectus,
the Time of Sale Prospectus and the Prospectus Supplement, each as of its respective date, comply in all material respects with
the Securities Act and the Exchange Act and the applicable Rules&nbsp;and Regulations. Each of the Base Prospectus, the Time of
Sale Prospectus and the Prospectus Supplement, as amended or supplemented, did not and will not contain as of the date thereof
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed with
the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules&nbsp;and Regulations,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted
to state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference
in the Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they were made not misleading;
and any further documents so filed and incorporated by reference in the Base Prospectus, the Time of Sale Prospectus or Prospectus
Supplement, when such documents are filed with the Commission, will conform in all material respects to the requirements of the
Exchange Act and the applicable Rules&nbsp;and Regulations, as applicable, and will not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading. No post-effective amendment to the Registration Statement reflecting any facts or events arising after
the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no documents required to be filed with the Commission in connection with the
transaction contemplated hereby that (x)&nbsp;have not been filed as required pursuant to the Securities Act or (y)&nbsp;will not
be filed within the requisite time period. There are no contracts or other documents required to be described in the Base Prospectus,
the Time of Sale Prospectus or Prospectus Supplement, or to be filed as exhibits or schedules to the Registration Statement, which
(x)&nbsp;have not been described or filed as required or (y)&nbsp;will not be filed within the requisite time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company is eligible to use free writing prospectuses in connection with the Placement pursuant to Rules&nbsp;164 and 433 under
the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the
Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the
applicable rules&nbsp;and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or
is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act or that was prepared by or behalf of or used by
the Company complies or will comply in all material respects with the requirements of the Securities Act and the applicable rules&nbsp;and
regulations of the Commission thereunder. The Company will not, without the prior consent of the Placement Agent, prepare, use
or refer to, any free writing prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">4.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">There
are no affiliations with any FINRA member firm among the Company&rsquo;s officers, directors or, to the knowledge of the Company,
any five percent (5.0%) or greater shareholder of the Company, except as set forth in the Registration Statement and the other
documents the Company has filed or furnished with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">B.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Covenants
of the Company</U>. The Company has delivered, or will as promptly as practicable deliver, to the Placement Agent materially complete
conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof,
and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, the Time of Sale Prospectus and the
Prospectus Supplement, as amended or supplemented, in such quantities and at such places as the Placement Agent reasonably requests.
Neither the Company nor any of its directors and officers has distributed and none of them will distribute, prior to the Closing
Date, any offering material in connection with the offering and sale of the Securities pursuant to the Placement other than the
Base Prospectus, the Time of Sale Prospectus, the Prospectus Supplement, the Registration Statement, copies of the documents incorporated
by reference therein and any other materials permitted by the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;2.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>REPRESENTATIONS
OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i)&nbsp;is a member in good standing of FINRA,
(ii)&nbsp;is registered as a broker/dealer under the Exchange Act, (iii)&nbsp;is licensed as a broker/dealer under the laws of
the states applicable to the offers and sales of the Securities by such Placement Agent, (iv)&nbsp;is and will be a body corporate
validly existing under the laws of its place of incorporation, and (v)&nbsp;has full power and authority to enter into and perform
its obligations under this Agreement. The Placement Agent will immediately notify the Company in writing of any change in its
status as such. The Placement Agent covenants that it will use its reasonable best efforts to conduct the Placement hereunder
in compliance with the provisions of this Agreement and the requirements of applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;3.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>COMPENSATION</U>.
In consideration of the services to be provided for hereunder, the Company shall pay to the Placement Agent or their respective
designees their pro rata portion (based on the Securities placed) of the following compensation with respect to the Securities
which they are placing:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">A.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">A
cash fee (the &ldquo;<B>Cash Fee</B>&rdquo;) equal to an aggregate of seven percent (7%) of the aggregate gross proceeds raised
in the Placement. The Cash Fee shall be paid at the closing of the Placement (the &ldquo;<B>Closing</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">B.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Subject
to compliance with FINRA Rule&nbsp;5110(f)(2)(D), the Company also agrees, in case of Closing of the Placement, to reimburse the
Placement Agent for all travel and other out-of-pocket expenses incurred, including the reasonable fees, costs and disbursements
of its legal counsel, in an amount not to exceed an aggregate of $40,000 (against invoices provided to the Company). The Company
will reimburse Placement Agent directly upon the Closing of the Placement from the gross proceeds raised in the Placement (if detailed
invoices are provided in advance).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">C.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">In
addition, if within the Participation Period (as defined below) the Company completes any financing of equity, equity-linked, or
debt (but excluding commercial or bank debt) of the Company (other than the exercise by any person or entity of any options, warrants
or other convertible securities) with the six investors who are participating in the offering to which this Agreement relates (the
 &ldquo;<B>PA Investors</B>&rdquo;), if the Placement Agent is not acting as an underwriter or placement agent in such financing,
then the Company will pay to the Placement Agent upon the closing of such financing as a financing participation right the compensation
set forth in Section&nbsp;3(A)&nbsp;above with respect the funds received by the Company from the PA Investors. The &ldquo;Participation
Period&rdquo; shall be the period of time nine (9)&nbsp;months after the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">D.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Placement Agent reserves the right to reduce any item of its compensation or adjust the terms thereof as specified herein in the
event that a determination shall be made by FINRA to the effect that such Placement Agent&rsquo;s aggregate compensation is in
excess of FINRA rules&nbsp;or that the terms thereof require adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;4.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>INDEMNIFICATION</U>.
The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the &ldquo;<B>Indemnification</B>&rdquo;)
attached hereto as <U>Addendum A</U>, the provisions of which are incorporated herein by reference and shall survive the termination
or expiration of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;5.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder shall be until the earlier of (i)&nbsp;the final closing date of the
Placement, (ii)&nbsp;the date the Company elects to terminate this Agreement, and (iii)&nbsp;February&nbsp;25, 2021. If the Company
elects to terminate this Agreement prior to Closing for any reason even though the Placement Agent and all purchasers under the
Purchase Agreement were prepared to proceed with the Closing within the intent of this Agreement and the Purchase Agreement, and
if within nine (9)&nbsp;months following such termination, the Company completes any financing of equity, equity-linked or debt
(but excluding commercial or bank debt) of the Company (other than the exercise by any person or entity of any options, warrants
or other convertible securities) with any PA Investor, if the Placement Agent is not acting as an underwriter or placement agent
in such financing, then the Company will pay the Placement Agent upon the closing of such financing the compensation set forth
in Section&nbsp;3(A)&nbsp;above to the extent of the gross proceeds received by the Company from such PA Investors. Notwithstanding
anything to the contrary contained herein, the provisions concerning confidentiality and indemnification and contribution contained
herein and the Company&rsquo;s obligations contained in the Indemnification Provisions will survive any expiration or termination
of this Agreement. The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement
Agent by the Company for any purposes other than those contemplated under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;6.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>PLACEMENT
AGENT INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this
engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s
prior written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;7.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>NO
FIDUCIARY RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person
or entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company acknowledges
and agrees that the Placement Agent is not and shall not be construed as a fiduciary of the Company and shall have no duties or
liabilities to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention
of such Placement Agent hereunder, all of which are hereby expressly waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;8.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>CLOSING</U>.
The obligations of the Placement Agent, and the closing of the sale of the Securities hereunder are subject to the accuracy, when
made and on the Closing Date, of the representations and warranties on the part of the Company and its subsidiaries contained
herein and in the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates
pursuant to the provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and
to each of the following additional terms and conditions, except as otherwise disclosed to and acknowledged and waived by the
Placement Agent to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">A.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose
shall have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission
(to be included in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall have been complied
with to the reasonable satisfaction of the Placement Agent. Any filings required to be made by the Company in connection with the
Placement shall have been timely filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">B.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement,
the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue statement of a fact which,
in the reasonable opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the reasonable opinion
of such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">C.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of
this Agreement, the Shares, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all other legal matters
relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all material respects to
counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and information that they may
reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">D.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Placement Agent shall have received from outside counsel to the Company such counsel&rsquo;s written opinions, addressed to the
Placement Agent and the Purchasers and dated as of the Closing Date, in form and substance reasonably satisfactory to the Placement
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">E.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">On
the Closing Date, the Placement Agent shall have received a &ldquo;comfort&rdquo; letter from <FONT STYLE="background-color: white">Ernst&nbsp;&amp;
Young (Hellas) Certified Auditors-Accountants S.A. (the Company&rsquo;s independent registered accounting firm)</FONT> (&ldquo;<B>E&amp;Y</B>&rdquo;)
as of each such date, addressed to each of the Placement Agent and in form and substance satisfactory in all respects to the Placement
Agent and Placement Agent&rsquo;s counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">F.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">On
the Closing Date, Placement Agent shall have received a certificate of the chief financial officer of the Company, dated, as applicable,
as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the applicable date, the representations
and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material respects, except
for such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly limited
to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations
to be performed by the Company hereunder on or prior thereto have been fully performed in all material respects. Such officer shall
also provide a customary certification as to such accounting or financial matters that are included or incorporated by reference
in the Registration Statement or the Prospectus Supplement that E&amp;Y is unable to provide assurances on in the letter contemplated
by Section&nbsp;8(E)&nbsp;above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">G.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">On
the Closing Date, Placement Agent shall have received a certificate of the Secretary of the Company, dated, as applicable, as of
the date of such Closing, certifying to the organizational documents, good standing in the jurisdiction of incorporation of the
Company and board resolutions relating to the Placement of the Securities from the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">H.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Neither
the Company nor any of its subsidiaries (i)&nbsp;shall have sustained since the date of the latest audited financial statements
included or incorporated by reference in the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss
or interference with its business from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance,
or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated by the
Registration Statement, the Base Prospectus and the Prospectus Supplement, (ii)&nbsp;since such date there shall not have been
any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, or any development involving
a prospective change, in or affecting the business, general affairs, management, financial position, shareholders&rsquo; equity,
results of operations or prospects of the Company and its subsidiaries, otherwise than as set forth in or contemplated by the Registration
Statement, the Base Prospectus and the Prospectus Supplement, and (iii)&nbsp;since such date there shall not have been any new
or renewed inquiries by the Commission, FINRA or any other regulatory body regarding the Company, the effect of which, in any such
case described in clause (i), (ii)&nbsp;or (iii), is, in the judgment of the Placement Agent, so material and adverse as to make
it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated
by the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">I.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Common Stock is registered under the Exchange Act and, as of the Closing Date, the Shares shall be listed and admitted and authorized
for trading on the Trading Market or other applicable U.S. national exchange, or an application for such listing shall have been
submitted to the Trading Market, and satisfactory evidence of such action shall have been provided to the Placement Agent. The
Company shall have taken no action designed to, or likely to have the effect of terminating the registration of the Common Stock
under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable U.S.
national exchange, nor, except as disclosed in the Base Prospectus, Time of Sale Prospectus and Prospectus Supplement, has the
Company received any information suggesting that the Commission or the Trading Market or other U.S. applicable national exchange
is contemplating terminating such registration or listing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">J.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely
affect or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order
of any other nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which
would prevent the issuance or sale of the Securities or materially and adversely affect or potentially and adversely affect the
business or operations of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">K.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company shall have prepared and filed with the Commission a Form&nbsp;6-K with respect to the Placement, including as an exhibit
thereto this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">L.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and
effect and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">M.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">FINRA
shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition,
the Company shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s
behalf, any filing with the FINRA Corporate Financing Department pursuant to FINRA Rule&nbsp;5110 with respect to the Placement
and pay all filing fees required in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">N.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Prior
to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents
as the Placement Agent may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If any of the conditions specified in this
Section&nbsp;8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written
statements or letters furnished to the Placement Agent or to Placement Agent&rsquo;s counsel pursuant to this Section&nbsp;8 shall
not be reasonably satisfactory in form and substance to the Placement Agent and to Placement Agent&rsquo;s counsel, all obligations
of the Placement Agent hereunder may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing.
Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly
thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;9.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>WARRANT
SOLICITATION FEE</U>. The Company hereby agrees to pay the Placement Agent a warrant solicitation fee of six percent (6%) of the
gross proceeds received by the Company for each exercise of a Warrant sold in the Placement that has been solicited by the Placement
Agent at the request of the Company. The warrant solicitation fee will be payable in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;10.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>GOVERNING
LAW; AGENT FOR SERVICE OF PROCESS,&nbsp;ETC</U>. This Agreement will be governed by, and construed in accordance with, the laws
of the State of New York applicable to agreements made and to be performed entirely in such State, without regard to the conflicts
of laws principles thereof. This Agreement may not be assigned by either party without the prior written consent of the other
party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and
permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct
in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New
York or into the federal court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby
accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party
hereto hereby irrevocably waives personal service of process and consents, to the extent permitted by applicable law, to process
being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. The Company agrees that a final judgment in any such action, proceeding or counterclaim
brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction
of which the Company is or may be subject, by suit upon such judgment. If either party shall commence an action or proceeding
to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed
by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it
has appointed Watson Farley&nbsp;&amp; Williams LLP, 250 West 55th Street, 31st Floor, New York, New York 10019, as its authorized
agent (the &ldquo;<B>Authorized Agent</B>&rdquo;) upon whom process may be served in any suit, action or proceeding arising out
of or based upon the this Agreement or the Transaction Documents or the transactions contemplated herein which may be instituted
in any New York federal or state court, by the Placement Agent, the directors, officers, partners, members, managers, employees
and agents of the Placement Agent, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such
suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment
and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing
of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company
hereby authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall
be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent
for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify
you of such appointment. Notwithstanding the foregoing, any action arising out of or based upon this Agreement may be instituted
by the Placement Agent, the directors, officers, partners, members, managers, employees and agents of the Placement Agent, in
any court of competent jurisdiction in the Republic of the Marshall Islands. This paragraph shall survive any termination of this
Agreement, in whole or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;11.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>ENTIRE
AGREEMENT/MISC</U>. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding
between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof, except
for that certain Underwriting Agreement dated June&nbsp;18, 2020 by and between the Placement Agent and the Company, that certain
Placement Agency Agreement dated June&nbsp;26, 2020 between the Placement Agent and the Company, that certain Placement Agency
Agreement dated July&nbsp;17, 2020 between the Placement Agent and the Company, that certain Placement Agency Agreement dated
December&nbsp;7, 2020 between the Placement Agent and the Company, and that certain Placement Agency Agreement dated January&nbsp;27,
2021 between the Placement Agent and the Company. If any provision of this Agreement is determined to be invalid or unenforceable
in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement,
which will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument
in writing signed by both Placement Agent and the Company. The representations, warranties, agreements and covenants contained
herein shall survive the closing of the Placement and delivery of the Securities. This Agreement may be executed in two or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign
the same counterpart. In the event that any signature is delivered by facsimile transmission or a .pdf format file, such signature
shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile or .pdf signature page&nbsp;were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;12.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>CONFIDENTIALITY</U>.
The Placement Agent (i)&nbsp;will keep the Confidential Information (as such term is defined below) confidential and will not
(except as required by applicable law or stock exchange requirement, regulation or legal process (&ldquo;<B>Legal Requirement</B>&rdquo;),
without the Company&rsquo;s prior written consent, disclose to any person any Confidential Information, and (ii)&nbsp;will not
use any Confidential Information other than in connection with the Placement. The Placement Agent further agrees, severally and
not jointly, to disclose the Confidential Information only to its Representatives (as such term is defined below) who need to
know the Confidential Information for the purpose of the Placement, and who are informed by the Placement Agent of the confidential
nature of the Confidential Information. The term &ldquo;<B>Confidential Information</B>&rdquo; shall mean, all confidential, proprietary
and non-public information (whether written, oral or electronic communications) furnished by the Company to a Placement Agent
or its Representatives in connection with such Placement Agent&rsquo;s evaluation of the Placement. The term &ldquo;<B>Confidential
Information</B>&rdquo; will not, however, include information which (i)&nbsp;is or becomes publicly available other than as a
result of a disclosure by a Placement Agent or its Representatives in violation of this Agreement, (ii)&nbsp;is or becomes available
to a Placement Agent or any of its Representatives on a non-confidential basis from a third-party, (iii)&nbsp;is known to a Placement
Agent or any of its Representatives prior to disclosure by the Company or any of its Representatives, or (iv)&nbsp;is or has been
independently developed by a Placement Agent and/or the Representatives without use of any Confidential Information furnished
to it by the Company. The term &ldquo;Representatives&rdquo; shall mean the Placement Agent&rsquo;s directors, board committees,
officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force until the earlier of
(a)&nbsp;the date that the Confidential Information ceases to be confidential and (b)&nbsp;two years from the date hereof. Notwithstanding
any of the foregoing, in the event that the Placement Agent or any of their respective Representatives are required by Legal Requirement
to disclose any of the Confidential Information, such Placement Agent and their respective Representatives will furnish only that
portion of the Confidential Information which such Placement Agent or their respective Representative, as applicable, is required
to disclose by Legal Requirement as advised by counsel, and will use reasonable efforts to obtain reliable assurance that confidential
treatment will be accorded the Confidential Information so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;13.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a)&nbsp;the date of transmission, if such notice or communication is sent
to the email address specified on the signature pages&nbsp;attached hereto prior to 6:30 p.m.&nbsp;(New York City time) on a business
day, (b)&nbsp;the next business day after the date of transmission, if such notice or communication is sent to the email address
on the signature pages&nbsp;attached hereto on a day that is not a business day or later than 6:30 p.m.&nbsp;(New York City time)
on any business day, (c)&nbsp;the third business day following the date of mailing, if sent by U.S. internationally recognized
air courier service, or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given. The address for
such notices and communications shall be as set forth on the signature pages&nbsp;hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000"><U>SECTION&nbsp;14.</U></FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>PRESS
ANNOUNCEMENTS</U>. The Company agrees that the Placement Agent shall, from and after any Closing, have the right to reference
the Placement and the Placement Agent&rsquo; role in connection therewith in the Placement Agent&rsquo; marketing materials and
on its website and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[The remainder of this page&nbsp;has
been intentionally left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Please confirm that the foregoing correctly
sets forth our agreement by signing and returning to Maxim the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>MAXIM GROUP LLC</B></FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/ Clifford A. Teller</B></FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clifford A. Teller</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Executive Managing Director,&nbsp;Investment Banking</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Address for notice:</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">405 Lexington Avenue</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">New York, New York 10174</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clifford A. Teller</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>cteller@maximgrp.com</U></FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and Agreed to as of the date first written
above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>GLOBUS MARITIME LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%; font-size: 10pt">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; font-size: 10pt; text-align: left">/s/ Athanasios Feidakis</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Athanasios Feidakis</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt; text-align: left">Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><BR>&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for notice:</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">Globus Maritime Limited</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">128 Vouliagmenis Avenue, 3rd Floor</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">166 74 Glyfada</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Athens, Greece</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athanasios Feidakis, Chief Executive Officer</FONT></TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>a.g.feidakis@globusmaritime.gr</U></FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADDENDUM A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>INDEMNIFICATION PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the engagement of Maxim
Group LLC (the &ldquo;Placement Agent&rdquo;) by <FONT STYLE="background-color: white">Globus Maritime Limited</FONT> (the &ldquo;Company&rdquo;)
pursuant to a placement agency agreement dated as of the date hereof, between the Company and the Placement Agent, as it may be
amended from time to time in writing (the &ldquo;Agreement&rdquo;), the Company hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">1.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">To
the extent permitted by law, the Company will indemnify the Placement Agent and its affiliates, directors, officers, employees
and controlling persons (within the meaning of Section&nbsp;15 of the Securities Act of 1933, as amended, or Section&nbsp;20 of
the Securities Exchange Act of 1934) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including
the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement,
except, with regard to the Placement Agent, to the extent that any losses, claims, damages, expenses or liabilities (or actions
in respect thereof) are found in a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly
from any indemnitee&rsquo;s willful misconduct or gross negligence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">2.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">Promptly
after receipt by the Placement Agent of notice of any claim or the commencement of any action or proceeding with respect to which
the Placement Agent is entitled to indemnity hereunder, the Placement Agent will notify the Company in writing of such claim or
of the commencement of such action or proceeding, and the Company will assume the defense of such action or proceeding and will
employ counsel reasonably satisfactory to the Placement Agent and will pay the fees and expenses of such counsel. Notwithstanding
the preceding sentence, the Placement Agent will be entitled to employ counsel separate from counsel for the Company and from any
other party in such action if counsel for the Placement Agent reasonably determines that it would be inappropriate under the applicable
rules&nbsp;of professional responsibility for the same counsel to represent both the Company and the Placement Agent. In such event,
the reasonable fees and disbursements of no more than one such separate counsel will be paid by the Company. The Company will have
the exclusive right to settle the claim or proceeding provided that the Company will not settle any such claim, action or proceeding
without the prior written consent of the Placement Agent, which will not be unreasonably withheld. The Placement Agent and all
other indemnitees shall not settle any claim, action or proceeding without the prior written consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">3.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">The
Company agrees to notify the Placement Agent promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">4.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">If
for any reason the foregoing indemnity is unavailable to the Placement Agent or insufficient to hold the Placement Agent harmless,
then the Company shall contribute to the amount paid or payable by the Placement Agent, as the case may be, as a result of such
losses, claims, damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received
by the Company on the one hand, and the Placement Agent on the other, but also the relative fault of the Company on the one hand
and the Placement Agent on the other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable
considerations. The amounts paid or payable by a party in respect of losses, claims, damages and liabilities referred to above
shall be deemed to include any legal or other fees and expenses incurred in defending any litigation, proceeding or other action
or claim. Notwithstanding the provisions hereof, the Placement Agent&rsquo;s share of the liability hereunder shall not be in
excess of the amount of fees actually received, or to be received, by the Placement Agent under the Agreement (excluding any amounts
received as reimbursement of expenses incurred by the Placement Agent).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">5.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">These
Indemnification Provisions shall remain in full force and effect whether or not the transaction contemplated by the Agreement is
completed and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might
otherwise have to any indemnified party under the Agreement or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>tm216516d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase
Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of February&nbsp;12, 2021, between Globus Maritime Limited, a Marshall
Islands corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages&nbsp;hereto (each,
including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to
the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act
of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE,&nbsp;IN
CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;I.</B></FONT><B><BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the
meanings set forth in this Section&nbsp;1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<U>Acquiring Person</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to
close; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized or required by
law to remain closed due to &ldquo;stay at home,&rdquo; &ldquo;shelter-in-place,&rdquo; &ldquo;non-essential employee&rdquo;&nbsp;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New
York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section&nbsp;2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all conditions precedent to (i)&nbsp;the Purchasers&rsquo; obligations to pay the Subscription Amount and
(ii)&nbsp;the Company&rsquo;s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event
later than the second (2<SUP>nd</SUP>) Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Shares</U>&rdquo; means the common shares of the Company, par value $0.004 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Watson Farley&nbsp;&amp; Williams LLP, with offices located at 250 West 55<SUP>th</SUP> Street, 31<SUP>st</SUP>
Floor, New York, New York 10019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>December&nbsp;Warrants</U>&rdquo;
means the common stock purchase warrants issued in a registered direct offering on December&nbsp;9, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means (i)&nbsp;the issuance (or exercise) of Securities or any issuance of Common Shares on exercise of the
Company&rsquo;s Class&nbsp;A Warrants, Prior Warrants, December&nbsp;Warrants, and January&nbsp;Warrants outstanding on the date
hereof, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
or combinations) or to extend the term of such securities, (ii)&nbsp;any grants or issuances of securities, or the filing of a
registration statement, related to the Company&rsquo;s 2012 Equity Incentive Plan, as amended and restated, or any other incentive
compensation plan of the Company in effect at date hereof, or any issuance of securities to directors of the Company as compensation
for their service as directors provided such grants or issuances are undertaken in a manner consistent with past practice of the
Company, (iii)&nbsp;the issuance by the Company of any common shares upon the exercise of an option or warrant or the conversion
of a security or loan facility outstanding on the date hereof, including the conversion of the loan facility with Firment Shipping
Inc., and provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits
or combinations) or to extend the term of such securities, or (iv)&nbsp;any issuance of securities (which may include preferred
shares) in a private placement of &ldquo;restricted securities&rdquo; (as defined in Rule&nbsp;144), which carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the prohibitive period set
forth in Section&nbsp;4.12 hereof, to members of management of the Company or their associated or affiliated persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>IFRS</U>&rdquo;
shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Inactive
Subsidiary</U>&rdquo; means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)(ii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
means (x)&nbsp;any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred
in the ordinary course of business), (y)&nbsp;all guaranties, endorsements and other contingent obligations in respect of indebtedness
of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business; and (z)&nbsp;the present value of any lease payments in excess of $50,000 due under leases required to be capitalized
in accordance with IFRS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>January&nbsp;Warrants</U>&rdquo;
means the common stock purchase warrants issued in a registered direct offering on January&nbsp;29, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreements entered into by certain directors and officers of the Company in connection with
the Securities Purchase Agreement dated as of January&nbsp;27, 2021 by and among the Company and the purchasers parties thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Loeb</U>&rdquo;
means Loeb&nbsp;&amp; Loeb LLP, with offices located at 345 Park Avenue, New York, New York 10154.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section&nbsp;3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per
Pre-Funded Warrant Purchase Price</U>&rdquo; equals $6.24, subject to adjustment for reverse and forward stock splits, stock dividends,
stock combinations and other similar transactions of Common Shares that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $6.25, subject to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of Common Shares that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Maxim Group LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Subscription Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Pre-Funded Warrants
purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the
heading &ldquo;Pre-Funded Warrant Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means collectively, the pre-funded Common Share purchase warrants issued or issuable to certain Purchasers
pursuant to this Agreement in a number equal to such Purchaser&rsquo;s Pre-Funded Warrant Subscription Amount divided by the Per
Pre-Funded Warrant Purchase Price at the Closing in accordance with Section&nbsp;2.2(a)&nbsp;hereof, which Pre-Funded Warrants
shall be exercisable immediately and shall be in the form of <U>Exhibit&nbsp;B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the Common Shares issuable upon the exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prior
Warrants</U>&rdquo; means the common stock purchase warrants issued in a private placement transaction on June&nbsp;30, 2020, and
the common stock purchase warrants issued in a private placement transaction on July&nbsp;21, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule&nbsp;424(b)&nbsp;of the Securities Act that is
filed with the Commission and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No.&nbsp;333-240265 which registers the sale
of the Shares, the Warrants, the Warrant Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;144</U>&rdquo;
means Rule&nbsp;144 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted
from time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule&nbsp;424</U>&rdquo;
means Rule&nbsp;424 promulgated by the Commission pursuant to the Securities Act, as such Rule&nbsp;may be amended or interpreted
from time to time, or any similar rule&nbsp;or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section&nbsp;3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means, collectively, the Shares, the Warrants, the Warrant Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Share
Subscription Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares purchased hereunder
as specified below such Purchaser&rsquo;s name on the signature page&nbsp;of this Agreement and next to the heading &ldquo;Share
Subscription Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the Common Shares issued or issuable to each Purchaser pursuant to this Agreement in a number equal to such Purchaser&rsquo;s
Share Subscription Amount divided by the Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but
shall not be deemed to include locating and/or borrowing of borrowable Common Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Shares and Warrants (or, if applicable,
the aggregate amount to be paid for the Shares, Pre-Funded Warrants and Warrants) purchased hereunder as specified below such Purchaser&rsquo;s
name on the signature page&nbsp;of this Agreement and next to the headings &ldquo;Share Subscription Amount&rdquo; and &ldquo;Pre-Funded
Warrant Subscription Amount&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company which is actively engaged in a trade or business as set forth on <U>Schedule 3.1(a)(i)</U>,
and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Pre-Funded Warrants, the Placement Agency Agreement and any other
documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Computershare Inc., the current transfer agent of the Company, with a mailing address of at 150 Royall Street,
Canton, MA 02021, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Share purchase warrants delivered to the Purchasers at the Closing in accordance with Section&nbsp;2.2(a)&nbsp;hereof,
which Warrants shall be exercisable immediately at an exercise price of $6.25 per Common Share and have a term of exercise equal
to five and one-half (5.5) years from the Closing Date, in the form of <U>Exhibit&nbsp;A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the Common Shares issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;II.</B></FONT><B><BR>
PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution
and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $30,000,000 of Shares, Pre-Funded Warrants and Warrants. Each Purchaser&rsquo;s Subscription
Amount as set forth on the signature page&nbsp;hereto executed by such Purchaser shall be made available for &ldquo;Delivery Versus
Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) settlement with the Company. The Company shall deliver to each Purchaser its respective
Shares, Pre-Funded Warrants and Warrants as determined pursuant to Section&nbsp;2.2(a), and the Company and each Purchaser shall
deliver the other items set forth in Section&nbsp;2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions
set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Loeb or such other location as the parties shall mutually
agree. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via DVP (i.e., on the Closing Date,
the Company shall issue the Shares registered in the Purchasers&rsquo; names and addresses and released by the Transfer Agent directly
to the account(s)&nbsp;at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall
promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent
(or its clearing firm) by wire transfer to the Company). Notwithstanding anything to the contrary in this Agreement, to the extent
that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser's Affiliates, and any Person
acting as a group together with such purchaser or any of such Holder's Affiliates) would beneficially own in excess of 4.99% (or,
upon election by the Purchaser prior to the issuance of any Warrants or Pre-Funded Warrants, 9.99%) of the number of Common Shares
outstanding (the &ldquo;Beneficial Ownership Maximum&rdquo;), such Purchaser may elect to receive Pre-Funded Warrants in lieu of
Shares for the amount in excess of the Beneficial Ownership Maximum. The determination pursuant to the provisions of the previous
sentences of whether any Purchaser&rsquo;s beneficial ownership exceeds the Beneficial Ownership Maximum shall be in the sole discretion
of such Purchaser and the Company shall have no obligation to verify or confirm the accuracy of such determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">this
Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
legal opinion of Company Counsel, including on matters of United States law and Marshall Islands law, in a form satisfactory to
the Placement Agent and each Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
cold comfort letter, addressed to the Placement Agent, from <FONT STYLE="background-color: white">Ernst&nbsp;&amp; Young (Hellas)
Certified Auditors-Accountants S.A. </FONT>in a form and substance reasonably satisfactory in all respects to the Placement Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the
Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via
The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) Shares equal to such Purchaser&rsquo;s
Share Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">for
any Purchaser who has elected to receive Pre-Funded Warrants in lieu of Shares pursuant to Section&nbsp;2.1, Pre-Funded Warrants
registered in the name of such Purchaser equal to such Purchaser&rsquo;s Pre-Funded Warrant Subscription Amount divided by the
Per Pre-Funded Warrant Price (provided that ink-original copies of such Pre-Funded Warrant certificates may be delivered to the
Placement Agent within five Business Days of the Closing Date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a
Warrant registered in the name of such Purchaser to purchase up to a number of Common Shares equal to 100% of such Purchaser&rsquo;s
Shares and/or such Purchaser&rsquo;s Pre-Funded Warrants, rounded down to the nearest whole Share, with an exercise price equal
to $6.25 per Common Share, subject, in each case, to adjustment therein (provided that ink-original copies of such Warrant certificates
may be delivered to the Placement Agent within five Business Days of the Closing Date); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule&nbsp;172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">this
Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing
Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as
of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
delivery by each Purchaser of the items set forth in Section&nbsp;2.2(b)&nbsp;of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being
met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein
(unless as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">the
delivery by the Company of the items set forth in Section&nbsp;2.2(a)&nbsp;of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">there
shall have been no Material Adverse Effect with respect to the Company since the date hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">each
of the Lock-up Agreements shall remain in full force and effect; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">from
the date hereof to the Closing Date, trading in the Common Shares shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg
L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are
reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national
or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in
each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Sales
During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution
of this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing
(the &ldquo;<B>Pre-Settlement Period</B>&rdquo;), such Purchasersells (excluding &ldquo;short sales&rdquo; as defined in Rule&nbsp;200
of Regulation SHO) to any Person all, or any portion, of any Common Shares to be issued hereunder to such Purchaser at the Closing
(collectively, the &ldquo;<B>Pre-Settlement Common Shares</B>&rdquo;), such Purchaser shall, automatically hereunder (without any
additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, and the Company
shall be deemed unconditionally bound to sell, such Pre-Settlement Common Shares to such Purchaser at the Closing; provided, that
the Company shall not be required to deliver any Pre-Settlement Common Shares to such Purchaser prior to the Company&rsquo;s receipt
of the purchase price of such Pre-Settlement Common Shares hereunder; and provided further that the Company hereby acknowledges
and agrees that the foregoing shall not constitute a representation or covenant by such Purchaser as to whether or not during the
Pre-Settlement Period such Purchaser shall sell any Common Shares to any Person and that any such decision to sell any Common Shares
by such Purchaser shall be made, in the sole discretion of such Purchaser, at the time such Purchaser elects to effect any such
sale, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;III.</B></FONT><B><BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed
a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding
section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries (other than the Inactive Subsidiaries) that are not set forth in the SEC Reports are
set forth on <U>Schedule 3.1(a)(i)</U>. The Company owns, directly or indirectly, all of the capital stock or other equity interests
of each Subsidiary free and clear of any Liens (<FONT STYLE="background-color: white">except for those arising under any credit
facility, financial lease, loan agreement or convertible promissory note (or any related security agreement or pledge agreement)
included as part of the Indebtedness (as defined below) to which the Company or any of its Subsidiaries is a party and as is disclosed
in the Registration Statement, the Prospectus and the Prospectus Supplement).</FONT> All of the issued and outstanding shares of
capital stock of each Subsidiary and each Inactive Subsidiary are validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase securities (other than preemptive and similar rights held by the Company).
<FONT STYLE="background-color: white">The Inactive Subsidiaries hold no material assets or liabilities and conduct no business
operations.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company
nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business
and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted
or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as
the case may be, could not have or reasonably be expected to result in: (i)&nbsp;a material adverse effect on the legality, validity
or enforceability of any Transaction Document, (ii)&nbsp;a material adverse effect on the results of operations, assets, business,
prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii)&nbsp;a material
adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction
Document (any of (i), (ii)&nbsp;or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding has been instituted
in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by
it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors or the Company&rsquo;s shareholders in connection herewith
or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the
terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby
and thereby do not and will not (i)&nbsp;conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii)&nbsp;conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien
upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary Indebtedness or otherwise) or other understanding
to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or
affected, unless a waiver has been obtained, or (iii)&nbsp;subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or <FONT STYLE="background-color: white">any
international, national, state or local regulatory or administrative agencies or bodies (governmental or otherwise, and including
any maritime regulatory bodies, collectively, &ldquo;<U>Governmental Authorities</U>&rdquo;)</FONT> to which the Company or a Subsidiary
is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of clauses (ii)&nbsp;and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect, and in each case accounting for waivers granted by the Company&rsquo;s contractual
counterparties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice
to, or make any filing or registration with, any court or other federal, state, local or other Governmental Authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)&nbsp;the
filings required pursuant to Section&nbsp;4.4 of this Agreement, (ii)&nbsp;the filing with the Commission of the Prospectus Supplement,
(iii)&nbsp;application(s)&nbsp;to each applicable Trading Market for the listing of the Shares, the Warrant Shares and the Pre-Funded
Warrant Shares for trading thereon in the time and manner required thereby, and (iv)&nbsp;such filings as are required to be made
under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;), and other than those which
have already been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable,
free and clear of all Liens imposed by the Company. The Pre-Funded Warrant Shares, when issued in accordance with the terms of
the Pre-Funded Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Company has reserved from its duly authorized capital stock the maximum number of Common Shares issuable pursuant to this Agreement,
the Warrants and the Pre-Funded Warrants. The Company has prepared and filed the Registration Statement in conformity with the
requirements of the Securities Act, which became effective on August&nbsp;12, 2020 (the &ldquo;<U>Effective Date</U>&rdquo;), including
the Prospectus and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of the Prospectus and/or the Prospectus Supplement has been issued by the Commission
and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.
The Company, if required by the rules&nbsp;and regulations of the Commission, shall file the Prospectus with the Commission pursuant
to Rule&nbsp;424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement
and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects
to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus
and any amendments or supplements thereto, including without limitation, the Prospectus Supplement, at the time the Prospectus
or any such amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects
to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form&nbsp;F-3. The Company
is eligible to use Form&nbsp;F-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate
market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set
forth in General Instruction I.B.5 of Form&nbsp;F-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Capitalization</U>.
The capitalization of the Company as of the close of business on date immediately preceding the date hereof is as set forth in
<U>Schedule 3.1(g)</U>. Other than as reflected in the SEC Reports, the Company has not issued any capital stock since its most
recently filed periodic or annual report under the Exchange Act, other than pursuant to the exercise of employee stock options
under the Company&rsquo;s stock option plans, the issuance of Common Shares to employees, directors or consultants, and pursuant
to the conversion and/or exercise of Common Share Equivalents or loan facilities outstanding as of the date of the most recently
filed periodic or annual report under the Exchange Act, or as otherwise disclosed to the public in filings with the Commission,
including in recent registration statements. No Person has any right of first refusal, preemptive right, right of participation,
or any similar right to participate in the transactions contemplated by the Transaction Documents that has not been waived. Except
as a result of the purchase and sale of the Securities or disclosed in its SEC Reports or as otherwise disclosed to the public
in filings with the Commission, including in recent registration statements, or set forth in <U>Schedule 3.1(g)</U>, there are
no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or
securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any Common Shares or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional Common Shares or Common Share Equivalents or
capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
Common Shares or other securities to any Person (other than the Purchasers). Except as disclosed in <U>Schedule 3.1(g)</U>, there
are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price under any of such securities as a result of the issuance and sale of the Securities. Except as disclosed
in the <U>Schedule 3.1(g)</U>, there are no outstanding securities or instruments of the Company or any Subsidiary that contain
any securities redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not
have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of
the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation
of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any
shareholder or the Board of Directors is required for the issuance and sale of the Securities. There are no shareholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party
or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;thereof,
for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such
material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with
the Registration Statement, Prospectus and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC
Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports
prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never
been an issuer subject to Rule&nbsp;144(i)&nbsp;under the Securities Act. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules&nbsp;and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with international
financial reporting standards applied on a consistent basis during the periods involved (&ldquo;<U>IFRS</U>&rdquo;), except as
may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may
not contain all footnotes required by IFRS, and fairly present in all material respects the financial position of the Company and
its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then
ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. T<FONT STYLE="background-color: white">he
Company is a &ldquo;foreign private issuer&rdquo; as defined in Rule&nbsp;405 of the Securities Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, (i)&nbsp;there has been no event, occurrence or development that has had or that could reasonably be expected
to result in a Material Adverse Effect, (ii)&nbsp;the Company has not incurred any liabilities (contingent or otherwise) other
than (A)&nbsp;trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and
(B)&nbsp;liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to IFRS or disclosed in
filings made with the Commission, (iii)&nbsp;the Company has not altered its method of accounting, (iv)&nbsp;the Company has not
declared or made any dividend or distribution of cash or other property to its shareholders or purchased, redeemed or made any
agreements to purchase or redeem any shares of its capital stock and (v)&nbsp;the Company has not issued any equity securities
to any officer, director or Affiliate, except the issuance of preferred stock to an affiliate of the Chief Executive Officer and
the issuance of shares to directors for their service as directors. The Company does not have pending before the Commission any
request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement, no
event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist
with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial
condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation
is made or deemed made that has not been publicly disclosed prior to such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company,
threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator
or Governmental Authority (collectively, an &ldquo;<U>Action</U>&rdquo;) which (i)&nbsp;adversely affects or challenges the legality,
validity or enforceability of any of the Transaction Documents or the Securities or (ii)&nbsp;could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any
director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal
or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there
is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or
officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of
the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or
any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and
conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Compliance</U>.
Neither the Company nor any Subsidiary: (i)&nbsp;is in default under or in violation of (and no event has occurred that has not
been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is
bound, except in each case as disclosed in the Registration Statement (ii)&nbsp;is in violation of any judgment, decree or order
of any court, arbitrator or other Governmental Authority or (iii)&nbsp;is or has been in violation of any statute, rule, ordinance
or regulation of any Governmental Authority, including without limitation all foreign, federal, state and local laws relating to
taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except
in each case as could not have or reasonably be expected to result in a Material Adverse Effect, and in each case accounting for
waivers granted by the Company&rsquo;s contractual counterparties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white"><U>Compliance
with Environmental Laws</U>. Except as disclosed in the </FONT><FONT STYLE="font-size: 10pt">Registration Statement, Prospectus
and the Prospectus Supplement<FONT STYLE="background-color: white">, (i)&nbsp;neither the Company nor any of its Subsidiaries is
in violation of any applicable international, national, state or local convention, law, regulation, order, Material Permit or other
requirement relating to pollution or protection of human health or safety (as they relate to exposure to Materials of Environmental
Concern (as defined below)) or protection of the environment (including, without limitation, ambient air, surface water, groundwater,
land surface or subsurface strata) or protection of natural resources, including without limitation, conventions, laws or regulations
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, wastes, toxic substances,
hazardous substances, petroleum and petroleum products (collectively, &ldquo;<U>Materials of Environmental Concern</U>&rdquo;),
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of
Materials of Environmental Concern (collectively, &ldquo;<U>Environmental Laws</U>&rdquo;), nor has the Company or any Subsidiary
received any written communication, whether from a Governmental Authority, citizens group, employee or otherwise, that alleges
that the Company or any such Subsidiary is in violation of any Environmental Law or Material Permit required pursuant to Environmental
Law; except, in each case, as does not or would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect; (ii)&nbsp;there is no claim, action or cause of action filed with a court or Governmental Authority and no investigation,
or other action with respect to which the Company or any Subsidiary has received written notice alleging potential liability for
investigatory costs, cleanup costs, governmental response costs, natural resources damages, property damages, personal injuries,
attorneys&rsquo; fees or penalties&nbsp;arising out of, based on or resulting from the presence, or release into the environment,
of any Material of Environmental Concern at any location owned, leased or operated by the Company or any Subsidiary, now or in
the past, or from any vessel owned, leased or operated by the Company or any Subsidiary, now or in the past (collectively, &ldquo;<U>Environmental
Claim</U>&rdquo;), pending or, to the knowledge of the Company, threatened against the Company or any Subsidiary or any person
or entity whose liability for any Environmental Claim the Company or any Subsidiary has retained or assumed either contractually
or by operation of law, except as does not or would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect; (iii)&nbsp;to the knowledge of the Company, there are no past or present actions, activities, circumstances, conditions,
events or incidents, including, without limitation, the release, emission, discharge, presence or disposal of any Material of Environmental
Concern, that reasonably would be expected to result in a violation of any Environmental Law, require expenditures to be incurred
pursuant to Environmental Law, or form the basis of an Environmental Claim against the Company, any Subsidiary or against any person
or entity whose liability for any Environmental Claim the Company or any Subsidiary has retained or assumed either contractually
or by operation of law, except as does not or would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect (for the avoidance of doubt, the operation of vessels in the ordinary course of business shall not be deemed, by
itself, an action, activity, circumstance or condition set forth in this clause (iii)); and (iv)&nbsp;none of the Company or any
Subsidiary is subject to any pending proceeding under Environmental Law to which a Governmental Authority is a party and which
the Company reasonably believes is likely to result in monetary sanctions of US$100,000 or more. The Company has reasonably concluded
that associated costs and liabilities arising under Environmental Laws and resulting from the business, operations or properties
of the Company or any Subsidiary does not or would not reasonably be expected, individually or in the aggregate, to have a Material
Adverse Effect, except as set forth in or contemplated in the </FONT>Registration Statement, Prospectus and the Prospectus Supplement<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, licenses, authorizations and permits issued by the appropriate
federal, state, local or international regulatory authorities (governmental or otherwise) necessary to conduct their respective
businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to
result in a Material Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received
any notice of proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Title
to Assets</U>. Except as disclosed in SEC Reports, the Company and the Subsidiaries have good and marketable title in fee simple
to all real property owned by them and good and marketable title in all personal property owned by them that is material to the
business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i)&nbsp;Liens as do not materially
affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by
the Company and the Subsidiaries and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate reserves
have been made therefor in accordance with IFRS and, the payment of which is neither delinquent nor subject to penalties. Any real
property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable
leases with which the Company and the Subsidiaries are in compliance, except as disclosed in SEC Reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark
applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports
and which the failure to so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;).
None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual
Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2)&nbsp;years
from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial
statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property
Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material
Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing
infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure
to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and
in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the
Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without
a significant increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transactions
With Affiliates and Employees</U>. Except as disclosed in the <U>Schedule 3.1(r)</U>, none of the officers or directors of the
Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or
personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments
to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, shareholder, member or partner, in each case
in excess of $120,000 other than for (i)&nbsp;payment of salary or consulting fees or director fees and shares for services rendered,
(ii)&nbsp;reimbursement for expenses incurred on behalf of the Company and (iii)&nbsp;other employee benefits, including stock
option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of
the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules&nbsp;and regulations
promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the
Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary
to permit preparation of financial statements in conformity with IFRS and to maintain asset accountability, (iii)&nbsp;access to
assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv)&nbsp;the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and
15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules&nbsp;and forms. The Company&rsquo;s certifying
officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the
end of the period covered by the most recently filed annual report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed annual report under the Exchange Act the conclusions of the
certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation
Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined
in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect,
the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Certain
Fees</U>. Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency Agreement and
as set forth in the Prospectus Supplement relating to the placement of the Securities, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent,
investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees
of a type contemplated in this Section&nbsp;that may be due in connection with the transactions contemplated by the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will
not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as
amended. The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject
to registration under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Registration
Rights</U>. Except as disclosed in the Registration Statement or in the SEC Reports, no person has any right to cause the Company
or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Listing
and Maintenance Requirements</U>. The Common Shares are registered pursuant to Section&nbsp;12(b)&nbsp;or 12(g)&nbsp;of the Exchange
Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Shares under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. Except as disclosed in the <FONT STYLE="background-color: white">Registration Statement</FONT>,
the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Shares
are or have been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Common Shares are currently eligible for electronic transfer through the Depository Trust Company or
another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or
such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents)
or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and
the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation
as a result of the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company
confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel
with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed
in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation
in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers
regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the
Disclosure Schedules to this Agreement, is true and correct and does not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement
taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when
made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in Section&nbsp;3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section&nbsp;3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made
any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i)&nbsp;has made or filed all United States federal, state and
local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it
is subject, (ii)&nbsp;has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations and (iii)&nbsp;has set aside on its books provision reasonably adequate for
the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There
are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the
Company or of any Subsidiary know of no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent
or other person acting on behalf of the Company or any Subsidiary, has (i)&nbsp;directly or, to its knowledge, indirectly, used
any funds for contributions, gifts, entertainment or other expenses related to foreign or domestic political activity, in each
case, in violation of the FCPA or any other anti-corruption law applicable to such party, (ii)&nbsp;made any payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds,
in each case, in violation of the FCPA or any other anti-corruption law applicable to such party, (iii)&nbsp;failed to disclose
fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is
aware) which is in violation of the FCPA or any other anti-corruption law applicable to such party, or (iv)&nbsp;violated in any
material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Accountants</U>.
The Company&rsquo;s registered independent accounting firm is <FONT STYLE="background-color: white">Ernst&nbsp;&amp; Young (Hellas)
Certified Auditors-Accountants S.A</FONT>. To the knowledge and belief of the Company, such accounting firm (i)&nbsp;is a registered
public accounting firm as required by the Exchange Act and (ii)&nbsp;shall express its opinion with respect to the financial statements
to be included in the Company&rsquo;s Annual Report for the fiscal year ending December&nbsp;31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting
solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given
by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to
each Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based
solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Acknowledgement
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Sections 3.2(f)&nbsp;and 4.14 hereof), it is understood and acknowledged by the Company that: (i)&nbsp;none of the
Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or
short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the
Securities for any specified term; (ii)&nbsp;past or future open market or other transactions by any Purchaser, specifically including,
without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities; (iii)&nbsp;any
Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or indirectly,
presently may have a &ldquo;short&rdquo; position in the </FONT><FONT STYLE="font-size: 10pt">Common Shares<FONT>,
and (iv)&nbsp;each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. </FONT>The Company further understands and acknowledges that (y)&nbsp;one or more
Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including,
without limitation, during the periods that the value of the Warrant Shares and/or Pre-Funded Warrant Shares deliverable with respect
to Securities are being determined, and (z)&nbsp;such hedging activities (if any) could reduce the value of the existing shareholders&rsquo;
equity interests in the Company at and after the time that the hedging activities are being conducted.&nbsp; The Company acknowledges
that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Regulation
M Compliance</U>.&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i)&nbsp;taken, directly or
indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of any of the Securities, (ii)&nbsp;sold, bid for, purchased, or, paid any compensation
for soliciting purchases of, any of the Securities, or (iii)&nbsp;paid or agreed to pay to any Person any compensation for soliciting
another to purchase any other securities of the Company, other than, in the case of clauses (ii)&nbsp;and (iii), compensation paid
to the Company&rsquo;s placement agent in connection with the placement of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Maritime
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white">Each
of the vessels described in the </FONT><FONT STYLE="font-size: 10pt">Registration Statement, Prospectus and the Prospectus Supplement
<FONT STYLE="background-color: white">as being owned by the Company or any Subsidiary (&ldquo;<U>Owned Vessels</U>&rdquo;) has
been duly and validly registered in the name of the owner of such Owned Vessel as disclosed in the </FONT>Registration Statement,
Prospectus and the Prospectus Supplement <FONT STYLE="background-color: white">under the laws and regulations and flag of the nation
of its registration; no other action is necessary to establish and perfect such entity&rsquo;s title to and interest in any of
the Owned Vessels as against any third party; and each Owned Vessel is owned directly by such entity free and clear of all liens,
claims, security interests or other encumbrances, except such as are described in the </FONT>Registration Statement, Prospectus
and the Prospectus Supplement<FONT STYLE="background-color: white">. Each such entity has good title to the applicable Owned Vessel,
free and clear of all mortgages, pledges, liens, security interests and claims and all defects of title of record except for maritime
liens incurred in the ordinary course and those liens arising under any Indebtedness, each as disclosed in the </FONT>Registration
Statement, Prospectus and the Prospectus Supplement<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white">Each
of the Owned Vessels is in good standing with respect to the payment of past and current taxes, fees and other amounts payable
under the laws of the jurisdiction in which it is registered, except for any failure which would not result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white">Each
of the vessels described in the Registration Statement, the General Disclosure Package and the Prospectus as being owned or bareboat
chartered by the Company or any Subsidiary as described therein (&ldquo;<U>Operated&nbsp;Vessels</U>&rdquo;) is operated in compliance
with the rules, codes of practice, conventions, protocols, guidelines or similar requirements or restrictions imposed, published
or promulgated by any Governmental Authority, with moral jurisdiction over, or classification society or insurer applicable to
the respective Operated Vessel (collectively, &ldquo;<U>Maritime Guidelines</U>&rdquo;) and all applicable international, national,
state and local conventions, laws, regulations, orders, Governmental Licenses and other requirements (including, without limitation,
all Environmental Laws), in each case as in effect on the date hereof, except where such failure to be in compliance is not resulting
or would not reasonably be expected to result in a Material Adverse Effect. The Company and each applicable Subsidiary are qualified
to own or lease, as the case may be, and operate such Operated Vessels under all applicable international, national, state and
local conventions, laws, regulations, orders, Material Permits and other requirements (including, without limitation, all Environmental
Laws) and Maritime Guidelines, including the laws, regulations and orders of each such vessel&rsquo;s flag state, in each case
as in effect on the date hereof, except where such failure to be so qualified is not resulting or would not reasonably be expected
to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white">Each
of the Operated Vessels is classed by a classification society which is a full member of the International Association of Classification
Societies and such Operated Vessels are in class with valid class and trading certificates, without any overdue recommendations,
in each case based on the classification and certification requirements in effect on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white">Except
as disclosed in the Registration Statement, neither the Company nor any Subsidiary is a party to or bound by any memorandum, option,
agreement, instrument or understanding pursuant to which it has contracted to purchase, sell or build any shipping vessels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970,
as amended, applicable money laundering statutes and applicable rules&nbsp;and regulations thereunder (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of
the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt; background-color: white"><U>PFIC
Status</U>. The Company did not qualify as a &ldquo;passive foreign investment company&rdquo; within the meaning of Section&nbsp;1297
of the United States Internal Revenue Code of 1986, as amended, for its most recently completed taxable year, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i)&nbsp;the fair saleable value of the Company&rsquo;s assets
exceeds the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities
(including known contingent liabilities) as they mature, (ii)&nbsp;the Company&rsquo;s assets do not constitute unreasonably small
capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account
the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and
capital availability thereof, and (iii)&nbsp;the current cash flow of the Company, together with the proceeds the Company would
receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient
to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to
incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will
file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the
Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as
of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they
shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability
company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and
performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction
Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with
the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except: (i)&nbsp;as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)&nbsp;as limited
by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii)&nbsp;insofar
as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise
in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary
course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on
which it exercises any Warrants and/or Pre-Funded Warrants, it will be an &ldquo;accredited investor&rdquo; as defined in Rule&nbsp;501(a)(1),
(a)(2), (a)(3), or (a)(7)&nbsp;under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk
of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i)&nbsp;the opportunity to ask such questions as
it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of
the offering of the Securities and the merits and risks of investing in the Securities; (ii)&nbsp;access to information about the
Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable
it to evaluate its investment; and (iii)&nbsp;the opportunity to obtain such additional information that the Company possesses
or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to
the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement
Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice
necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company
or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect
to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such
Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not,
nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that
the Company or any other Person representing the Company first contacted such Purchaser regarding the material pricing terms of
the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in
the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions
of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio
managers managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect
to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered
by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including,
without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser
has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and
terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares to borrow in order to effect
Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company acknowledges and agrees that the representations contained in </FONT>this Section&nbsp;3.2 shall not modify, amend or affect
such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance
of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating
or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;IV.</B></FONT><B><BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Legends</U>.
The Securities shall be issued free of any restrictive legends (except if at the time of exercise of Warrants or Pre-Funded Warrants
there is no effective registration statement registering, or the prospectus contained therein is not available for the issuance
of Warrant Shares or Pre-Funded Warrant Shares, and the Holder does not utilize cashless exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Furnishing
of Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Until
the earlier of the time that (i)&nbsp;no Purchaser owns Securities or (ii)&nbsp;all of the Warrants have expired, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting
requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined
in Section&nbsp;2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the
rules&nbsp;and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a)&nbsp;by 9:00 a.m.. (New York City time) on February&nbsp;12, 2021 issue a
press release disclosing the material terms of the transactions contemplated hereby, and (b)&nbsp;file a Form&nbsp;6-K, including
the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after
the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material,
non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective
officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar
obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the
other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other press releases with
respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor
otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser,
or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide
the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not
publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of such Purchaser, except (a)&nbsp;the filing of final Transaction
Documents with the Commission and (b)&nbsp;to the extent such disclosure is required by law, regulation or Trading Market or FINRA
rules&nbsp;or regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b), except disclosures in reliance on a Schedule 13G or Schedule 13D filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any
Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company,
or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities
under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section&nbsp;4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt
of such information and agreed with the Company to keep such information confidential. The Company understands and confirms that
each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent
that the Company delivers any material, non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company
hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries,
or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the Company, any of its Subsidiaries
or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public
information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant
to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries,
the Company shall simultaneously file such notice with the Commission pursuant to a Form&nbsp;6-K. The Company understands and
confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Use
of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities in the manner specified in the Prospectus
Supplement and shall not use such proceeds in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section&nbsp;4.8, the Company will indemnify and hold each Purchaser and its
directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section&nbsp;15 of the Securities Act and Section&nbsp;20 of the Exchange Act), and the directors, officers,
shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding
such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;)
harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments,
amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser
Party may suffer or incur as a result of or relating to (a)&nbsp;any breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or in the other Transaction Documents or (b)&nbsp;any action instituted against
the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any shareholder of the Company who is
not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless
such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations, warranties or covenants under
the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such shareholder or any violations
by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially
determined to constitute fraud, gross negligence or willful misconduct), the Company will indemnify each Purchaser Party, to the
fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses, as incurred, arising out of or relating to (i)&nbsp;any untrue
or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus
or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus
or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but
only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished
in writing to the Company by such Purchaser Party expressly for use therein, or (ii)&nbsp;any violation or alleged violation by
the Company of the Securities Act, the Exchange Act or any state securities law, or any rule&nbsp;or regulation thereunder in connection
therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this
Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the
defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the
right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (x)&nbsp;the employment thereof has been specifically
authorized by the Company in writing, (y)&nbsp;the Company has failed after a reasonable period of time to assume such defense
and to employ counsel or (z)&nbsp;in such action there is, in the reasonable opinion of counsel, a material conflict on any material
issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible
for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser
Party under this Agreement (1)&nbsp;for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written
consent, which shall not be unreasonably withheld or delayed; or (2)&nbsp;to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants
or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required
by this Section&nbsp;4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of
action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to
pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Reservation
of Common Shares</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available
at all times, free of preemptive rights, a sufficient number of Common Shares for the purpose of enabling the Company to issue
Shares pursuant to this Agreement, Warrant Shares pursuant to any exercise of the Warrants and Pre-Funded Warrant Shares pursuant
to any exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Listing
of Common Shares</U> The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the
Common Shares on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall have
applied to list or quote all of the Shares, the Warrant Shares and the Pre-Funded Warrant Shares on such Trading Market and promptly
to secure the listing of all of the Shares, Warrant Shares and Pre-Funded Warrant Shares on such Trading Market. The Company further
agrees, if the Company applies to have the Common Shares traded on any other Trading Market, it will then include in such application
all of the Shares, the Warrant Shares and the Pre-Funded Warrant Shares and will take such other action as is necessary to cause
all of the Shares, the Warrant Shares and the Pre-Funded Warrant Shares to be listed or quoted on such other Trading Market as
promptly as possible. The Company will take all action reasonably necessary to continue the listing and trading of its Common Shares
on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the
bylaws or rules&nbsp;of the Trading Market. The Company agrees to maintain the eligibility of the Common Shares for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely
payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic
transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>[Reserved]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsequent
Equity Sales</U>. From the date hereof until the date which is forty five (45) days after the Closing Date, neither the Company
nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Shares
or Common Share Equivalents, other than the Securities, or file any registration statement (other than any post-effective amendment
to any currently effective registration statement of the Company which does not register any additional securities); provided,
however, that this Section&nbsp;4.12 shall not apply to Exempt Issuances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to
treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither
it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending
at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release
as described in Section&nbsp;4.4.<FONT>&nbsp; </FONT>Each Purchaser, severally and not jointly with
the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed
by the Company pursuant to the initial press release as described in Section&nbsp;4.4, such Purchaser will maintain the confidentiality
of the existence and terms of this transaction and any confidential information provided to such Purchaser.&nbsp; N<FONT>otwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and
agrees that (i)&nbsp;no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section&nbsp;4.4, (ii)&nbsp;no Purchaser shall be restricted or prohibited
from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section&nbsp;4.4 and (iii)&nbsp;no Purchaser shall have any duty of confidentiality or duty not to trade in the securities
of the Company to the Company or its Subsidiaries after the issuance of the initial press release as described in Section&nbsp;4.4.&nbsp;
</FONT>Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio
managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase
the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants and the Pre-Funded Warrants set forth the totality of the
procedures required of the Purchasers in order to exercise the Warrants and the Pre-Funded Warrants, respectively. No additional
legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants and Pre-Funded
Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion
guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants.
The Company shall honor exercises of the Warrants and Pre-Funded Warrants and shall deliver Warrant Shares and Pre-Funded Warrant
Shares, as applicable, in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>QEF
Election</U>. If the Company determines or otherwise becomes aware that it is a Passive Foreign Investment Company (PFIC) for any
taxable year, upon request of any U.S. Purchaser at any time and from time to time, the Company will promptly provide the information
necessary for such U.S. Purchaser to make a Qualified Electing Fund (QEF) Election with respect to the Company and will use reasonable
best efforts to cause each direct and indirect subsidiary that the Company controls that is a PFIC to provide such information
with respect to such Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Lock-Up.
</U>The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements without the consent
of the Placement Agent except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE&nbsp;V.</B></FONT><B><BR>
MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect
whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing
has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Fees
and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident
to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent
fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company
and any exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery
of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of: (a)&nbsp;the time of transmission, if such notice or communication is delivered
via facsimile or email attachment at the facsimile number or email address as set forth on the signature pages&nbsp;attached hereto
at or prior to 5:30 p.m.&nbsp;(New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the time of transmission,
if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address as set
forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City
time) on any Trading Day, (c)&nbsp;the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given.
The address for such notices and communications shall be as set forth on the signature pages&nbsp;attached hereto. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding
the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form&nbsp;6-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed,
in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and/or Pre-Funded
Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in
the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment,
modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately
impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition
or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default
or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any
right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately,
materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations
of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in
accordance with this Section&nbsp;5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of
each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to
whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Third-Party
Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section&nbsp;3.1 and the representations and warranties of the Purchasers in Section&nbsp;3.2. This Agreement is intended for
the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may
any provision hereof be enforced by, any other Person, except as otherwise set forth in Section&nbsp;4.8, this Section&nbsp;5.8
and/or the Placement Agency Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Governing
Law; Venue; Agent for Service of Process</U>. All questions concerning the construction, validity, enforcement and interpretation
of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State
of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents
(whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees
or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for
the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein
(including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not
to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that
such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal
service of process and, to the extent permitted by law, consents to process being served in any such Action or Proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner
permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then,
in addition to the obligations of the Company under Section&nbsp;4.8, the prevailing party in such Action or Proceeding shall be
reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such Action or Proceeding. <FONT STYLE="background-color: white">The Company hereby
irrevocably designates and appoints </FONT>Watson Farley&nbsp;&amp; Williams LLP, 250 West 55th Street, 31st Floor, New York, New
York 10019 <FONT STYLE="background-color: white">(the &ldquo;<U>Process Agent</U>&rdquo;) as its authorized agent upon whom process
may be served in any claim brought against the Company, it being understood that the designation and appointment of the Process
Agent as such authorized agent shall become effective immediately without any further action on the part of the Company. The Company
represents to each Purchaser that it has notified the Process Agent of such designation and appointment and that the Process Agent
has accepted the same. The Company hereby irrevocably authorizes and directs the Process Agent to accept such service. The provisions
of this Section&nbsp;5.9 shall survive any termination of this Agreement, in whole or in part.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being
understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or by electronic signature, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as
if such facsimile or &ldquo;.pdf&rdquo; signature page&nbsp;or electronic signature were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of)
any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the
case of a rescission of an exercise of a Warrant or a Pre-Funded Warrant, the applicable Purchaser shall be required to return
any Common Shares subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate
exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant
to such Purchaser&rsquo;s Warrant or Pre-Funded Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company
shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or
in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory
to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of
the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation
the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or
exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from,
disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person
under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several
and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any
other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the
Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers
are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the
rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate
legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each
Purchaser and its respective counsel have chosen to communicate with the Company through Loeb. Loeb does not represent any of the
Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction
Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It
is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between
the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the
Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other
amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages
or other amounts are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc.</U></FONT> <FONT STYLE="font-size: 10pt">If the last or appointed
day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such
action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule&nbsp;of construction to the effect that any ambiguities are to be resolved against the
drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition,
each and every reference to share prices and Common Shares in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Shares that occur after
the date of this Agreement. All references herein to matters disclosed within filings made by the Company with the Commission shall
be construed to include documents incorporated by reference into such filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE
PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,&nbsp;IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.22</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Waiver</U>.
Each Purchaser agrees that Section&nbsp;4.12 of the Securities Purchase Agreement, dated January&nbsp;27, 2021 (the &ldquo;January&nbsp;SPA&rdquo;),
by and between the Company and the purchasers signatories thereto will not apply and is hereby waived with respect to the execution
and delivery by the Company of the Transaction Documents and the consummation of the transactions contemplated thereunder, including
the issuance and exercise of the Securities. The parties hereto acknowledge and agree that except as set forth in the preceding
sentence, the January&nbsp;SPA remains unchanged and in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages&nbsp;Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>GLOBUS MARITIME LIMITED</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">128 Vouliagmenis Avenue, 3rd Floor</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">166 74 Glyfada</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Athens, Greece</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Chief Executive Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Athanasios Feidakis </FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: a.g.feidakis@globusmaritime.gr</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Athanasios Feidakis</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Watson Farley&nbsp;&amp; Williams LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250 West 55th Street, 31st Floor</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Steven J. Hollander</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: SHollander@wfw.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO GLOBUS MARITIME
LIMITED SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as
of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Purchaser: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Purchaser</I>: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address of Authorized Signatory:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile Number of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Notice to Purchaser:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Address for Delivery of Warrants to Purchaser (if not same as address for notice):</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC for Shares:</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Subscription Amount:</FONT></TD>
    <TD STYLE="text-align: right; padding-right: 5.4pt; padding-left: 0in; width: 2%; vertical-align: bottom">$</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; width: 50%"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded Warrants Subscription Amount: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Pre-Funded Warrant Shares: </FONT></TD>
    <TD STYLE="width: 49%; border-bottom: black 1pt solid; padding-right: 5.4pt; text-align: right; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right; font-size: 10pt">*</TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; width: 50%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN Number: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">* Please insert the number of Pre-Funded Warrants here. This
number should not be duplicative with the number of Shares, if any, purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GLOBUS MARITIME LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: [_______]</FONT></TD>
    <TD STYLE="width: 49%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: February&nbsp;[&#9679;], 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This COMMON SHARE PURCHASE
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the Issue Date and on or prior to 5:00 p.m.&nbsp;(New York City time) on August&nbsp;[&#9679;], 2026 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Globus Maritime Limited, a Marshall Islands corporation
(the &ldquo;<U>Company</U>&rdquo;), up to ______ Common Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;).&nbsp;
The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;1.</FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Definitions</U>.&nbsp;
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section&nbsp;1.
Capitalized terms not otherwise defined in this Warrant shall have the meanings assigned to such terms in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bid Price</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Share so reported, or (d)&nbsp;in all other cases, the fair market value
of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of
the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to
be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations at the direction
of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Shares</B>&rdquo;
means the common shares of the Company, par value $0.004 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Share
Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchase
Agreement</B>&rdquo; means that certain Securities Purchase Agreement, dated February&nbsp;12, 2021, among the Company and the
Holders signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where applicable, also include
any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means a day on which the Common Shares are traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on the date in question:
the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange
(or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transfer
Agent</B>&rdquo; means Computershare Inc. or its affiliate with offices located at 150 Royall Street, Canton, MA 02021, and any
successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest
preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is
not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB
or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent bid price per Common Share so reported, or (d)&nbsp;in all other cases, the fair market value
of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of
the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Common Share Purchase Warrants issued by the Company on or around the Issue Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;2.</FONT><FONT STYLE="color: #010000">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a)</FONT>&nbsp;&nbsp;
 &nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise of Warrant</U>.&nbsp; Subject to the provisions
of Section&nbsp;2(e)&nbsp;herein, exercise of the purchase rights represented by this Warrant may be made, in whole or in
part, at any time or times on or after the Issue Date and on or before the Termination Date by delivery to the Company of a
duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the
 &ldquo;<U>Notice of Exercise</U>&rdquo;).&nbsp; Within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the
number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i)&nbsp;herein) following
the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the
applicable Notice of Exercise by wire transfer in United States dollars unless the cashless exercise procedure specified in
Section&nbsp;2(c)&nbsp;below is specified in the applicable Notice of Exercise.<B>&nbsp;</B>No ink-original Notice of
Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required.&nbsp; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the
Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation
within three (3)&nbsp;Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial
exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
lower the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant
Shares purchased.&nbsp; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and
the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)&nbsp;Business
Day of receipt of such notice.&nbsp; <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face
hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>.&nbsp; The exercise price per Common Share under this Warrant shall be $6.25, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>.&nbsp; If at any time after the Issue Date, there is no effective registration statement registering, or the prospectus
contained therein is not available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised,
in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A)&#8239;= as applicable: (i)&nbsp;the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)&nbsp;both
executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a day that is not a Trading Day or (2)&nbsp;both executed and
delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&nbsp;600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&nbsp;at
the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of
Exercise or (z)&nbsp;the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. as of the
time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours
after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;2(a)&nbsp;hereof or (iii)&nbsp;the
VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(B)&#8239;= the Exercise Price of this Warrant,
as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(X)&#8239;= the number of Warrant Shares
that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means
of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this Section&nbsp;2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to
this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Mechanics
of Exercise</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
of Warrant Shares Upon Exercise</U>.&nbsp; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then
a participant in such system and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder or (B)&nbsp;this Warrant is being exercised via cashless exercise, and
otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or
its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
by the Holder in the Notice of Exercise by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading Days after the delivery
to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of
a cashless exercise) is received by the Company one (1)&nbsp;Trading Day prior to such second Trading Day after the delivery of
the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading Day after delivery of the aggregate Exercise Price to the Company and (iii)&nbsp;the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise, provided
that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company one
(1)&nbsp;Trading Day prior to such number of Trading Days comprising the Standard Settlement Period after the delivery of the Notice
of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
shall be deemed, solely for purposes of Regulation SHO of the Securities Act, to have become the holder of record of such Warrant
Shares, irrespective of the date of delivery of such Warrant Shares, provided that payment of the aggregate Exercise Price (other
than in the case of a cashless exercise) is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails
for any reason (other than failure of the Holder to timely deliver the aggregate Exercise Price, unless the Warrant is validly
exercised by means of a cashless exercise) to deliver or cause the delivery to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as
a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the
applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or
Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long
as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the
standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to
the Common Shares as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
of New Warrants Upon Exercise</U>.&nbsp; If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a
new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new
Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Rescission
Rights</U>.&nbsp; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&nbsp;2(d)(i)&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>.&nbsp; In addition to any other rights available to the
Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section&nbsp;2(d)(i)&nbsp;above pursuant to an exercise on or before the Warrant Share Delivery Date (other than as a result
of failure of the Holder to timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a
cashless exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise)
or the Holder&rsquo;s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the
Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall
(A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price (including brokerage
commissions, if any) for the Common Shares so purchased exceeds (y)&nbsp;the amount obtained by multiplying (1)&nbsp;the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)&nbsp;the
price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the option of the Holder, either
reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which
case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued
had the Company timely complied with its exercise and delivery obligations hereunder.&nbsp; For example, if the Holder purchases
Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant
to purchase Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)&nbsp;of
the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company
written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence
of the amount of such loss.&nbsp; Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it
hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Company&rsquo;s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares or Scrip</U>.&nbsp; No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall round down to the nearest whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Charges,
Taxes and Expenses</U>.&nbsp; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by
the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the
Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of
the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed
by the Holder (along with a medallion guarantee if requested by the Company) and the Company may require, as a condition thereto,
the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&nbsp; The Company shall pay all Transfer
Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing
of Books</U>.&nbsp; The Company will not close its shareholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s
Exercise Limitations</U>.&nbsp; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of Common Shares which would be issuable upon (i)&nbsp;exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other&nbsp; Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; For purposes of this Section&nbsp;2(e),
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith.&nbsp;&nbsp; To the extent that the limitation contained in this Section&nbsp;2(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of
which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination, and a submission of a Notice of Exercise shall be deemed
a representation and warranty by the Holder of the foregoing determination.&nbsp;&nbsp; In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding Common Shares,
a Holder may rely on the number of outstanding Common Shares as reflected in (A)&nbsp;the Company&rsquo;s most recent periodic
or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a
more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&nbsp; Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the
number of Common Shares then outstanding.&nbsp; In any case, the number of outstanding Common Shares shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding Common Shares was reported.&nbsp; The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by the Holder prior to the issuance of any Warrants, 9.99%) of
the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise
of this Warrant.&nbsp; The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the Common
Shares outstanding immediately after giving effect to the issuance of Common Shares upon exercise of this Warrant held by the Holder
and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company.&nbsp; The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e)&nbsp;to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;3.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.75in">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common
Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant),
(ii)&nbsp;subdivides outstanding Common Shares into a larger number of shares, (iii)&nbsp;combines (including by way of reverse
stock split) outstanding Common Shares into a smaller number of shares or (iv)&nbsp;issues by reclassification of the Common Shares
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and
of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares
issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged.&nbsp; Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after
the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsequent
Rights Offerings</U>.&nbsp; In addition to any adjustments pursuant to Section&nbsp;3(a)&nbsp;above, if at any time the Company
grants, issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record
is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record
holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such
extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Pro
Rata Distributions</U>.&nbsp; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) except to
the extent an adjustment was already made pursuant to Section&nbsp;3(a)&nbsp;(a &ldquo;<U>Distribution</U>&rdquo;), then the Exercise
Price shall be decreased, effective immediately after the effective date of such Distribution, by the amount of cash and/or the
fair market value (as determined by the Company&rsquo;s Board of Directors, in good faith) of any securities or other assets paid
on each Common Share in respect of such Distribution in order that subsequent thereto upon exercise of the Warrants the Holder
may obtain the equivalent benefit of such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii)&nbsp;the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and
has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv)&nbsp;the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any
compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a stock or share
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder
shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e)&nbsp;on
the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant).&nbsp;
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration.&nbsp; If holders of Common Shares are given any choice as to
the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as
to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&nbsp; Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall,
at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction.&nbsp; &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental
Transaction for pricing purposes and reflecting (A)&nbsp;a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and
the Termination Date, (B)&nbsp;an expected volatility equal to the greater of 100% and the 30 day volatility obtained from the
HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the
public announcement of the applicable contemplated Fundamental Transaction, (C)&nbsp;the underlying price per share used in such
calculation shall be the greater of (i)&nbsp;the sum of the price per share being offered in cash, if any, plus the value of any
non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)&nbsp;the greater of (x)&nbsp;the last VWAP
immediately prior to the public announcement of such contemplated Fundamental Transaction and (y)&nbsp;the last VWAP immediately
prior to the consummation of such Fundamental Transaction, (D)&nbsp;a remaining option time equal to the time between the date
of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E)&nbsp;a zero
cost of borrow.&nbsp; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within
five Business Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction). The Company
shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions
of this Section&nbsp;3(d)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved
by the Holders holding Warrants to purchase at least a majority of the Common Shares underlying the then outstanding Warrants (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance
to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent
entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations
on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price
hereunder to such shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being
for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction),
and which is reasonably satisfactory in form and substance to the Holders holding Warrants to purchase at least a majority of the
Common Shares underlying the then outstanding Warrants. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right
and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such
Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section&nbsp;3, the number of Common Shares deemed to be issued and outstanding as of a given date shall
be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 1in">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall
promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a Distribution on the Common Shares, (B)&nbsp;the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C)&nbsp;the Company shall authorize
the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital stock of
any class or of any rights, (D)&nbsp;the approval of any shareholders of the Company shall be required in connection with any reclassification
of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken as a whole) is a party, any
sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common
Shares are converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 10 Trading Days prior to the applicable record or effective date hereinafter specified, a notice stating
(x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice.&nbsp; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form&nbsp;6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Voluntary
Adjustment by Company</U>.&nbsp; Subject to the rules&nbsp;and regulations of the Trading Market, the Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by
the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;4.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;<U>Transfer
of Warrant.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.&nbsp;
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
duly executed by the Holder or its agent or attorney (along with a medallion guarantee if requested by the Company) and funds sufficient
to pay any transfer taxes payable upon the making of such transfer.&nbsp; Upon such surrender and, if required, such payment, the
Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the
denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&nbsp; Notwithstanding anything herein
to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned
this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading Days
of the date on which the Holder delivers an assignment form (along with a medallion guarantee if requested by the Company) to the
Company assigning this Warrant in full.&nbsp; The Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney.&nbsp; Subject to compliance with Section&nbsp;4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time.&nbsp; The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #010000">Section&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>.&nbsp; This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except
as expressly set forth in Section&nbsp;3.&nbsp; Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section&nbsp;2(c)&nbsp;or to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and Section&nbsp;2(d)(iv)&nbsp;herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of an affidavit of loss
reasonably satisfactory to the Company evidencing the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to
it (which, in the case of the Warrant, shall not include the posting of a bond), and upon surrender and cancellation of such Warrant
or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated
as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>.&nbsp; If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next
succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&nbsp;
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&nbsp; The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be
listed.&nbsp; The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except and to the extent
as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares
underlying such Warrants) which are not beneficially owned by Affiliates of the Company, the Company shall not by any action, including,
without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of
any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment;
provided, however, that no modification of the terms (including but not limited to the adjustments described in Section&nbsp;3)
upon which the Warrants are exercisable or the rights of holders of Warrants to receive liquidated damages or other payments in
cash from the Company or reducing the percentage required for consent to modification of this Warrant may be made without the consent
of the Holder of each outstanding Warrant affected thereby.&nbsp; Without limiting the generality of the foregoing, the Company
will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use
commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before taking any action
which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public
regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>.&nbsp; A<FONT STYLE="background-color: white">ll questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Jurisdiction;
Agent for Process</U>. <FONT STYLE="background-color: white">Each party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state
and federal courts sitting in the City of New York.&nbsp; Each party hereby irrevocably submits to the exclusive jurisdiction of
the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy
thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of
this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
attorneys&rsquo; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
or proceeding. Notwithstanding the foregoing, nothing in this paragraph shall limit or restrict the federal district court and
the state court in which a Holder may bring a claim under the federal securities laws.</FONT>&nbsp;<FONT STYLE="background-color: white">The
Company hereby irrevocably designates and appoints </FONT>Watson Farley&nbsp;&amp; Williams LLP, 250 West 55th Street, 31st Floor,
New York, New York 10019 <FONT STYLE="background-color: white">(the &ldquo;<U>Process Agent</U>&rdquo;) as its authorized agent
upon whom process may be served in any claim brought against the Company, it being understood that the designation and appointment
of the Process Agent as such authorized agent shall become effective immediately without any further action on the part of the
Company. The Company represents to each Purchaser that it has notified the Process Agent of such designation and appointment and
that the Process Agent has accepted the same.&nbsp; The Company hereby irrevocably authorizes and directs the Process Agent to
accept such service.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Restrictions</U>.&nbsp;
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Nonwaiver
and Expenses</U>.&nbsp; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies.&nbsp; Without limiting
any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notices</U>.&nbsp;
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized overnight
courier service, addressed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>If to the Company</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Globus Maritime Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">128 Vouliagmenis Avenue, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">166 74 Glyfada</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Athens, Greece</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel: +30 210 960 8300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: a.g.feidakis@globusmaritime.gr</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile: +30 210 9608359</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or such other facsimile number, email address
or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or
deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent
by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e- mail address or address
of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of (a)&nbsp;the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or e-mail attachment at the email address set forth on the signature pages&nbsp;attached hereto at or prior
to 5:30 p.m.&nbsp;(New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth
on the signature pages&nbsp;attached hereto on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time)
on any Trading Day, (c)&nbsp;the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Limitation
of Liability</U>.&nbsp; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.&nbsp;
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant.&nbsp;The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>.&nbsp; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder.&nbsp; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this
Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendment</U>.&nbsp;
This Warrant may be modified or amended (or the provisions hereof waived) by the Holders holding Warrants to purchase at least
a majority of the Common Shares underlying the then outstanding Warrants; provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall also be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severability</U>.&nbsp;
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.&nbsp;
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify"><B>GLOBUS MARITIME LIMITED</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="text-align: justify; width: 3%">By:</TD>
                              <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">Name:</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: justify">Title:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">GLOBUS
MARITIME LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
required if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[&nbsp; ]&#8239; wire transfer in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[&nbsp; ]&#8239; if permitted, the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Shares
shall be delivered to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 27%"></TD>
    <TD STYLE="width: 26%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 47%; text-align: right">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute
this form and supply required information.&nbsp; Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:&#8239;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s&#8239;Signature:&#8239;&#8239;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Split-Segment; Name: 4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON SHARES PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON SHARES PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>GLOBUS
MARITIME LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif">Warrant Shares: [_______]</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 49%; font: 10pt Times New Roman, Times, Serif">Initial Exercise Date: February&nbsp;[&#9679;], 2021</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON
SHARES PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
 &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Globus Maritime
Limited, a Republic of the Marshall Islands corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ Common Shares (as subject
to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;. The purchase price of one Common Share under this Warrant shall
be equal to the Exercise Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;1</U>.</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section&nbsp;1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the
Common Shares are then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp; if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX
and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Share so reported, or (d)&nbsp;in all
other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders
of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of
which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed
to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations at the direction
of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Shares</U>&rdquo; means the common shares of the Company, par value $0.004 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form&nbsp;F-3 (File No.&nbsp;333-240265).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company which is actively engaged in a trade or business, and shall, where applicable, also include
any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Shares are traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Inc. or its affiliate with offices located at 150 Royall Street, Canton, MA 02021, and any successor transfer
agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the
nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp; if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX
and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d)&nbsp;in all other cases,
the fair market value of Common Share as determined by an independent appraiser selected in good faith by the holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Pre-Funded Common Share purchase warrants issued by the Company pursuant to the Registration Statement
on or around the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;2</U>.</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
of Warrant</U>. Subject to the provisions of Section&nbsp;2(e)&nbsp;herein, exercise of the purchase rights represented by this
Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise
in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i)&nbsp;two (2)&nbsp;Trading
Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i)&nbsp;herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in
the applicable Notice of Exercise by wire transfer in United States dollars unless the cashless exercise procedure specified in
Section&nbsp;2(c)&nbsp;below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the
Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall lower the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
Exercise within one (1)&nbsp;Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per Warrant Share, was pre-funded
to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal
exercise price of $0.01 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of
this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior
to the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.01, subject to adjustment
hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement registering the Warrant Shares or
the prospectus contained therein is not available for issuance of the Warrant Shares to the Holder, then this Warrant may be exercised,
in whole or in part by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of
Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">(A)&nbsp;=
as applicable: (i)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
Notice of Exercise is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a day that is not a Trading
Day or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a Trading Day prior to the opening of
 &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)(68) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii)&nbsp;at the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding
the date of the applicable Notice of Exercise or (z)&nbsp;the Bid Price of the Common Shares on the principal Trading Market as
reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours
thereafter (including until two (2)&nbsp;hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to Section&nbsp;2(a)&nbsp;hereof or (iii)&nbsp;the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof
after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">(B)&nbsp;=
the Exercise Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">(X)&nbsp;=
the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify"><U>Delivery of Warrant Shares Upon
                                         Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
                                         by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or
                                         its designee&rsquo;s balance account with The Depository Trust Company through its Deposit
                                         or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then
                                         a participant in such system and either (A)&nbsp;there is an effective registration statement
                                         permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the
                                         Holder or (B)&nbsp;this Warrant is being exercised via cashless exercise, and otherwise
                                         by physical delivery of a certificate, registered in the Company&rsquo;s share register
                                         in the name of the Holder or its designee, for the number of Warrant Shares to which
                                         the Holder is entitled pursuant to such exercise to the address specified by the Holder
                                         in the Notice of Exercise by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading
                                         Days after the delivery to the Company of the Notice of Exercise, provided that payment
                                         of the aggregate Exercise Price (other than in the instance of a cashless exercise) is
                                         received by the Company one (1)&nbsp;Trading Day prior to such second Trading Day after
                                         the delivery of the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading Day after delivery
                                         of the aggregate Exercise Price to the Company and (iii)&nbsp;the number of Trading Days
                                         comprising the Standard Settlement Period after the delivery to the Company of the Notice
                                         of Exercise, provided that payment of the aggregate Exercise Price (other than in the
                                         instance of a cashless exercise) is received by the Company one (1)&nbsp;Trading Day
                                         prior to such number of Trading Days comprising the Standard Settlement Period after
                                         the delivery of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
                                         Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed,
                                         solely for purposes of Regulation SHO of the Securities Act, to have become the holder
                                         of record of such Warrant Shares, irrespective of the date of delivery of such Warrant
                                         Shares, provided that payment of the aggregate Exercise Price (other than in the case
                                         of a cashless exercise) is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading
                                         Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period
                                         following delivery of the Notice of Exercise. If the Company fails for any reason (other
                                         than failure of the Holder to timely deliver the aggregate Exercise Price, unless the
                                         Warrant is validly exercised by means of a cashless exercise) to deliver to the Holder
                                         the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date,
                                         the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
                                         for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the
                                         Common Shares on the date of the applicable Notice of Exercise), $10 per Trading Day
                                         (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages
                                         begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such
                                         Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to
                                         maintain a transfer agent that is a participant in the FAST program so long as this Warrant
                                         remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
                                         means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s
                                         primary Trading Market with respect to the Common Shares as in effect on the date of
                                         delivery of the Notice of Exercise. Notwithstanding the foregoing, with respect to any
                                         Notice(s)&nbsp;of Exercise delivered on or prior to 12:00 p.m.&nbsp;(New York City time)
                                         on the Initial Exercise Date, which may be delivered at any time after the time of execution
                                         of the Securities Purchase Agreement, dated February&nbsp;12, 2021 among the Company
                                         and the purchasers party thereto, the Company agrees to deliver the Warrant Shares subject
                                         to such notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on the Initial Exercise
                                         Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes
                                         hereunder, provided that payment of the aggregate Exercise Price (other than in the case
                                         of a cashless exercise) is received by the Company prior to 12:00 p.m.&nbsp;(New York
                                         City time) on the Initial Exercise Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Delivery
                                         of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part,
                                         the Company shall, at the request of a Holder and upon surrender of this Warrant certificate,
                                         at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
                                         the rights of the Holder to purchase the unpurchased Warrant Shares called for by this
                                         Warrant, which new Warrant shall in all other respects be identical with this Warrant.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Rescission
                                         Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder
                                         the Warrant Shares pursuant to Section&nbsp;2(d)(i)&nbsp;by the Warrant Share Delivery
                                         Date, then the Holder will have the right to rescind such exercise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify"><U>Compensation for Buy-In on
                                         Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other
                                         rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit
                                         to the Holder the Warrant Shares in accordance with the provisions of Section&nbsp;2(d)(i)&nbsp;above
                                         pursuant to an exercise on or before the Warrant Share Delivery Date (other than as a
                                         result of failure of the Holder to timely deliver the aggregate Exercise Price, unless
                                         the Warrant is validly exercised by means of a cashless exercise), and if after such
                                         date the Holder is required by its broker to purchase (in an open market transaction
                                         or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Shares
                                         to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
                                         anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company
                                         shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s
                                         total purchase price (including brokerage commissions, if any) for the Common Shares
                                         so purchased exceeds (y)&nbsp;the amount obtained by multiplying (1)&nbsp;the number
                                         of Warrant Shares that the Company was required to deliver to the Holder in connection
                                         with the exercise at issue times (2)&nbsp;the price at which the sell order giving rise
                                         to such purchase obligation was executed, and (B)&nbsp;at the option of the Holder, either
                                         reinstate the portion of the Warrant and equivalent number of Warrant Shares for which
                                         such exercise was not honored (in which case such exercise shall be deemed rescinded)
                                         or deliver to the Holder the number of Common Shares that would have been issued had
                                         the Company timely complied with its exercise and delivery obligations hereunder. For
                                         example, if the Holder purchases Common Shares having a total purchase price of $11,000
                                         to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase Common
                                         Shares with an aggregate sale price giving rise to such purchase obligation of $10,000,
                                         under clause (A)&nbsp;of the immediately preceding sentence the Company shall be required
                                         to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
                                         the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,
                                         evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right
                                         to pursue any other remedies available to it hereunder, at law or in equity including,
                                         without limitation, a decree of specific performance and/or injunctive relief with respect
                                         to the Company&rsquo;s failure to timely deliver Common Shares upon exercise of the Warrant
                                         as required pursuant to the terms hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">v.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No
                                         Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional
                                         shares shall be issued upon the exercise of this Warrant. As to any fraction of a share
                                         which the Holder would otherwise be entitled to purchase upon such exercise, the Company
                                         shall round down to the nearest whole share.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify"><U>Charges, Taxes and Expenses</U>.
                                         Issuance of Warrant Shares shall be made without charge to the Holder for any issue or
                                         transfer tax or other incidental expense in respect of the issuance of such Warrant Shares,
                                         all of which taxes and expenses shall be paid by the Company, and such Warrant Shares
                                         shall be issued in the name of the Holder or in such name or names as may be directed
                                         by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares
                                         are to be issued in a name other than the name of the Holder, this Warrant when surrendered
                                         for exercise shall be accompanied by the Assignment Form&nbsp;attached hereto duly executed
                                         by the Holder and the Company may require, as a condition thereto, the payment of a sum
                                         sufficient to reimburse it for any transfer tax incidental thereto. The Company shall
                                         pay all Transfer Agent fees required for same-day processing of any Notice of Exercise
                                         and all fees to the Depository Trust Company (or another established clearing corporation
                                         performing similar functions) required for same-day electronic delivery of the Warrant
                                         Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.3in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">vii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Closing
                                         of Books</U>. The Company will not close its shareholder books or records in any manner
                                         which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
exercise any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of Common Shares that are beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of Common Shares that are issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Common Shares which would be issuable upon (i)&nbsp;exercise of the remaining,
unexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or non-converted portion of any other securities of the Company (including, without limitation,
any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; For purposes of this Section&nbsp;2(e),
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section&nbsp;2(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination, and a submission of a Notice of Exercise shall
be deemed a representation and warranty by the Holder of the foregoing determination. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding Common Shares,
a Holder may rely on the number of outstanding Common Shares as reflected in (A)&nbsp;the Company&rsquo;s most recent periodic
or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a
more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&nbsp; Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder
the number of Common Shares then outstanding.&nbsp; In any case, the number of outstanding Common Shares shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding Common Shares was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by the Holder prior to the issuance of any Warrants, 9.99%)
of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon
exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation
provisions of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares upon exercise of this Warrant
held by the Holder and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of
this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e)&nbsp;to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;3</U>.</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common
Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant),
(ii)&nbsp;subdivides outstanding Common Shares into a larger number of shares, (iii)&nbsp;combines (including by way of reverse
stock split) outstanding Common Shares into a smaller number of shares, or (iv)&nbsp;issues by reclassification of the Common
Shares any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately
after the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become
effective immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;3(a)&nbsp;above, if at any time the Company grants,
issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held
in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or
otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a
dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) except to the
extent an adjustment was already made pursuant to Section&nbsp;3(a)&nbsp;(a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon
complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken,
the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such
extent (or in the beneficial ownership of any Common Shares as a result of such Distribution to such extent) and the portion of
such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would
not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii)&nbsp;the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and
has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv)&nbsp;the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any
compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a stock or
share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder
shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e)&nbsp;on
the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as
a result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any
successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section&nbsp;3(d)&nbsp;pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holders holding Warrants
to purchase at least a majority of the Common Shares underlying the then outstanding Warrants (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is
exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to
the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to
such shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holders holding Warrants to purchase at least a majority of the Common
Shares underlying the then outstanding Warrants. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and
power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such
Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section&nbsp;3, the number of Common Shares deemed to be issued and outstanding as of a given date shall
be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">f)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall
promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a Distribution on the Common Shares, (B)&nbsp;the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C)&nbsp;the Company shall authorize
the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital stock of
any class or of any rights, (D)&nbsp;the approval of any shareholders of the Company shall be required in connection with any
reclassification of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken as a whole)
is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Shares are converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause
to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the
Warrant Register of the Company, at least 10 Trading Days prior to the applicable record or effective date hereinafter specified,
a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it
is expected that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash
or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that
the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such
notice with the Commission pursuant to a Current Report on Form&nbsp;6-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may
otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;4</U>.</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transfer
of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>Transferability</U>.
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making
of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this
Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender
this Warrant to the Company within three (3)&nbsp;Trading Days of the date on which the Holder delivers an assignment form to
the Company assigning this Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new
holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed
by the Holder or its agent or attorney. Subject to compliance with Section&nbsp;4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable
pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;5</U>.</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#9;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except
as expressly set forth in Section&nbsp;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section&nbsp;2(c)&nbsp;or to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and Section&nbsp;2(d)(iv)&nbsp;herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&#9;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of an affidavit of loss
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating
to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which,
in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or
stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated
as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding
Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company
covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this
Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Shares may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of
Warrant Shares underlying such Warrants) which are not beneficially owned by Affiliates of the Company, the Company shall not
by any action, including, without limitation, amending its articles of incorporation or through any reorganization, transfer of
assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid
the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying
out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder
as set forth in this Warrant against impairment; provided, however, that no modification of the terms (including but not limited
to the adjustments described in Section&nbsp;3) upon which the Warrants are exercisable or the rights of holders of Warrants to
receive liquidated damages or other payments in cash from the Company or reducing the percentage required for consent to modification
of this Warrant may be made without the consent of the Holder of each outstanding Warrant affected thereby. Without limiting the
generality of the foregoing, the Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise
of this Warrant and (iii)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from
any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations
under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law; Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner
permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the
prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys' fees
and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim
under the federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">f)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder
does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">g)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by
the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">h)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized
overnight courier service, addressed to the Company, at 128 Vouliagmenis Avenue, 3rd Floor, 166 74 Glyfada, Attica, Greece, Attention:
Chief Executive Officer, facsimile number +30 210 9608359, E-mail: a.g.feidakis@globusmaritime.gr, or such other facsimile number,
email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or
sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e- mail address or
address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall
be deemed given and effective on the earliest of (i)&nbsp;the time of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section&nbsp;prior to 5:30 p.m.&nbsp;(New
York City time) on a Trading Day, (ii)&nbsp;the next Trading Day after the time of transmission, if such notice or communication
is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section&nbsp;on a day
that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (iii)&nbsp;the second Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&nbsp;upon actual receipt
by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">j)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">k)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">l)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendment;
Waiver</U>. This Warrant may be modified or amended (or the provisions hereof waived with the written consent of the Company,
on the one hand, and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">m)</FONT>&#9;&nbsp;&nbsp;&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">n)</FONT>&#9;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)<BR STYLE="clear: both"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>GLOBUS
    MARITIME LIMITED</B></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Title:</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To: GLOBUS MARITIME
LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(1)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(2)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"> <FONT STYLE="font-family: Wingdings">&#168;</FONT>
wire transfer in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT> if permitted, the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(3)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered
to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 18%">Name of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 82%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; width: 35%">Signature of Authorized Signatory of Investing Entity:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; width: 65%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Name of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 19%">Title of Authorized Signatory:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 79%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">Date:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 97%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">Dated:
_______________ __, ______</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: left; padding-bottom: 1pt">Holder&rsquo;s Signature:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: left; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; width: 12%">Holder&rsquo;s Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; width: 38%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; width: 50%">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 81; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>tm216516d1_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON SHARE PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GLOBUS MARITIME LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Warrant Shares: [_______]</FONT></TD>
    <TD STYLE="width: 49%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 10pt">Issue Date: February&nbsp;[&bull;],
    2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This COMMON SHARE
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on
or after the Issue Date and on or prior to 5:00 p.m.&nbsp;(New York City time) on August&nbsp;[&bull;], 2026 (the &ldquo;<U>Termination
Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Globus Maritime Limited, a Marshall Islands corporation
(the &ldquo;<U>Company</U>&rdquo;), up to ______ Common Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;).&nbsp;
The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">Section&nbsp;1.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Definitions</U>.&nbsp;
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section&nbsp;1.
Capitalized terms not otherwise defined in this Warrant shall have the meanings assigned to such terms in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bid Price</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based on a Trading
Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the
Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Share so reported, or (d)&nbsp;in all other cases, the fair market
value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest
of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed
to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations at the direction
of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commission</B>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Shares</B>&rdquo;
means the common shares of the Company, par value $0.004 per share, and any other class of securities into which such securities
may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Share
Equivalents</B>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive,
Common Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Purchase
Agreement</B>&rdquo; means that certain Securities Purchase Agreement, dated February&nbsp;12, 2021, among the Company and the
Holders signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where applicable, also include
any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the Common Shares are traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market
or the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transfer
Agent</B>&rdquo; means Computershare Inc. or its affiliate with offices located at 150 Royall Street, Canton, MA 02021, and any
successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the
nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX
and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d)&nbsp;in all other cases,
the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Warrants</B>&rdquo;
means this Warrant and other Common Share Purchase Warrants issued by the Company on or around the Issue Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">Section&nbsp;2.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
of Warrant</U>.&nbsp; Subject to the provisions of Section&nbsp;2(e)&nbsp;herein, exercise of the purchase rights represented
by this Warrant may be made, in whole or in part, at any time or times on or after the Issue Date and on or before the Termination
Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise
in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).&nbsp; Within the earlier of (i)&nbsp;two (2)&nbsp;Trading
Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i)&nbsp;herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in
the applicable Notice of Exercise by wire transfer in United States dollars unless the cashless exercise procedure specified in
Section&nbsp;2(c)&nbsp;below is specified in the applicable Notice of Exercise.<B>&nbsp;</B>No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be
required.&nbsp; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall lower the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&nbsp; The Holder and the
Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall
deliver any objection to any Notice of Exercise within one (1)&nbsp;Business Day of receipt of such notice.&nbsp; <B>The Holder
and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any
given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>.&nbsp; The exercise price per Common Share under this Warrant shall be $6.25, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>.&nbsp; If at any time after the Issue Date, there is no effective registration statement registering, or the prospectus
contained therein is not available for, the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised,
in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A)&nbsp;= as applicable: (i)&nbsp;the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)&nbsp;both
executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a day that is not a Trading Day or (2)&nbsp;both executed
and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule&nbsp;600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&nbsp;at
the option of the Holder, either (y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice
of Exercise or (z)&nbsp;the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. as of
the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours
after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;2(a)&nbsp;hereof or (iii)&nbsp;the
VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice
of Exercise is both executed and delivered pursuant to Section&nbsp;2(a)&nbsp;hereof after the close of &ldquo;regular trading
hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(B)&nbsp;= the Exercise Price of this
Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(X)&nbsp;= the number of Warrant Shares
that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means
of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Mechanics
of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
of Warrant Shares Upon Exercise</U>.&nbsp; The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then
a participant in such system and either (A)&nbsp;there is an effective registration statement permitting the issuance of the Warrant
Shares to or resale of the Warrant Shares by the Holder or (B)&nbsp;this Warrant is being exercised via cashless exercise, and
otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or
its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
by the Holder in the Notice of Exercise by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading Days after the delivery
to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of
a cashless exercise) is received by the Company one (1)&nbsp;Trading Day prior to such second Trading Day after the delivery of
the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading Day after delivery of the aggregate Exercise Price to the Company and (iii)&nbsp;the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise,
provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise) is received by the Company
one (1)&nbsp;Trading Day prior to such number of Trading Days comprising the Standard Settlement Period after the delivery of
the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise,
the Holder shall be deemed, solely for purposes of Regulation SHO of the Securities Act, to have become the holder of record of
such Warrant Shares, irrespective of the date of delivery of such Warrant Shares, provided that payment of the aggregate Exercise
Price (other than in the case of a cashless exercise) is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and
(ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If
the Company fails for any reason (other than failure of the Holder to timely deliver the aggregate Exercise Price, unless the
Warrant is validly exercised by means of a cashless exercise) to deliver or cause the delivery to the Holder the Warrant Shares
subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated
damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares
on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in
the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with
respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Delivery
of New Warrants Upon Exercise</U>.&nbsp; If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which
new Warrant shall in all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">iii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Rescission
Rights</U>.&nbsp; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&nbsp;2(d)(i)&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">iv.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>.&nbsp; In addition to any other rights available to the
Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section&nbsp;2(d)(i)&nbsp;above pursuant to an exercise on or before the Warrant Share Delivery Date (other than as a result
of failure of the Holder to timely deliver the aggregate Exercise Price, unless the Warrant is validly exercised by means of a
cashless exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or
otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the
Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the
Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase price
(including brokerage commissions, if any) for the Common Shares so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at
issue times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the
option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that
would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&nbsp; For example,
if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted
exercise of this Warrant to purchase Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000,
under clause (A)&nbsp;of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder
shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request
of the Company, evidence of the amount of such loss.&nbsp; Nothing herein shall limit a Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver Common Shares upon exercise of the Warrant as
required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">v.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Fractional Shares or Scrip</U>.&nbsp; No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall round down to the nearest whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">vi.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Charges,
Taxes and Expenses</U>.&nbsp; Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form&nbsp;attached hereto
duly executed by the Holder (along with a medallion guarantee if requested by the Company) and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&nbsp; The Company shall pay
all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">vii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Closing
of Books</U>.&nbsp; The Company will not close its shareholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s
Exercise Limitations</U>.&nbsp; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such
issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which such determination is being
made, but shall exclude the number of Common Shares which would be issuable upon (i)&nbsp;exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other&nbsp; Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained
herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; For purposes of this Section&nbsp;2(e),
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith.&nbsp;&nbsp; To the extent that the limitation contained in this Section&nbsp;2(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and
of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination, and a submission of a Notice of Exercise shall
be deemed a representation and warranty by the Holder of the foregoing determination.&nbsp;&nbsp; In addition, a determination
as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act
and the rules&nbsp;and regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of
outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A)&nbsp;the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement
by the Company or (C)&nbsp;a more recent written notice by the Company or the Transfer Agent setting forth the number of Common
Shares outstanding.&nbsp; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally
and in writing to the Holder the number of Common Shares then outstanding.&nbsp; In any case, the number of outstanding Common
Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant,
by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was
reported.&nbsp; The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by the Holder prior
to the issuance of any Warrants, 9.99%) of the number of the Common Shares outstanding immediately after giving effect to the
issuance of Common Shares issuable upon exercise of this Warrant.&nbsp; The Holder, upon notice to the Company, may increase or
decrease the Beneficial Ownership Limitation provisions of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common
Shares upon exercise of this Warrant held by the Holder and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply.
Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered
to the Company.&nbsp; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section&nbsp;2(e)&nbsp;to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">Section&nbsp;3.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common
Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant),
(ii)&nbsp;subdivides outstanding Common Shares into a larger number of shares, (iii)&nbsp;combines (including by way of reverse
stock split) outstanding Common Shares into a smaller number of shares or (iv)&nbsp;issues by reclassification of the Common Shares
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and
of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares
issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged.&nbsp; Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after
the record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsequent
Rights Offerings</U>.&nbsp; In addition to any adjustments pursuant to Section&nbsp;3(a)&nbsp;above, if at any time the Company
grants, issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled
to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired
if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a
record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the
Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right
to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase
Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Pro
Rata Distributions</U>.&nbsp; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of
a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) except to
the extent an adjustment was already made pursuant to Section&nbsp;3(a)&nbsp;(a &ldquo;<U>Distribution</U>&rdquo;), then the Exercise
Price shall be decreased, effective immediately after the effective date of such Distribution, by the amount of cash and/or the
fair market value (as determined by the Company&rsquo;s Board of Directors, in good faith) of any securities or other assets paid
on each Common Share in respect of such Distribution in order that subsequent thereto upon exercise of the Warrants the Holder
may obtain the equivalent benefit of such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii)&nbsp;the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and
has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv)&nbsp;the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any
compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a stock or
share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder
shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to
the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e)&nbsp;on
the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as
a result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant).&nbsp;
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration.&nbsp; If holders of Common Shares are given any choice as to
the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as
to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&nbsp; Notwithstanding
anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall,
at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining
unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction.&nbsp; &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg, L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) determined as of the day of consummation of the applicable Fundamental
Transaction for pricing purposes and reflecting (A)&nbsp;a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction
and the Termination Date, (B)&nbsp;an expected volatility equal to the greater of 100% and the 30 day volatility obtained from
the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following
the public announcement of the applicable contemplated Fundamental Transaction, (C)&nbsp;the underlying price per share used in
such calculation shall be the greater of (i)&nbsp;the sum of the price per share being offered in cash, if any, plus the value
of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)&nbsp;the greater of (x)&nbsp;the
last VWAP immediately prior to the public announcement of such contemplated Fundamental Transaction and (y)&nbsp;the last VWAP
immediately prior to the consummation of such Fundamental Transaction, (D)&nbsp;a remaining option time equal to the time between
the date of the public announcement of the applicable contemplated Fundamental Transaction and the Termination Date and (E)&nbsp;a
zero cost of borrow.&nbsp; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
within five Business Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction).
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions
of this Section&nbsp;3(d)&nbsp;pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holders holding Warrants to purchase at least a majority of the Common Shares underlying the then outstanding
Warrants (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to
the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which
applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the Common
Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the
consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holders holding
Warrants to purchase at least a majority of the Common Shares underlying the then outstanding Warrants. Upon the occurrence of
any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date
of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall refer instead to
the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section&nbsp;3, the number of Common Shares deemed to be issued and outstanding as of a given date shall
be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall
promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a Distribution on the Common Shares, (B)&nbsp;the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C)&nbsp;the Company shall authorize
the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital stock of
any class or of any rights, (D)&nbsp;the approval of any shareholders of the Company shall be required in connection with any
reclassification of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken as a whole)
is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Shares are converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary
or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause
to be delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the
Warrant Register of the Company, at least 10 Trading Days prior to the applicable record or effective date hereinafter specified,
a notice stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it
is expected that holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash
or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that
the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate
action required to be specified in such notice.&nbsp; To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such
notice with the Commission pursuant to a Current Report on Form&nbsp;6-K. The Holder shall remain entitled to exercise this Warrant
during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may
otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Voluntary
Adjustment by Company</U>.&nbsp; Subject to the rules&nbsp;and regulations of the Trading Market, the Company may at any time
during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate
by the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">Section&nbsp;4.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Transfer
of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.&nbsp;
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney (along with a medallion guarantee if requested by the Company) and
funds sufficient to pay any transfer taxes payable upon the making of such transfer.&nbsp; Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&nbsp; Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3)&nbsp;Trading
Days of the date on which the Holder delivers an assignment form (along with a medallion guarantee if requested by the Company)
to the Company assigning this Warrant in full.&nbsp; The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed
by the Holder or its agent or attorney.&nbsp; Subject to compliance with Section&nbsp;4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time.&nbsp; The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt; color: #010000">Section&nbsp;5.</FONT><FONT STYLE="color: #010000">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>.&nbsp; This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i),
except as expressly set forth in Section&nbsp;3.&nbsp; Without limiting any rights of a Holder to receive Warrant Shares on a
 &ldquo;cashless exercise&rdquo; pursuant to Section&nbsp;2(c)&nbsp;or to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and
Section&nbsp;2(d)(iv)&nbsp;herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of an affidavit of loss
reasonably satisfactory to the Company evidencing the loss, theft, destruction or mutilation of this Warrant or any stock certificate
relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to
it (which, in the case of the Warrant, shall not include the posting of a bond), and upon surrender and cancellation of such Warrant
or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated
as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>.&nbsp; If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next
succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&nbsp;
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&nbsp; The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be
listed.&nbsp; The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in
accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges
created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant
Shares underlying such Warrants) which are not beneficially owned by Affiliates of the Company, the Company shall not by any action,
including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
impairment; provided, however, that no modification of the terms (including but not limited to the adjustments described in Section&nbsp;3)
upon which the Warrants are exercisable or the rights of holders of Warrants to receive liquidated damages or other payments in
cash from the Company or reducing the percentage required for consent to modification of this Warrant may be made without the
consent of the Holder of each outstanding Warrant affected thereby.&nbsp; Without limiting the generality of the foregoing, the
Company will (i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately
prior to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use
commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise
Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any
public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>.&nbsp; All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Jurisdiction;
Agent for Process</U>. Each party agrees that all legal proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors,
officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York.&nbsp; Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner
permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the
prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding
the foregoing, nothing in this paragraph shall limit or restrict the federal district court and the state court in which a Holder
may bring a claim under the federal securities laws.&nbsp;The Company hereby irrevocably designates and appoints Watson Farley&nbsp;&amp;
Williams LLP, 250 West 55th Street, 31st Floor, New York, New York 10019 (the &ldquo;<U>Process Agent</U>&rdquo;) as its authorized
agent upon whom process may be served in any claim brought against the Company, it being understood that the designation and appointment
of the Process Agent as such authorized agent shall become effective immediately without any further action on the part of the
Company. The Company represents to each Purchaser that it has notified the Process Agent of such designation and appointment and
that the Process Agent has accepted the same.&nbsp; The Company hereby irrevocably authorizes and directs the Process Agent to
accept such service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Restrictions</U>.&nbsp;
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Nonwaiver
and Expenses</U>.&nbsp; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies.&nbsp; Without limiting
any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notices</U>.&nbsp;
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation,
any Notice of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized
overnight courier service, addressed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>If to the Company</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Globus Maritime Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">128 Vouliagmenis Avenue, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">166 74 Glyfada</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Athens, Greece</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tel: +30 210 960 8300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email: a.g.feidakis@globusmaritime.gr</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Facsimile: +30 210 9608359</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attn: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or such other facsimile number, email
address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications
or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or
sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e- mail address or
address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall
be deemed given and effective on the earliest of (a)&nbsp;the time of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or e-mail attachment at the email address set forth on the signature pages&nbsp;attached
hereto at or prior to 5:30 p.m.&nbsp;(New York City time) on a Trading Day, (b)&nbsp;the next Trading Day after the date of transmission,
if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address
as set forth on the signature pages&nbsp;attached hereto on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New
York City time) on any Trading Day, (c)&nbsp;the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d)&nbsp;upon actual receipt by the party to whom such notice is required to be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Limitation
of Liability</U>.&nbsp; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.&nbsp;
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant.&nbsp;The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and
not to assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>.&nbsp; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder.&nbsp; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of
this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">m)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Amendment</U>.&nbsp;
This Warrant may be modified or amended (or the provisions hereof waived) by the Holders holding Warrants to purchase at least
a majority of the Common Shares underlying the then outstanding Warrants; provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall also be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;n)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Severability</U>.&nbsp;
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Headings</U>.&nbsp;
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I></I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                          <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2"><B>GLOBUS MARITIME LIMITED</B></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 50%"></TD><TD STYLE="width: 3%">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%"></TD></TR>                                                                                                                                                                           <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">Name:</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">Title:</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">TO:</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">GLOBUS
MARITIME LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(1)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
required if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(2)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[&nbsp; ] wire transfer in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[&nbsp; ] if permitted, the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(3)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Warrant Shares
shall be delivered to the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; text-align: justify"><FONT STYLE="font-size: 10pt">DTC number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Account name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Account number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Name of Investing Entity:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Name of Authorized Signatory:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Title of Authorized</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD> Signatory:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 25%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 50%; text-align: right">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B></B></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">19</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute
this form and supply required information.&nbsp; Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Dated: _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature: _______________</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address: _______________</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>5
<FILENAME>tm216516d1_ex4-4.htm
<DESCRIPTION>EXHIBIT 4.4
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.4</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED COMMON SHARES PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>GLOBUS
MARITIME LIMITED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt">Warrant Shares: [_______]</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 0in; font-size: 10pt"><FONT STYLE="font-size: 10pt">Initial Exercise Date: February&nbsp;[&#9679;], 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS PRE-FUNDED COMMON
SHARES PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its assigns (the
 &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and <FONT>until
this Warrant is exercised in full</FONT> (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase
from Globus Maritime Limited, a Republic of the Marshall Islands corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ Common
Shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;. The purchase price of one Common Share under
this Warrant shall be equal to the Exercise Price, as defined in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;1</U>.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.
In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this Section&nbsp;1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule&nbsp;405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the
Common Shares are then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the
nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
(based on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp; if OTCQB or
OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date)
on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and
if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its
functions of reporting prices), the most recent bid price per share of the Common Share so reported, or (d)&nbsp;in all other cases,
the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the holders of a majority
in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be
paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to
be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations at the direction
of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks
in The City of New York generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Shares</U>&rdquo; means the common shares of the Company, par value $0.004 per share, and any other class of securities into which
such securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Share Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the Company&rsquo;s registration statement on Form&nbsp;F-3 (File No.&nbsp;333-240265).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company which is actively engaged in a trade or business, and shall, where applicable, also include
any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Shares are traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on
the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market,
or the New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&ldquo;<U>Transfer Agent</U>&rdquo;
means Computershare Inc. or its affiliate with offices located at 150 Royall Street, Canton, MA 02021, and any successor transfer
agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Shares are
then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest
preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp; if OTCQB or OTCQX
is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on
OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if
prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent bid price per Common Share so reported, or (d)&nbsp;in all other cases, the fair market value
of Common Share as determined by an independent appraiser selected in good faith by the holders of a majority in interest of the
Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means this Warrant and other Pre-Funded Common Share purchase warrants issued by the Company pursuant to the Registration Statement
on or around the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;2</U>.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Exercise
of Warrant</U>. Subject to the provisions of Section&nbsp;2(e)&nbsp;herein, exercise of the purchase rights represented by this
Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination
Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise
in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days
and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period (as defined in Section&nbsp;2(d)(i)&nbsp;herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in
the applicable Notice of Exercise by wire transfer in United States dollars unless the cashless exercise procedure specified in
Section&nbsp;2(c)&nbsp;below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the
Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the
Holder shall surrender this Warrant to the Company for cancellation within three (3)&nbsp;Trading Days of the date on which the
final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of
the total number of Warrant Shares available hereunder shall lower the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
Exercise within one (1)&nbsp;Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on
the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Exercise
Price</U>. <FONT>The aggregate exercise price of this Warrant, except for a nominal exercise price
of $0.01 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional
consideration (other than the nominal exercise price of $0.01 per Warrant Share) shall be required to be paid by the Holder to
any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion,
of such pre-paid aggregate exercise price under any circumstance or for any reason whatsoever, including in the event this Warrant
shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant
shall be $0.01, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>. If at the time of exercise hereof, there is no effective registration statement registering the Warrant Shares or
the prospectus contained therein is not available for issuance of the Warrant Shares to the Holder, then this Warrant may be exercised,
in whole or in part by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of
Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)=</TD><TD STYLE="text-align: justify"> as applicable: (i)&nbsp;the VWAP on the Trading Day
immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)&nbsp;both executed and delivered
pursuant to Section&nbsp;2(a)&nbsp;hereof on a day that is not a Trading Day or (2)&nbsp;both executed and delivered pursuant
to Section&nbsp;2(a)&nbsp;hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)(68)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii)&nbsp;at the option of the Holder, either
(y)&nbsp;the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z)&nbsp;the Bid Price
of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution
of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading
Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after the close of &ldquo;regular
trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;2(a)&nbsp;hereof or (iii)&nbsp;the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section&nbsp;2(a)&nbsp;hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(B)=</TD><TD STYLE="text-align: justify"> the Exercise Price of this Warrant, as adjusted hereunder;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(X)=</TD><TD STYLE="text-align: justify"> the number of Warrant Shares that would be issuable
upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather
than a cashless exercise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">If Warrant
Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section&nbsp;3(a)(9)&nbsp;of
the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company
agrees not to take any position contrary to this Section&nbsp;2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD STYLE="text-align: justify"><U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased
hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s
balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A)&nbsp;there is an effective registration statement permitting
the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B)&nbsp;this Warrant is being exercised
via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in
the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i)&nbsp;two (2)&nbsp;Trading
Days after the delivery to the Company of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other
than in the instance of a cashless exercise) is received by the Company one (1)&nbsp;Trading Day prior to such second Trading Day
after the delivery of the Notice of Exercise, (ii)&nbsp;one (1)&nbsp;Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii)&nbsp;the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise, provided that payment of the aggregate Exercise Price (other than in the instance of a cashless exercise)
is received by the Company one (1)&nbsp;Trading Day prior to such number of Trading Days comprising the Standard Settlement Period
after the delivery of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of
the Notice of Exercise, the Holder shall be deemed, solely for purposes of Regulation SHO of the Securities Act, to have become
the holder of record of such Warrant Shares, irrespective of the date of delivery of such Warrant Shares, provided that payment
of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i)&nbsp;two
(2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading Days comprising the Standard Settlement Period following delivery of
the Notice of Exercise. If the Company fails for any reason (other than failure of the Holder to timely deliver the aggregate Exercise
Price, unless the Warrant is validly exercised by means of a cashless exercise) to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages
and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the
date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after
such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares
are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with
respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise. Notwithstanding the foregoing, with
respect to any Notice(s)&nbsp;of Exercise delivered on or prior to 12:00 p.m.&nbsp;(New York City time) on the Initial Exercise
Date, which may be delivered at any time after the time of execution of the Securities Purchase Agreement, dated February&nbsp;12,
2021 among the Company and the purchasers party thereto, the Company agrees to deliver the Warrant Shares subject to such notice(s)&nbsp;by
4:00 p.m.&nbsp;(New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery
Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by the Company prior to 12:00 p.m.&nbsp;(New York City time) on the Initial Exercise Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">ii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Delivery of New Warrants
Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender
of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the
rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">iii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Rescission Rights</U>.
If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section&nbsp;2(d)(i)&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD STYLE="text-align: justify"><U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition
to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant
Shares in accordance with the provisions of Section&nbsp;2(d)(i)&nbsp;above pursuant to an exercise on or before the Warrant Share
Delivery Date (other than as a result of failure of the Holder to timely deliver the aggregate Exercise Price, unless the Warrant
is validly exercised by means of a cashless exercise), and if after such date the Holder is required by its broker to purchase
(in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Shares to deliver
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;),
then the Company shall (A)&nbsp;pay in cash to the Holder the amount, if any, by which (x)&nbsp;the Holder&rsquo;s total purchase
price (including brokerage commissions, if any) for the Common Shares so purchased exceeds (y)&nbsp;the amount obtained by multiplying
(1)&nbsp;the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at
issue times (2)&nbsp;the price at which the sell order giving rise to such purchase obligation was executed, and (B)&nbsp;at the
option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that
would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of this Warrant to purchase Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under
clause (A)&nbsp;of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall
provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the
Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available
to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with
respect to the Company&rsquo;s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the
terms hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">v.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>No Fractional Shares
or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant.
As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round
down to the nearest whole share.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD STYLE="text-align: justify"><U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to
the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of
which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in
such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are
to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the
Assignment Form&nbsp;attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment
of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required
for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">vii.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Closing of Books</U>.
The Company will not close its shareholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section&nbsp;2 or otherwise, to the extent that after giving effect to such issuance after
exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution
Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes
of the foregoing sentence, the number of Common Shares that are beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of Common Shares that are issuable upon exercise of this Warrant with respect to which such determination
is being made, but shall exclude the number of Common Shares which would be issuable upon (i)&nbsp;exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or non-converted portion of any other securities of the Company (including, without limitation,
any other Common Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein
beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&nbsp; For purposes of this Section&nbsp;2(e),
beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that
such calculation is in compliance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section&nbsp;2(e)&nbsp;applies,
the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the
Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of
which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination, and a submission of a Notice of Exercise shall be deemed
a representation and warranty by the Holder of the foregoing determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;and
regulations promulgated thereunder. For purposes of this Section&nbsp;2(e), in determining the number of outstanding Common Shares,
a Holder may rely on the number of outstanding Common Shares as reflected in (A)&nbsp;the Company&rsquo;s most recent periodic
or annual report filed with the Commission, as the case may be, (B)&nbsp;a more recent public announcement by the Company or (C)&nbsp;a
more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&nbsp; Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the
number of Common Shares then outstanding.&nbsp; In any case, the number of outstanding Common Shares shall be determined after
giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding Common Shares was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by the Holder prior to the issuance of any Warrants, 9.99%) of
the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise
of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section&nbsp;2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the Common
Shares outstanding immediately after giving effect to the issuance of Common Shares upon exercise of this Warrant held by the Holder
and the provisions of this Section&nbsp;2(e)&nbsp;shall continue to apply. Any increase in the Beneficial Ownership Limitation
will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;2(e)&nbsp;to
correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation
herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations
contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;3</U>.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i)&nbsp;pays a stock dividend or otherwise
makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common
Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this Warrant),
(ii)&nbsp;subdivides outstanding Common Shares into a larger number of shares, (iii)&nbsp;combines (including by way of reverse
stock split) outstanding Common Shares into a smaller number of shares, or (iv)&nbsp;issues by reclassification of the Common Shares
any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding immediately before such event and
of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares
issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section&nbsp;3(a)&nbsp;shall become effective immediately after the
record date for the determination of shareholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&#8239;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section&nbsp;3(a)&nbsp;above, if at any time the Company grants,
issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the
record holders of any class of Common Shares (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder
had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken
for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders
of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership
of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in
abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) except to the extent an
adjustment was already made pursuant to Section&nbsp;3(a)&nbsp;(a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance
of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that
the Holder would have participated therein if the Holder had held the number of Common Shares acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which
the record holders of Common Shares are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>,
that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any Common Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held
in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i)&nbsp;the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii)&nbsp;the Company (and
all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;any, direct
or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and
has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv)&nbsp;the Company, directly or indirectly,
in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any
compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities,
cash or property, or (v)&nbsp;the Company, directly or indirectly, in one or more related transactions consummates a stock or share
purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than
50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business
combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder
shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the
occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section&nbsp;2(e)&nbsp;on
the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a
result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section&nbsp;2(e)&nbsp;on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative
value of any different components of the Alternate Consideration. If holders of Common Shares are given any choice as to the securities,
cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any
successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;)
to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section&nbsp;3(d)&nbsp;pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holders holding Warrants
to purchase at least a majority of the Common Shares underlying the then outstanding Warrants (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is
exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to
the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which
is reasonably satisfactory in form and substance to the Holders holding Warrants to purchase at least a majority of the Common
Shares underlying the then outstanding Warrants. Upon the occurrence of any such Fundamental Transaction, the Successor Entity
shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this
Warrant referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor
Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&nbsp;3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
be. For purposes of this Section&nbsp;3, the number of Common Shares deemed to be issued and outstanding as of a given date shall
be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">f)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section&nbsp;3, the Company shall
promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting
adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">ii.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
to Allow Exercise by Holder</U>. If (A)&nbsp;the Company shall declare a Distribution on the Common Shares, (B)&nbsp;the Company
shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C)&nbsp;the Company shall authorize
the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital stock of
any class or of any rights, (D)&nbsp;the approval of any shareholders of the Company shall be required in connection with any reclassification
of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken as a whole) is a party, any
sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common
Shares are converted into other securities, cash or property, or (E)&nbsp;the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 10 Trading Days prior to the applicable record or effective date hereinafter specified, a notice stating
(x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver
such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form&nbsp;6-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;4</U>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transferability</U>.
This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office
of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of
such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants
in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this
Warrant to the Company within three (3)&nbsp;Trading Days of the date on which the Holder delivers an assignment form to the Company
assigning this Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for
the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed
by the Holder or its agent or attorney. Subject to compliance with Section&nbsp;4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable
pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered
Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and
for all other purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><U>Section&nbsp;5</U>.</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Rights as Shareholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a shareholder of the Company prior to the exercise hereof as set forth in Section&nbsp;2(d)(i), except
as expressly set forth in Section&nbsp;3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless
exercise&rdquo; pursuant to Section&nbsp;2(c)&nbsp;or to receive cash payments pursuant to Section&nbsp;2(d)(i)&nbsp;and Section&nbsp;2(d)(iv)&nbsp;herein,
in no event shall the Company be required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">b)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of an affidavit of loss
reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock
certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Saturdays,
Sundays, Holidays,&nbsp;etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding
Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt"><U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient
number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged
with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by
the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such
issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and
to the extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant
Shares underlying such Warrants) which are not beneficially owned by Affiliates of the Company, the Company shall not by any action,
including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
impairment; provided, however, that no modification of the terms (including but not limited to the adjustments described in Section&nbsp;3)
upon which the Warrants are exercisable or the rights of holders of Warrants to receive liquidated damages or other payments in
cash from the Company or reducing the percentage required for consent to modification of this Warrant may be made without the consent
of the Holder of each outstanding Warrant affected thereby. Without limiting the generality of the foregoing, the Company will
(i)&nbsp;not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii)&nbsp;take all such action as may be necessary or appropriate in order that the Company may
validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii)&nbsp;use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction
thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking
any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Law; Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the interpretations, enforcement
and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal
courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
this Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient service of process and
notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing
party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys' fees and other
costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. Notwithstanding the
foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under
the federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate
as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any
material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by
the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at 128 Vouliagmenis Avenue, 3rd Floor, 166 74 Glyfada, Attica, Greece, Attention: Chief Executive Officer, facsimile number +30 210 9608359, E-mail: a.g.feidakis@globusmaritime.gr, or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e- mail address or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i)&nbsp;the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section&nbsp;prior to 5:30 p.m.&nbsp;(New York City time) on a Trading Day, (ii)&nbsp;the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section&nbsp;on a day that is not a Trading Day or later than 5:30 p.m.&nbsp;(New York City time) on any Trading Day, (iii)&nbsp;the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&nbsp;upon actual receipt by the party to whom such notice is required to be given.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase
Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder
for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled
to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert
the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and
shall be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment;
Waiver</U>. This Warrant may be modified or amended (or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Page&nbsp;Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the
Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>GLOBUS MARITIME LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; width: 49%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; width: 49%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">To: GLOBUS MARITIME
LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(1)</FONT>&#8239;<FONT STYLE="font-size: 10pt">The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(2)&#8239;</FONT>Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">[ ] wire transfer in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">[ ] if permitted, the cancellation
of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this
Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth
in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(3)&#8239;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="border-bottom: Black 1pt solid; width: 3.75in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to
the following DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="border-bottom: Black 1pt solid; width: 3.75in; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR>     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE OF HOLDER]</FONT></TD>
    <TD STYLE="width: 80%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    </TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 0in; text-align: justify; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity</I>: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 62%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 0in; text-align: justify; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 78%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 0in; text-align: justify; width: 22%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 78%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 0in; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 95%">&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>(To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant
and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Email Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0in">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
</FONT>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;,<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:</FONT>&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>tm216516d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm216516d1_ex8-1img001.jpg" ALT="" STYLE="height: 135pt; width: 610.5pt">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Globus Maritime Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">128 Vouliagmenis Avenue, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">166 74 Glyfada, Greece</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our Reference 25810.50008/US/80779743v3</FONT> &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February&nbsp;17, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Globus Maritime Limited: Exhibit&nbsp;5.1
Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to Globus Maritime
Limited, a Marshall Islands corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with the Company&rsquo;s offering of
(a)&nbsp;an aggregate of 3,850,000 shares of common stock of the Company, par value $0.004 per share (each, a &ldquo;<B>Common
Share</B>&rdquo;) of the Company (the &ldquo;<B>Issued Shares</B>&rdquo;), (b)&nbsp;pre-funded warrants (the &ldquo;<B>Pre-Funded
Warrants</B>&rdquo;) to purchase an aggregate of up to 950,000 Common Shares (collectively, the &ldquo;<B>Pre-Funded Warrant Shares</B>&rdquo;),
and (c)&nbsp;Warrants to purchase 4,800,000 Common Shares (the &ldquo;<B>Warrants</B>&rdquo;, and the Common Shares issuable upon
exercise thereof, the &ldquo;<B>Warrant Shares</B>&rdquo;; the Issued Shares, Pre-Funded Warrants, Pre-Funded Warrant Shares, Warrants,
and Warrant Shares, collectively, the &ldquo;<B>Securities</B>&rdquo;). The Company registered the issuance of the Securities on
Form&nbsp;F-3 (File No.&nbsp;333-240265) filed with the U.S. Securities and Exchange Commission on July&nbsp;31, 2020 and declared
effective on August&nbsp;12, 2020 (as amended to date and as may be further amended and supplemented, the &ldquo;<B>Registration
Statement</B>&rdquo;), including the base prospectus dated August&nbsp;12, 2020 (the &ldquo;<B>Base Prospectus</B>&rdquo;) and
the prospectus supplement dated February&nbsp;12, 2021 (as amended to date and as may be further amended and supplemented, the
 &ldquo;<B>Prospectus Supplement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As such counsel, we have examined originals
or copies (certified or otherwise identified to our satisfaction) of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Registration Statement, the Base Prospectus, and the Prospectus Supplement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) dated February&nbsp;12,
2021 made between the Company and the purchasers named therein relating to the issuance and sale of the Securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex5-1img002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT>Page&nbsp;2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex5-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Pre-Funded Warrants and Warrants;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the Company&rsquo;s amended and restated articles of incorporation and amended and restated bylaws;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">such other papers, documents, agreements, certificates of public officials and certificates of
representatives of the Company as we have deemed relevant and necessary as the basis for the opinions hereafter expressed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In such examination, we have assumed (a)&nbsp;the
legal competence or capacity of persons or entities (other than the Company) to complete the execution of documents, (b)&nbsp;the
genuineness of all signatures and the authenticity of all documents submitted to us as originals, (c)&nbsp;the conformity to original
documents of all documents submitted to us as conformed or photostatic copies, (d)&nbsp;that the documents reviewed by us in connection
with the rendering of the opinions set forth herein are true, correct and complete, and (e)&nbsp;the truthfulness of each statement
as to all factual matters contained in any document or certificate encompassed within the due diligence review undertaken by us.
As to matters of fact material to this opinion that have not been independently established, we have relied upon the representations
and certificates of officers or representatives of the Company and of public officials, in each case as we have deemed relevant
and appropriate. We have not independently verified the facts so relied on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In rendering this opinion, we have also
assumed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">that the issuance and sale of each of the Securities complies in all respects with the terms, conditions,
and restrictions set forth in the Base Prospectus and the Prospectus Supplement and all of the instruments and other documents
relating thereto or executed in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">that the Purchase Agreement will have been duly and validly authorized by the parties thereto (other
than the Company), and executed and delivered by the parties thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the validity and enforceability of the Purchase Agreement against the parties thereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the Company will, at the time of any issuance of Pre-Funded Warrant Shares or Warrant Shares, have
a sufficient number of authorized but unissued shares of common stock pursuant to its Articles to so issue such shares, after taking
into account any shares reserved for issuance; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">at or prior to the time of the delivery of any of the Pre-Funded Warrant Shares or Warrant Shares,
there will not have occurred any change in the law or the facts affecting the validity thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is limited to Marshall
Islands law and is as of the date hereof. We expressly disclaim any responsibility to advise of any development or circumstance
of any kind, including any change of law or fact that may occur after the date of this opinion letter that might affect the opinion
expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the foregoing and having regard
to legal considerations which we deem relevant, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">The Securities have been duly authorized by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex5-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">The Issued Shares, when issued upon full receipt of payment therefor in accordance with the terms
of the Articles and Bylaws, the Registration Statement, the Base Prospectus, and the Prospectus Supplement, will be validly issued,
fully paid, and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Assuming each of the Pre-Funded Warrants is issued and delivered as contemplated in the Purchase
Agreement, the Registration Statement, the Base Prospectus, and the Prospectus Supplement, the relevant Pre-Funded Warrant Shares,
when issued and delivered after full receipt of payment therefor upon the exercise of such Pre-Funded Warrants in accordance with
their respective terms, will be validly issued, fully paid and non-assessable. Assuming each of the Warrants is issued and delivered
as contemplated in the Purchase Agreement, the Registration Statement, the Base Prospectus, and the Prospectus Supplement, the
relevant Warrant Shares, when issued and delivered after full receipt of payment therefor upon the exercise of such Warrants in
accordance with their respective terms, will be validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">When the Pre-Funded Warrants and Warrants are issued and delivered as contemplated in the Purchase
Agreement, the Registration Statement, the Base Prospectus, and the Prospectus Supplement, the Pre-Funded Warrants and Warrants
will constitute valid and legally binding obligations of the Company in accordance with their terms, except as the enforcement
thereof (i)&nbsp;may be limited by any applicable bankruptcy, insolvency, reorganization, fraudulent conveyance, fraudulent transfer,
fraudulent obligation, moratorium or other similar laws affecting generally the enforceability of creditors&rsquo; rights and remedies
or the collection of debtor&rsquo;s obligations from time to time in effect, and (ii)&nbsp;is subject to general principles of
equity, regardless of whether such enforceability is considered in a proceeding in equity or at law, including the application
of principles of good faith, fair dealing, course of dealing, course of performance, commercial reasonableness, materiality, unconscionability
and conflict with public policy and other similar principles, or other law relating to or affecting creditors&rsquo; rights generally
and general principles of equity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the filing of this opinion
as an exhibit to a Current Report on Form&nbsp;6-K, the discussion of this opinion in the Registration Statement and the Prospectus
Supplement, and the references to our firm in the Base Prospectus and the Prospectus Supplement. In giving this consent, we do
not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act of
1933, as amended, and the rules&nbsp;and regulations thereunder (the &ldquo;<B>Securities Act</B>&rdquo;), nor do we admit that
we are experts with respect to any part of the Registration Statement within the meaning of the term &ldquo;expert&rdquo; as used
in the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Watson Farley&nbsp;&amp; Williams LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Watson Farley&nbsp;&amp; Williams LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>7
<FILENAME>tm216516d1_ex8-1.htm
<DESCRIPTION>EXHIBIT 8.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 8.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="tm216516d1_ex8-1img001.jpg" ALT="" STYLE="height: 135pt; width: 610.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Globus Maritime Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">128 Vouliagmenis Avenue, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">166 74 Glyfada, Greece</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Our Reference 25810.50008/US/80773255v1</FONT> &nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">February&nbsp;17<FONT STYLE="font-family: Times New Roman, Times, Serif">,
2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Globus Maritime Limited - Exhibit&nbsp;8.1
Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To Whom It May&nbsp;Concern:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to Globus Maritime
Limited, a Marshall Islands corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with the Company&rsquo;s offering of
shares of common stock of the Company, par value $0.004 per share (each, a &ldquo;<B>Common Share</B>&rdquo;) of the Company, pre-funded
warrants to purchase one Common Share each, and warrants to purchase one Common Share each (together, &ldquo;<B>Warrants</B>&rdquo;),
all of which were registered on Form&nbsp;F-3 (File No.&nbsp;333-240265) filed with the U.S. Securities and Exchange Commission
on July&nbsp;31, 2020 and declared effective on August&nbsp;12, 2020 (as amended to date and as may be further amended and supplemented,
the &ldquo;<B>Registration Statement</B>&rdquo;), the base prospectus dated August&nbsp;12, 2020 (the &ldquo;<B>Base Prospectus</B>&rdquo;)
and the prospectus supplement dated February&nbsp;12, 2021 (as amended to date and as may be further amended and supplemented,
the &ldquo;<B>Prospectus Supplement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In rendering this opinion, we have examined
originals or copies (certified or otherwise identified to our satisfaction) of the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the Registration Statement, the Base Prospectus, and the Prospectus Supplement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">such other papers, documents, agreements, certificates of public officials and certificates of
representatives of the Company, as we have deemed relevant and necessary as the basis for the opinions hereafter expressed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In such examination, we have assumed (a)&nbsp;the
legal capacity of each natural person, (b)&nbsp;the genuineness of all signatures and the authenticity of all documents submitted
to us as originals, (c)&nbsp;the conformity to original documents of all documents submitted to us as conformed or photostatic
copies, (d)&nbsp;that the documents reviewed by us in connection with the rendering of the opinion set forth herein are true, correct
and complete and (e)&nbsp;the truthfulness of each statement as to all factual matters contained in any document or certificate
encompassed within the due diligence review undertaken by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex8-1img002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT>Page&nbsp;2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex8-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As to matters of fact material to this
opinion that have not been independently established, we have relied upon the representations and certificates of public officials,
directors and officers of the Company and others, in each case as we have deemed relevant and appropriate. We have not independently
verified the facts so relied on.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed the discussion set forth
in the Prospectus Supplement under the caption &ldquo;Tax Considerations&mdash;United States Tax Considerations&mdash;Allocation
of Purchase Price&rdquo;; &ldquo;&mdash;Tax Treatment of the Pre-Funded Warrants&ldquo;; and &ldquo;&mdash;United States Federal
Income Taxation of United States Holders&rdquo;. Based on the representations, covenants, assumptions, conditions and qualifications
described in such sections, and taking into account the fact that the discussions set forth in such sections do not purport to
discuss all possible U.S. federal income tax consequences of the ownership and disposition of the Common Shares, and of the ownership,
exercise and disposition of the Warrants, and subject to the qualifications, limitations and assumptions set forth herein, we confirm
that the discussions set forth in such sections, to the extent they constitute summaries of law or legal conclusions, unless otherwise
noted, constitute our opinion with respect to the material U.S. federal income tax consequences of the ownership and disposition
of the Common Shares, and of the ownership, exercise and disposition of the Warrants as of the date of the Prospectus Supplement,
and accurately state our views as to the tax matters discussed therein (except for the representations and statements of fact of
the Company included under such caption, as to which we express no opinion). We express no opinion as to any U.S. federal income
tax consequences other than the opinion set forth above. Except as set forth in the paragraph below concerning Marshall Islands
tax considerations, we express no opinion with respect to tax consequences under any state, local, or non-U.S. tax law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have reviewed the discussion set forth
in the Prospectus Supplement under the caption &ldquo;Tax Considerations&mdash;Marshall Islands Tax Considerations&rdquo;. Based
on the facts as set forth in the Registration Statement and the Prospectus Supplement, and having regard to legal considerations
which we deem relevant, and subject to the qualifications, limitations and assumptions set forth herein, we confirm that the statements
in such discussion, to the extent they constitute legal conclusions, unless otherwise noted, are the opinion of Watson Farley&nbsp;&amp;
Williams LLP with respect to Marshall Islands tax consequences as of the date of the Prospectus Supplement (except for the representations
and statements of fact of the Company included under such caption, as to which we express no opinion).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our opinions and the tax discussion as
set forth in the Prospectus Supplement are based on the current provisions of the Internal Revenue Code of 1986, as amended, the
Treasury Regulations promulgated thereunder, published pronouncements of the Internal Revenue Service which may be cited or used
as precedents and case law, and the law of the Republic of the Marshall Islands as in effect on the date hereof, any of which may
be changed at any time with retroactive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion is expressed as of the date
hereof, and we are under no obligation to supplement or revise our opinion to reflect any legal developments or factual matters
arising subsequent to the date hereof or the impact of any information, document, certificate, record, statement, representation,
covenant, or assumption relied upon herein that becomes incorrect or untrue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page&nbsp;3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm216516d1_ex8-1img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the filing of this opinion
as an exhibit to a Current Report on Form&nbsp;6-K, the discussion of this opinion in the Registration Statement and the Prospectus
Supplement, and to the references to our firm in the Registration Statement, the Base Prospectus, and the Prospectus Supplement.
In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7
of the Securities Act of 1933, or the rules&nbsp;and regulations promulgated thereunder, nor do we admit that we are experts with
respect to any part of the Registration Statement within the meaning of the term &ldquo;expert&rdquo; as used in the Securities
Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Watson Farley&nbsp;&amp; Williams LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">/s/ Watson Farley&nbsp;&amp; Williams LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>tm216516d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit&#8239;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="tm216516d1_ex99-1img001.jpg" ALT="" STYLE="height: 105px; width: 468px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Globus Maritime Limited Announces Pricing
of $30.0 Million Registered Direct<BR>
 Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>February&nbsp;12, 2021 - Glyfada, Greece</B>
- Globus Maritime Limited (the &ldquo;Company&rdquo; or &ldquo;Globus&rdquo;) (NASDAQ: GLBS) announced today that it has entered
into a securities purchase agreement with certain unaffiliated institutional investors to issue 4.8 million of its common shares
(or pre-funded warrants in lieu thereof) and purchase warrants to purchase up to an aggregate of 4.8 million common shares at a
purchase price of $6.25 per common share and accompanying purchase warrant (or $6.24 per pre-funded warrant and accompanying purchase
warrant) in a registered direct offering. The purchase warrants will have an exercise price of $6.25 per share, are exercisable
immediately, and will expire five and a half years following the date of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maxim Group LLC is acting as sole placement
agent for the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The gross proceeds to the Company from
the offering are estimated to be $30.0 million (assuming full exercise of all pre-funded warrants) before deducting the placement
agent&rsquo;s fees and other estimated offering expenses. The offering is expected to close on or about February&nbsp;17, 2021,
subject to the satisfaction of customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities described above are being
sold pursuant to a shelf registration statement on Form&nbsp;F-3 (File No.&nbsp;333-240265), previously filed with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on July&nbsp;31, 2020 and declared effective on August&nbsp;12, 2020. Such securities
are being offered only by means of a prospectus. A prospectus supplement and the accompanying prospectus relating to and describing
the terms of the offering will be filed with the SEC. When available, copies of the prospectus supplement and the accompanying
prospectus relating to the offering may be obtained at the SEC&rsquo;s website at www.sec.gov or by contacting Maxim Group LLC,
405 Lexington Avenue, 2nd Floor, New York, NY 10174, at 212-895-3745.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release shall not constitute
an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under
the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Globus Maritime Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Globus is an integrated dry bulk shipping
company that provides marine transportation services worldwide and presently owns, operates and manages a fleet of six dry bulk
vessels that transport iron ore, coal, grain, steel products, cement, alumina and other dry bulk cargoes internationally. Globus&rsquo;
subsidiaries own and operate six vessels with a total carrying capacity of 381,738 Dwt and a weighted average age of 11.2 years
as of December&nbsp;31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Safe Harbor Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This communication contains &ldquo;forward-looking
statements&rdquo; as defined under U.S. federal securities laws. Forward-looking statements provide the Company&rsquo;s current
expectations or forecasts of future events. Forward-looking statements include statements about the Company&rsquo;s expectations,
beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts or that are not present
facts or conditions. Words or phrases such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;estimate,&rdquo;
 &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo;
 &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;will&rdquo; or similar words or phrases, or the negatives of those words or
phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is
not forward-looking. Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially
inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking
statements. The Company&rsquo;s actual results could differ materially from those anticipated in forward-looking statements for
many reasons specifically as described in the Company&rsquo;s filings with the Securities and Exchange Commission. Accordingly,
you should not unduly rely on these forward-looking statements, which speak only as of the date of this communication. Globus undertakes
no obligation to publicly revise any forward-looking statement to reflect circumstances or events after the date of this communication
or to reflect the occurrence of unanticipated events. You should, however, review the factors and risks Globus describes in the
reports it files from time to time with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">For further information please contact:</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Globus Maritime Limited +30 210 960 8300</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Capital Link &ndash; New York +1 212 661 7566</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Athanasios Feidakis, CEO </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Nicolas Bornozis <U>globus@capitallink.com</U></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><U>a.g.feidakis@globusmaritime.gr</U></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #0563C1"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; color: #0563C1">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>9
<FILENAME>tm216516d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RISK FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>An investment in
our common shares involves a high degree of risk. Before deciding to invest in our common shares, you should carefully consider
the risks described in the accompanying prospectus and under the heading &ldquo;Risk Factors&rdquo; beginning on page 8 of our
annual report on Form 20-F for the year ended December 31, 2019, which is incorporated by reference into this prospectus supplement.
In addition, you should carefully consider the other information in the annual report and other documents that are incorporated
by reference into this prospectus supplement. See &ldquo;Where You Can Find Additional Information.&rdquo; The risks and uncertainties
referred to above are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known
to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occurs, our
business, financial condition and results of operations could be materially adversely affected. In that case, you may lose all
or part of your investment in the common shares.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Risks Relating
to this Offering</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>We have broad
discretion in the use of the net proceeds from this offering and may use the net proceeds in ways with which you disagree.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our management will
have broad discretion in the application of the net proceeds from this offering and could spend the proceeds in ways that do not
improve our results of operations or enhance the value of our securities. You will be relying on the judgment of our management
with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess
whether the net proceeds are being used appropriately. The failure by our management to apply these funds effectively could result
in financial losses that could have a material adverse effect on our business, cause the price of our securities to decline. Pending
the application of these funds, we may invest the net proceeds from this offering in a manner that does not produce income or that
loses value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Company Specific
Risk Factors</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>We may issue
additional common shares or other equity securities without shareholder approval, which would dilute our existing shareholders&rsquo;
ownership interests and may depress the market price of our common shares</I></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may issue additional
common shares or other equity securities of equal or senior rank in the future without shareholder approval in connection with,
among other things, future vessel acquisitions, the repayment of outstanding indebtedness, and the conversion of convertible financial
instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our issuance of additional
common shares or other equity securities of equal or senior rank in these situations would have the following effects:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">our existing shareholders&rsquo; proportionate ownership interest in us would decrease;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the proportionate amount of cash available for dividends payable on our common shares could decrease;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the relative voting strength of each previously outstanding common share could be diminished; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the market price of our common shares could decline.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may
be obligated to issue, upon exercise or conversion of outstanding agreements, warrants and credit facilities pursuant to the terms
thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">833,333 common shares issuable upon exercise of the July PP Warrants (at an exercise price of at
$18 per share) issued in a private placement that closed on July 21, 2020 and expire in January 2026;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">458,500 common shares issuable upon exercise of the June PP Warrants (at an exercise price of $18
per share) issued in a private placement that closed on June 30, 2020 and expire in December 2025;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">388,700 common shares issuable upon the exercise of outstanding Class A Warrants (at an exercise
price of $35 per share) which expire in June 2025;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">1,270,587 common shares issuable upon exercise of the December 2020 Warrants (at an exercise price
of $6.25 per share) which expire in June 2026;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">1,950,000 common shares issuable upon the exercise of the January 2021 Warrants (at an exercise
price of $6.25 per share) which expire in July 2026; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">the common shares issuable on exercise of the Warrants being offered in this Offering.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are
able to draw down up to $14.2 million from our $15 million credit facility with Firment Shipping Inc., which facility is permitted
to be repaid in our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also issue, on a
quarterly basis, common shares to certain of our directors. In addition, in 2020, we issued an aggregate of 300 of our Series B
preferred shares,&nbsp;par value $0.001 per share, to Goldenmare Limited in return for an aggregate of $300,000. The $300,000 was
settled by reducing, on a dollar for dollar basis, the amount payable by the Company to Goldenmare Limited pursuant to a consultancy
agreement. The maximum voting rights under the Series B preferred shares is 49.99%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our issuance of additional
common shares upon the exercise of such warrants and credit facilities would cause the proportionate ownership interest in us of
our existing shareholders, other than the exercising warrant or credit facility holder, to decrease; the relative voting strength
of each previously outstanding common share held by our existing shareholders to decrease; and, depending on our share price when
and if these warrants or notes are exercised, may result in dilution to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white"><B><I>Future
issuances or sales, or the potential for future issuances or sales, of our common shares may cause the trading price of our securities
to decline and could impair our ability to raise capital through subsequent equity offerings.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have issued a significant
number of our common shares and may do so in the future. Shares to be issued pursuant to the exercise of our outstanding warrants,
including the Warrants being issued in this offering, could cause the market price of our common shares to decline, and could have
an adverse effect on our earnings per share. In addition, future sales of our common shares or other securities in the public or
private markets, or the perception that these sales may occur, could cause the market price of our common shares to decline, and
could materially impair our ability to raise capital through the sale of additional securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of
our common shares could decline due to sales, or the announcements of proposed sales, of a large number of common shares in the
market, including sales of common shares by our large shareholders, or the perception that these sales could occur. These sales
or the perception that these sales could occur could also depress the market price of our common shares and impair our ability
to raise capital through the sale of additional equity securities or make it more difficult or impossible for us to sell equity
securities in the future at a time and price that we deem appropriate. We cannot predict the effect that future sales of common
shares or other equity-related securities would have on the market price of our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>The market price of our common shares
may be volatile, which could result in substantial losses for investors who purchase our shares; and the volatility in the stock
prices of other companies may contribute to volatility in our stock price.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our common shares have
experienced price and volume fluctuations and may continue to experience volatility in the future. The closing price of our common
shares within 2020 ranged from a peak of $109 on January 3, 2020 to a low of $5.68 on December 31, 2020, representing a decrease
of 94.8%. You may not be able to sell your shares quickly or at the latest market price if trading in our stock is not active or
the volume is low. Some of the factors that may cause the market price of our common shares to fluctuate include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the trading of our ships, and whether one or more ships are not trading or otherwise offhire;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory or legal developments in the United States and other countries;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the recruitment or departure of key personnel;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the level of expenses related to our business or to comply with changing laws, including in relation to environmental laws;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual or anticipated changes in estimates as to financial results or recommendations by securities analysts;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcement
or expectation of additional financing efforts;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
of our common shares by us, our insiders, or other shareholders;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
in our financial results or those of companies that are perceived to be similar to us;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in estimates or recommendations by securities analysts, if any, that cover our stock;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
conditions in the shipping industry and drybulk sector; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
economic, industry, and market conditions.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 31, 2020,
the closing price of our common shares on the Nasdaq Capital Market was $5.71 per share, as compared to $6.68, which was the closing
price on February 11, 2021. In addition, there has been volatility for our intra-day common share price. For example, the high
and low intra-day prices on February 11, 2021 were $6.39 and $7.14, respectively, and the high and low intra-day prices on December
4, 2020 were $10.86 and $9.00, respectively. As a result, there is a potential for rapid and substantial decreases in the price
of our common shares, including decreases unrelated to our operating performance or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years, the
stock market in general, Nasdaq, and the markets for shipping companies, has experienced significant price and volume fluctuations
and depressions that have often been unrelated or disproportionate to changes in the operating performance of the companies whose
stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect the market price
of our common shares, regardless of our actual operating performance. Following periods of such volatility in the market price
of a company&rsquo;s securities, securities class action litigation has often been brought against that company. Because of the
potential volatility of our stock price, we may become the target of securities litigation in the future. Securities litigation
could result in substantial costs and divert management&rsquo;s attention and resources from our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<B><I>A possible
 &ldquo;short squeeze&rdquo; due to a sudden increase in demand of our common shares that largely exceeds supply may lead to further
price volatility in our common shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Investors may purchase
our common shares to hedge existing exposure in our common shares or to speculate on the price of our common shares. Speculation
on the price of our common shares may involve long and short exposures. To the extent aggregate short exposure exceeds the number
of common shares available for purchase in the open market, investors with short exposure may have to pay a premium to repurchase
our common shares for delivery to lenders of our common shares. Those repurchases may in turn, dramatically increase the price
of our common shares until investors with short exposure are able to purchase additional common shares to cover their short position.
This is often referred to as a &ldquo;short squeeze.&rdquo; A short squeeze could lead to volatile price movements in common shares
that are not directly correlated to the performance or prospects of our company and once investors purchase the common shares necessary
to cover their short position the price of our common shares may decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Our loan agreements
and other financing arrangements contain, and we expect that other future loan agreements and financing arrangements will contain,
restrictive covenants that may limit our liquidity and corporate activities, which could limit our operational flexibility and
have an adverse effect on our financial condition and results of operations. In addition, because of the presence of cross-default
provisions in our loan agreements and financing arrangements, a default by us under one loan could lead to defaults under multiple
loans.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our loan agreements
and other financial arrangements contain, and we expect that other future loan agreements and financing arrangements will contain,
customary covenants and event of default clauses, financial covenants, restrictive covenants and performance requirements, which
may affect operational and financial flexibility. Such restrictions could affect, and in many respects limit or prohibit, among
other things, our ability to pay dividends, incur additional indebtedness, create liens, sell assets, or engage in mergers or acquisitions.
These restrictions could limit our ability to plan for or react to market conditions or meet extraordinary capital needs or otherwise
restrict corporate activities. There can be no assurance that such restrictions will not adversely affect our ability to finance
our future operations or capital needs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of these
restrictions, we may need to seek permission from our lenders and other financing counterparties in order to engage in some corporate
actions. Our lenders&rsquo; and other financing counterparties&rsquo; interests may be different from ours and we may not be able
to obtain their permission when needed. This may prevent us from taking actions that we believe are in our best interests, which
may adversely impact our revenues, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A failure by us to
meet our payment and other obligations, including our financial covenants and any security coverage requirements, could lead to
defaults under our financing arrangements. Likewise, a decrease in vessel values or adverse market conditions could cause us to
breach our financial covenants or security requirements (the market values of dry bulk vessels have generally experienced high
volatility). In the event of a default that we cannot remedy, our lenders and other financing counterparties could then accelerate
their indebtedness and foreclose on the respective vessels in our fleet. The loss of any of our vessels could have a material adverse
effect on our business, results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the recent past,
we obtained waivers and deferrals of some major financial covenants under our loan facilities with our lenders until the end of
the third quarter of 2020. (We have not needed to obtain waivers since the end of the third quarter of 2020.) However, there can
be no assurance that we will obtain similar waivers and deferrals from our lenders in the future, if needed, as we have obtained
in the past. We are currently in compliance with all applicable financial covenants under our existing loan facilities. For more
information regarding our current loan facilities, see please see &ldquo;Item 5. Operating and Financial Review and Prospects &ndash;
B. Liquidity and Capital Resources &ndash; Loan Arrangements&rdquo; in our annual report on Form 20-F for the fiscal year ended
December 31, 2019, which is incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because of the presence
of cross-default provisions in our loan agreements, a default by us under a loan and the refusal of any one lender to grant or
extend a waiver could result in the acceleration of our indebtedness under our other loans. A cross-default provision means that
if we default on one loan, we would then default on our other loans containing a cross-default provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The superior voting rights of our
Series B preferred shares limits the ability of our common shareholders to control or influence corporate matters, and the interests
of the holder of such shares could conflict with the interests of our other shareholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While our common shares
have one vote per share, each of our 300 Series B preferred shares presently outstanding has 25,000 votes per share; however, the
voting power of the Series B preferred shares is limited such that no holder of Series B preferred shares may exercise voting rights
pursuant to any Series B preferred shares that would result in the total number of votes a holder is entitled to vote on any matter
submitted to a vote of shareholders of the Company to exceed 49.99% of the total number of votes eligible to be cast on such matter.
The Series B preferred shares, however, have no dividend rights or distribution rights, other than the right upon dissolution to
receive a priority payment equal to the par value of $0.001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After the offering
described within this prospectus and until such time that we issue a significant number of additional securities, Goldenmare Limited,
a company affiliated with our Chief Executive Officer, can therefore control a significant portion of the voting power of our outstanding
capital stock. Until such time, Goldenmare Limited will have substantial control and influence over our management and affairs
and over matters requiring shareholder approval, including the election of directors and significant corporate transactions, even
though Goldenmare Limited owns significantly less than 50% of the Company economically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The superior voting
rights of our Series B preferred shares limit our common shareholders&rsquo; ability to influence corporate matters. The interests
of the holder of the Series B preferred shares may conflict with the interests of our common shareholders, and as a result, we
may take actions that our common shareholders do not view as beneficial. Any such conflicts of interest could adversely affect
our business, financial condition and results of operations, and the trading price of our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We further note that
our articles permit any action which may or is required by the BCA to be taken at a meeting of the shareholders to be authorized
by consents in writing signed by the holders of outstanding shares having not less than the minimum number of votes that would
be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.
Presently and until and unless we issue a significant number of securities, Goldenmare Limited, a company affiliated with our Chief
Executive Officer, holds Series B Preferred Shares controlling a significant portion of the voting power of our outstanding capital
stock. Goldenmare could, together with shareholders possessing a relatively small number of shares, act by written consent in lieu
of a meeting and authorize major transactions on behalf of the Company, all without calling a meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Provisions of our articles of incorporation
and bylaws may have anti-takeover effects<FONT STYLE="background-color: white">, which could depress the trading price of our common
shares.</FONT></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Several provisions
of our articles of incorporation and bylaws, which are summarized below, may have anti-takeover effects. These provisions are intended
to avoid costly takeover battles, lessen our vulnerability to a hostile change of control and enhance the ability of our board
of directors to maximize shareholder value in connection with any unsolicited offer to acquire our company. However, these anti-takeover
provisions could also discourage, delay or prevent the merger or acquisition of our company by means of a tender offer, a proxy
contest or otherwise that a shareholder may consider in its best interest and the removal of incumbent officers and directors,
which could affect the desirability of our shares and, consequently, our share price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Multi Class Stock</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our multi-class stock
structure, which consists of common shares, Class B common shares, and preferred shares, can provide holders of our Class B common
shares or preferred shares a significant degree of control over all matters requiring shareholder approval, including the election
of directors and significant corporate transactions, such as a merger or other sale of our company or its assets, because our different
classes of shares can have different numbers of votes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For instance, while
our common shares have one vote on matters before the shareholders, each of our 300 outstanding Series B preferred shares has 25,000
votes on matters before the shareholders;&nbsp;<I>provided however,&nbsp;</I>that no holder of Series B preferred shares may exercise
voting rights pursuant to any Series B preferred shares that would result in the total number of votes a holder is entitled to
vote on any matter submitted to a vote of shareholders of the Company to exceed 49.99% of the total number of votes eligible to
be cast on such matter. No Class B common shares are presently outstanding, but if and when we issue any, each Class B common share
will have 20 votes on matters before the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At present, and until
a substantial number of additional securities are issued, our holder of Series B preferred shares exerts substantial control of
the Company&rsquo;s votes and is able to exert substantial control over our management and all matters requiring shareholder approval,
including electing directors and significant corporate transactions, such as a merger. Such holder&rsquo;s interest could differ
from yours.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Blank Check Preferred
Shares</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of
our articles of incorporation, our board of directors has authority, without any further vote or action by our shareholders, to
issue up to 100 million &ldquo;blank check&rdquo; preferred shares, almost all of which currently remain available for issuance.
Our board could authorize the issuance of preferred shares with voting or conversion rights that could dilute the voting power
or rights of the holders of common shares, in addition to preferred shares that are already outstanding. The issuance of preferred
shares, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things,
have the effect of delaying, deferring or preventing a change in control of us or the removal of our management and may harm the
market price of our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Classified Board
of Directors</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our articles of incorporation
provide for the division of our board of directors into three classes of directors, with each class as nearly equal in number as
possible, serving staggered, three-year terms beginning upon the expiration of the initial term for each class. Approximately one-third
of our board of directors is elected each year. This classified board provision could discourage a third party from making a tender
offer for our shares or attempting to obtain control of us. It could also delay shareholders who do not agree with the policies
of our board of directors from removing a majority of our board of directors for up to two years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Election of Directors</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our articles of incorporation
do not provide for cumulative voting in the election of directors. Our bylaws require parties, other than the chairman of the board
of directors, board of directors and shareholders holding 30% or more of the voting power of the aggregate number of our shares
issued and outstanding and entitled to vote, to provide advance written notice of nominations for the election of directors. These
provisions may discourage, delay or prevent the removal of incumbent officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Advance Notice Requirements
for Shareholder Proposals and Director Nominations</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide
that shareholders, other than shareholders holding 30% or more of the voting power of the aggregate number of our shares issued
and outstanding and entitled to vote, seeking to nominate candidates for election as directors or to bring business before an annual
meeting of shareholders must provide timely notice of their proposal in writing to the corporate secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, to be timely,
a shareholder&rsquo;s notice must be received at our principal executive offices not less than 150 days or more than 180 days prior
to the first anniversary date of the immediately preceding annual meeting of shareholders. Our bylaws also specify requirements
as to the form and content of a shareholder&rsquo;s notice. These provisions may impede a shareholder&rsquo;s ability to bring
matters before an annual meeting of shareholders or make nominations for directors at an annual meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Calling of Special
Meetings of Shareholders</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our bylaws provide
that special meetings of our shareholders may be called only by the chairman of our board of directors, by resolution of our board
of directors or by holders of 30% or more of the voting power of the aggregate number of our shares issued and outstanding and
entitled to vote at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Action by Written
Consent in Lieu of a Meeting</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our articles permit
any action which may or is required by the BCA to be taken at a meeting of the shareholders to be authorized by consents in writing
signed by the holders of outstanding shares having not less than the minimum number of votes that would be necessary to authorize
or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Presently and until and unless
we issue a significant number of securities, Goldenmare Limited, a company affiliated with our Chief Executive Officer, holds Series
B Preferred Shares controlling a significant portion of the voting power of our outstanding capital stock. Goldenmare could, together
with shareholders possessing a relatively small number of shares, act by written consent in lieu of a meeting and authorize major
transactions on behalf of the Company, all without calling a meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><U>Risks Relating
to Our Industry</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Pandemics such as the novel coronavirus
(COVID-19) make it very difficult for us to operate in the short-term and have unpredictable long-term consequences, all of which
could decrease the supply of and demand for the raw materials we transport, the rates that we are paid to carry our cargo, and
our financial outlook.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 11, 2020,
the World Health Organization declared the spread of a novel coronavirus (COVID-19) to be a global pandemic. In the name of public
health, governments around the world have shuttered workplaces, restricted travel, and put in place other measures which have resulted
in a dramatic decrease of economic activity, including a reduction of goods imported and exported worldwide. While some economies
have begun re-opening in limited capacities, it is impossible to predict the course the virus will take; whether new, more virulent
or contagious strains will emerge; how quickly COVID-19 vaccines will be distributed; for how long the vaccines will provide immunity;
whether people who have received full courses of the vaccines will nonetheless remain vectors for the disease; whether the vaccines
will confer immunity upon new strains; and how the behavior of our clients will change, if at all, due to the coronavirus pandemic&rsquo;s
economic shock. Some experts fear that the economic consequences of COVID-19 could cause a recession that outlives the pandemic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have thus far been affected by COVID-19
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">The pandemic had a negative impact on our voyage revenues for the nine-month period ended September
30, 2020, which reached $7.8 million compared to $11.9 million for the same period in 2019. The 35% decrease in voyage revenues
is attributed to the low freight rates achieved in the nine-month period ended September 30, 2020 due to the outbreak of COVID-19
virus.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Based upon increased volatility in the charter market and its effect on the recoverability of the
carrying amount for our vessels, we concluded that the pandemic may have trigged the impairment of our vessels. We performed an
impairment assessment of our vessels by comparing the discounted projected net operating cash flows for each vessel to its carrying
value. As of March 31, 2020, we concluded that the recoverable amounts of the vessels were lower than their carrying amounts and
recorded an impairment loss of $4.6 million. For the second and third quarter of 2020, we have re-assessed impairment indicators
and performed an impairment test on the recoverability of the carrying amount of its vessels using discounted projected net operating
cash flows for each vessel and concluded that no further impairment of its vessels should be recorded or previously recognized
impairment should be reversed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Our vessels have been subject to quarantine checks upon arriving at certain ports. This has functionally
limited the amount of cargo that the Company (and its competitors) are able to move because countries worldwide have imposed quarantine
checks on arriving vessels, which have caused delays in loading and delivery of cargoes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 26.55pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Due to quarantine restrictions placed on persons and additional procedures using commercial aviation
and other forms of public transportation, our crew has had difficulty embarking and disembarking on our ships. This has not thus
far functionally affected our ability to crew our vessels.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect that pandemics generally, including
the current novel coronavirus pandemic, could affect our business in the following ways, among others:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Pandemics generally reduce the demand for goods worldwide without a commensurate corresponding
change in the number of vessels worldwide, thereby increasing competition for cargo and decreasing the market price for transporting
dry bulk products.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Countries could impose quarantine checks and hygiene measures on arriving vessels, which functionally
reduce the amount of cargo that we and our competitors are able to move by causing delays in loading and delivery of cargo.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">The process of buying, selling, and maintaining vessels is made more onerous and time-intensive.
For instance, delays may be caused at shipyards for newbuildings, drydocks and other works, in vessel inspections and related certifications
by class societies, customers or government agencies, as well as delays and shortages or a lack of access to required spare parts
and lack of berths or shortages in labor, which may in turn delay any repairs to, scheduled or unscheduled maintenance or modifications,
or drydocking of, our vessels.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">We have a decrease in productivity, generally, as people&mdash;including our office employees and
crews, as well as our counterparties&mdash;get sick and take time off from work. We are particularly vulnerable to our crew members
getting sick, as if even one of our crew members gets sick, local authorities could require us to detain and quarantine the ship
and its crew for an unspecified amount of time, disinfect and fumigate the vessels, or take similar precautions, which would add
costs, decrease our utilization, and substantially disrupt our cargo operations. If a vessel&rsquo;s entire crew fell seriously
ill, we may have substantial difficulty operating its vessel and may necessitate extraordinary external aid.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">International transportation of personnel could be limited or otherwise disrupted. In particular,
our crews generally work on a rotation basis, relying largely on international air transport for crew changes plan fulfillment.
Any such disruptions could impact the cost of rotating our crew, and possibly impact our ability to maintain a full crew synthesis
onboard all our vessels at any given time. It may also be difficult for our in-house technical teams to travel to ship yards to
observe vessel maintenance, and we may need to hire local experts, which local experts may vary in skill and are difficult to supervise
remotely, to conduct work we ordinarily address in-house.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Governments impose new regulations, directives or practices, which we may be obligated to implement
at our own expense.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Any or all of the foregoing could lead our charterers to try to invoke force majeure clauses. As
of the date hereof, however, none of our charterers have invoked a force majeure clause citing the pandemic</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(8)</TD><TD STYLE="text-align: justify">Credit tightening or declines in global financial markets, including to the prices of our publicly
traded securities and the securities of our peers, could make it more difficult for us to access capital, including to finance
our existing debt obligations.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any of these public health threats and
related consequences could adversely affect our financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is too early to assess the full long-term
impact of the ongoing novel coronavirus pandemic on global markets, and particularly on the shipping industry. It may take some
time to materialize and may not be fully reflected in the results for the nine months ended September 30, 2020 or year ended December
31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm216516d1_ex8-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex8-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "\ U(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\3Z***_K
M_P 5PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HI"0.I ^M+0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 (2!_G]?I[]*0^HZ'WX.,_GU/&<=<D=P@]AGO\ H.,>
M^.N<>V0#2 Y/!ZG&2..>N>1T '09QSD\J1:M[:*[U[:OIK9:NVMNC>A<5V?2
M[\E^@[<0202!TR .F>/[PYY]"< #O1Q^'^/^/ZTGMMSC[PSCD]\XP<YZ%1WY
MZ9,' (.X=1_7_:&TD#J<CC'-*ZLGWO9=7;1Z/97LE>R;?9-IN#:N[)?IT>WY
M^8=",=_Z=OH!T [^@ZNS30.2#D$=5+#KQDC'USQQ^0-(,C)QT!)&1T QCCCJ
M<\#N#SR0V[=&K:ZZ6OS?@K7?+?>-M783C;=Z[>OXCN3TR!W_  SG\L?KZ @@
MQDX_S_G_ #QBDW!6!''S;0<[MQ&0>>,;1C.<Y#'N#@ !XQUQSP<<X/48))'7
M//.3C%%]+V]=?3OHM6NKU:5QN-K)Z7_SZWW[;[BY'J#].3]?\^G<D"CC.<@^
MQY!^HSSCJ!V.335PQP""< D G(]N0>,9)_$;N31GZ\@# 4'.2%SU'('WAD#/
M;O24DU=/3>]I6MLWJD[)[W2>JLFG<.7MITZZ_A\Q5&/\_3^70?B1P0 [(]:8
M2O*[ACMDY) _+GH3P>^/9>I [C X]  ?;IG!['TP  7U2>E^^C7JMUYMK?2]
M] <7N]/D]NCUW_04_A^/'Y>_?\/Q"=C^A&23_4_S[#H"5 8;CSA>N,#)R1@'
M!Z \\>N#ZM!'0N PSP"I/7GICIQNR1SG@]"7U:[.V^SM>UF[[:M[);M7N'))
M+\7HW_5MF]EL]=!1VY_R?\X'7/N<&E[<?Y_S_*DQTR<G&#@8SU_ 9P,]N,=.
MH!S@$9QDCJ1R2>./<')))Z$XS0W9V?GIZ:^GI9OOMJURO77;?LONUTNM6EN&
M2?Z_Y[?3J#CMS3J0G&?0$D$]-HZ ]3DG'/<=@>B'A<C(4XP3C.,D<X[C X';
M^('BG^KBK]+R3<5OUL]KZJ[LM0Y6UHM-U;MW%/\ G\NW3^8^M&.G [_R'_ZA
MQT[CH3GT[<GC([?0^_Z9IN0#R3@X X.03NP>>@&.<Y..YH_SMTZ^MOZTW:$D
MWHO/\O47OU!Y]>GM_+CGG'J-KC[?Y_S^'U%-P<8SQVR>H[ <=<#)SD' [9%
MR>!R2"?3'&3W/8CISGIQT+]-^EU?1[VU2UMT5[6WZ#<=GH_U_1#OK1_G_/\
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MVECX=E6WN83)7Y3_ +*'[<GB/]FOP=\1/A%XF^&O@;X\? /XI3V>J>,?@_\
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M1^"7[5E_^TAJW[4?PQU_X8?#CX.Z-X/U;PUIO@O0O%$MXT6M_$6YOYKFRO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 (<\8YY'T/(X/L1G/('J10,$G)P,$YQD#/H#GL3@@ #&.3T0]^
MX[CH<' 'X Y)]L^G!$2>,$,0.,C@ 9XSZ8!X![G..A^BO;RV>MU:R:N[Z77D
M:PBVM+:6]7?Y/16NW9V6NVRGG&01E0>F>><GD'KZ>WN,KZ?+GKD '=@#CD#@
M=P 1R0,=<.,+!%9HY=I!P[0RA.5.TJY0(5X+<,1W!P,T*AD)"QR/D;AY,4KL
MZ\@N%C5CY8) )Y4'(+ DU#G!)OFA:-U)\\;)J*;BY<UDU>UM[Z;FWU:OSJ'L
M:_-))QA["LI24DFG"+I\TE):Q<;\R3:=AA&"".3CJ5R-V#P>#CD>PZG/!H!]
M >G/?GKC/'&,8)Z^O0E=ASM5LD*Q^Z<JHW,SLH!*A4PV6 "@DL0M)Y?(!$@.
MW>FY&3S(R" R;U =#SM92RL?NG P'S1O%7LVE*S:YN5MIOE4KZ*TNKY&I)6)
M=&=I-PFHQ?O3Y*BC&[Y5=NFHQ][W4FT^;2S:U3ZD*""<D9_N\8[X&2#@$<#@
M<4N%!QD $=<=\C P._N/3KUPJKB(R;9,*?OA'\HD\!6<J8]V2!MR"<<@]"F3
MN'*9"@N21@*2H'&,#)..QSP,9Q0I)JZ<79Q3M*.C?1KFNI*7Q+>.G-;2ZE2G
M&W-"24ES1;A-*4=;3C>G[T'9VG&\&XM)NSY0C&"2.#@C!!]\GG@G'.".>Y H
MX.WCV;*YP,]R02W!/([@$TX(S%0$8[L@!(Y)'=1]YD1=S-M((8JK#(.1P0&D
M')+*X*N RO&T;H0/E$B%05+\8#*I;C!)(H<XIM<R;6Z4HW:VO%.2<E=-<R:5
MTXVYAJA5Y5)4ZCBY<BFJ55Q<K<W(I*ERN:3YN5-RY?>UC:[OE'0CKU(.!C@G
M&,'(S@= <=^:9CC\<>AYXSTZ' ^4GOC' %2+&^R5Q')B-BK-Y3^7'C&Y99-@
M6-E#+@2,".,#GA@!.1AL !B<8VAUS&3P0OF $QY(#+DKG'!SKO%M)7490:3W
MLFI:R:=^6W-MH^:-AT*JM>G45X\R<J=17C[UY)NG9Q3BUS)\J<9)M-,,<]">
M#ZGL?3)ZXSP<G YZA.#QU]<# SW4 _KC@]>].2-G)$:2.%!R$CED89SM!\M6
MQDD=<#(YSS28W' 7=O "84YSR2N1@,1P6 &>0.I%/FB[IRC%I7:<E=73:3]Y
M-2LN91M=IJSW:/8U%&,G3J<LK\LO9U$I<LDI<LG!QERN24E%OEDXIZR2#T(
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M"*0[R3A5B 7$A4ACB,-@#)%"Q.Z,ZQW&(BV66"4Q@+G.]U7:I4\LKMN 8[L
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M1VW<'DG%+GG&<Y/S8)YP"<$D ^V.Z].V#;TSMW!0=I&"!G&6(P1PR[2QQDJ
M2<4+"SY 25L;U/EQ2,P= NY=J*6#@,I<8^7(W+S3YDU)N22BXJ3E*,4KJZLW
M*TGRV:>R^&6H*A4FTHTZD[NRY*4YMMVV4*6KOT6M]&M&P&1G!*@9^7OW(7@\
M=>O![GKP@!##(//(&>HQP,@=1P3UZ=3C@"L&5=K@%=P#(X8!00S,I ?:IW;C
MC 9><8P'"%V94\JX_P!7O8&&<M@D[7VM&2$8C:KXV,<J"32<XK5SA;EYKRG&
M/NMV3M*6UVDVM(NR?0<<-6G91HUI/FY6H4*LY*3O9-1IM\S::46[MIVVNV=
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M.>3@DD9Y&"#RWVM+M8HI"F38YA4@89#( 8U;+<AF#EL<9(%-*<A<#=@,#M+
M=\. .!M).6(W+@YP:.:]K--:K1Q:33UYFI>Z[=)+SO:P>QFDKQDKI25Z<U=7
M:NN:FN:*<97DKQ]V=K\LD.SP..<MD@<'#<X'H/S/IGBEI&0JB,5($@X9HWC0
MODD>5(P"N-N&^0LO3U%)WYXQQUSZ\Y]^.N03P<FFFI:IIK35--==+IM775;I
MZ/4SJT94W:<90;2E:<)P;4US1:4HQ;BT[QDDXN+3BVFAU%%%,Q"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ"GBS1[GQ1HT\_AG5-'T[5KJRO;6[T^VO([ZR,YI7[,6OSZ&GB3Q-\1OA?\
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M3NM2?1/AS\-_%^I^.9M.\5:UI%A;^*I=4^,,^GZ-#HL-G/IUEXON;76?#_\
M9?C&.WNKRPDN+)M^RW*I=U;QC^RKXFNOC-/XT\56UUKW[0%QI?A3P/K&A^%;
MG6CX \'>%?!^E2^#_$GQ'\3:QXET_5=#\6:[XV;P[>_$S4=*TKQ5>:I<^#_$
MZ0K]CUZ&XD^ O'?PL\9_#2W\#2>,],GT.Z\>^%7\8Z3I6H6U[8ZU8:4GB7Q!
MX65-7TZ_M;:2TNY[[PY>SPHAFCDL);2X$Q>5HT[W1/V8_BKKVA_";Q1:Z?I\
M?A7XS67B:Z\)>(9KYCI=O-X2OO$-EJ6F>(3:P3W>D:I<R>&=2ETJ&XMA'JD*
M,]K,_D7:V\5\JRUJGB?[2Q&&]M*M&%2%:*5:HL54QE2S?,HRC5BDU'2=*E""
MMS23ZLOXQXLB\5EL>$LMS"K@J>!JUL-6P%2<\)0_LS#Y)0E6ITZD).G4PE27
M\:<?8XO&2Q3?M(TU#Z=\1_%G]G2YA^)EO9V.D^'_ !6?V?/@CX$\.:YX?T>>
M[\.^/=>TYO@YJ?C*?6Q,Q/A_QGH.H:#XJA?6K6V%AXDTTM;7'V6_M5FU?V'Q
M=^T1\#-&^+/QR^*7PZUG3]/\":Y\/OB/X?\ A]\-=!U+6_"GB+0_B)<_$[P-
M>:WX@L?$MA:"ZF3XD:7#?^+M,U]'BNK32EN/!$T=KI^B6:S_ !!KW[)_COP_
MH.F:I)XA\):A?ZO\+[#XLV'AJST_X@6VHW/AJ_\ #6D>,GM;'5M7\$Z;X/UK
M6M-\*:NVO:K8Z'XDU(6-CI>J^;,)[9(9>0^)7[/'Q)^$5CK-W\0+#3- ET3Q
M5X=\(G3Y]12XU/5=2U[PE;^-!<Z3%:+-#=:9HNA7^B3:],9HYM.FU[2K9[>2
M:>9(>;#X+)L2Z7L<VKUE>45"4Y\U;VDTY\M.=.%6,>:E-PJTE*,.>I&%10DH
MKT\PSWCS*UC/KW!>68)*G2G*O'#4U3P2P].7L/:XBCBZF%56C1Q]"%;#8FI&
MIB7"A4Q&'=>G4JOZ:L/'7PQO-%\/?%'4?%7A&-]-_9X^+'PVUSP5J#:CJ'CV
M3XC^+/$'Q!BT&8PSZ<R:W%)9>,]$U>7Q9+>%([;3KQ;FZBU&&"UE]\^*G[57
M@&Z^-7AKQ5\+_B ?#W@JR\-?M$^']6N%U?Q _BEO$-]X.U:V\'P-</'#:GX<
M7.JQ>&=4^&6CV-I$GA;6[G6XI4CEA2^N/AFZ_9$^*&G/IUUJMYX.TS0]8MY=
M<TCQ5?:CJ@\.ZE\/+'1-/US5/BA:WD6D23#P)I\6L:1I4L\D,>M7?B:\_P"$
M;TO1K[6K2_L[6SX5_9)\:^.=5AA\(>-?A[XD\+7WA37/%>F^/=#C^(&K^'=2
MA\-:IH6C:[H=OHMAX'N/B#!XBTN\\2Z+)=Z7?>#[26+3[^WU5G73)8KMRK1R
M2I5^LSS6;C2C6C&*C*5&$)2E*=.35-\]6$I3]G%MUI*G*U*4:<FBAB_$"E@X
MY3A^#,-2JXRKE\W4YJ<,?5Q,:<(T\7#GQW/1PE>%*F\15C!8)>VI2GBZ#Q%%
M3^8KW4K_ %6]NM2U6\N-1U+4KN>_U/4K^>2YO+N^NIFFNKRZN93)+<7,TCO+
M++(S/*Y)9BV37Z>Z[\0_V5_B%J7Q<\*W(T3P)I/B;QC\"[S4/'MK?:IJ-UXC
M\*>$].GN?'TGAK1)-*%OI>J21V[06=DC0Q7VJ36UH\GDR-,OS3XW_8N^,7P]
M^&UE\5_%#>$=.\#7.K?$OP[>:\^JW[V&E^)/ACK\WAJ^\.7,\>EM%=Z[XFUB
M!X?">G:9)?W%_;+<:G>K8:;9:A=VWA?PO^'&K?%?QG9>"=(U+2-'O;W2_$6K
MOJFNKJ[Z98Z9X5\.ZEXIUBXN(/#^E:WK=RT>E:3=&WM-*TK4+RZN?*AM[=G<
M5ZV(EEV8T7B*>/J1HX*G[]3#2FHTK*-7GE'V<>::5'VD*;IS<5;FBKQ<OC,M
MCQ3PKCH95B>'J%7&\08R,J6#S.G1J5L7*4JF&<:<OK$I4J=6KB>2==5J"G[*
M:C6<8UJD/T-\7^,/V*_&^M_$+QZ=471M,^.'A?PI\,G\/0> [?PKJ_P?\01Z
ME?3ZE\2M)\(:5JWB2SAT'2K?P7X)GNHK#Q'=7^LP>*?$-LC6TCO;IUOP_P#B
MS^SG:W/Q!U7PUK&D>!_"/CK2?@]!=^#;K73HT>C>&/!O@CXU_#77[/Q/I3Z#
MK<OQ&N[FV_X0KQ;JOA.Q.G2>(M?URQNWU6W^RS31? /CK]FKXI^ -*\4^(]4
MTRUU#POX2\0^%O#=]XETEK]M/O)_%_AZQ\3Z3J%K;ZE8:=JUOIMMI>K: -8_
MM73M.O-&OO$.C:;J5G;W]ZEN/3O&O[#/Q>\$^)=2\,W6M> M5N](M=/FN+FR
MO/$FDVKW>H?$W0OA,UA&OBWPUX>O7-IXH\0Z?(^L_95\/WNE_:;S2M7U PM'
M7B5<+DDX45+/<5RN-Z;=?VB5+#3H.2FHT4HSC&I0A*4[5-8\T7^]Y_O\+G''
M\*F+E0\.LI3A5]G7C' JBWB<TIYA"G5I.IC).M0KSPV85Z:H5:F$C*,Y^U5/
MZNH>I:!XM^$^F:A=_$6\\?\ @:XTSQ=\'OV6_AO8^%TAU*3Q1I/BKX=^(_@O
M)X[N=<T4Z68M,TRUL?AGXCO)-4:XDBU&WUK3([1[R>YO8;?N_BA\<? /C[Q[
MXYU_X3^/]&\ ^*-:\+>&-/\ AUXY\4:SJ4?BVST71?%?C2_^)G@W5_'=Q:WL
MV@^)O$&H:KI4W@?Q5'9V-B?AKHVE^'99;"X>YTN3\Y?B7\/+_P"&/B[4/!^I
M:SHVN7^G>6EU=Z';Z_:013E66>RN;#Q5HOAWQ!9W=G*DD$\%_I-L&9%FMC-:
MRPS2>U6_['OQ9U#X<?#_ .)&D3>&=7LOB-J.D6>B>'X)=>L==L[?6Y_%,%OJ
MNHW^L:#IWA*;3+)?!NMW6MS:3XDU270+&&.\UB&R@?S!O+*\JIQP6*J9GB(0
MK15'"3K.]*K"-)2494I12G:E0;G4K*'M;7G&+48KAI<7<98R>>9-AN$LMJ5<
M#6GC<YH8&*ABL-6KX^-*M*AB:-23C%XW&4H4*>#G5='W73JU**K7Y7]IG4O!
M6L?%KQ!JG@7Q+>^,;*]TC0&UCQ%=MIT\>H^+?^$<LX/$S:?J&G^%O!<.L6,.
MK)/!%KT_AG3+S6Y8YM4NEN)KIKN;Z;O/B'^S_P"*M+UWP9;V?AGPYXC\2?LQ
M_ _X>M\4M0U351IL/BJRU;X51^*;:?0(]->"RN]'LM,UU]0U*U#S3QZ;=R12
M3RW15_G.#]F?Q7K^I^%;#X<^+?A_\6(?$_C>Q^&ZZIX"U#Q#'9Z!XQU**ZN-
M.TOQ!;^+O#WAO5+2"_LK'5+W3]:M+"ZT#4(-*U-K'4;AK.94L_#G]D[XJ_$6
M'PO>P6VF^&-(\8K\6)-'U3Q-!XDGCGB^"UCIM[XZD32/"^@>(O$=T]HVI)96
MD&G:/>W-U?P7D!A7R':NJK6RAX/#PEFLJ:P=&T)<\H8CW974JE%PA4=1.C*4
M(RH.-33FA**IL\3"8;C6GG>8UZ7!M#%//<=&M/#_ %:C6ROWO9QJ4L+CXXJK
MA*5&4,52I5<53QRE2<IQE6I5'5A3^LO$_P 4?V/[6;6?'GP[T?1-<L+'X,ZS
M\&;SX7^//!">&[KQ7_PCWB_P/_PBGBNRN-/U_P 3!O$NM^!)=8T^;QM#>Z)J
ML>N^&SK;:9I\M^D+X6K?$#X2)HV@:!^S]\3;+P-XWM?A!X)TO0/'_C73)?#6
MKZ);6WC?XJZ[XX^&]WXHL[6[CT;QC)!XB\%QIXLLVM;'7])T"]M5U*QCU)=)
MN/SLU_1)O#^OZOX?FECN[O1]5O-)EN(;;5=/AN9;2Y>T,\-IKVGZ5K-E',P+
M);ZOING7\*G9=V=O,KQ#Z.UC]D7XBZ3XMUSP2NO>"-0\0>&=)\+ZGKUK:7/B
M&W_LVY\6_$#P[\.-.TB;^V?#^FF[NTUSQ/I%Z=2L!=>'+[1)&U+2=9U"/:KY
M5,!EN%IT%6S/$Q511KT)XB3JJK1A"DHNM"5*-.I3BJ\4E55*53VO)44E!>S[
M<+Q+Q9G&*S*>"X2RFK*C6_L['4LNI1PU3#XW$/%RQ$<!7HXJ5:E6Q"P%2HI8
M58JC1^I*O0E3A6;K=O\ '+QW\.-7\!?$/1]'\1>'?%/CV]\6?L_WGB3Q5X>T
M:?2=+\>^(?#?@[XI67C[Q5H5K<Z?8RQ6$5]K7AS3-4U"2TL7\1ZK!)X@:T+7
MK25Y1\!?%_P^\(Z=\=_^%B:':^);3Q#\&AH?AWP[+J5WI$FL>(W^)?P^U..W
MLM4L[>>:RN[;2=-U6\,J"-9;>VFMGD"SD-/IO[*?QBU#7_$OAB?2=+T;7_"'
MCG1_ GB"RUW5;?3H;*76/#GC#Q>/%!U64'13X+L?#7@K6]8O/$*ZB;8Z>MM<
M62W44I>/F?%/P8DT1])M_"GQ+^%WQ:U'5/%,/@U=(^&.I^(M0U*'7[PHMA!#
M!X@\.Z OB&QU"0RPVVN>$9->T3SHA&^H(;BU$W32>51P]3+X9@YO$555YH3D
MW#EA&M%1JTTJ5&$XT7*FI5(WCSPH3E*#B_)QE/C*MF='B6KPQ"C/+\-/"QH5
M</&-.KSUJ^#G*>%Q,XU\96HU\=!8J,</4<)2HUL6J4*L:DOLC5?B;X+UU-;?
MX&?$CPE\#_'TFA?L_1MJ^MW6IV1U#PCX>^#?A'0]>\':-XWAT^>6RG\)>,K'
M5+GQ9IES%:MXWBE@99;Z33([2;)U[XI_LUZA82:%JVF:+?:?KOQDT_5]<\;^
M&?"_]G^*_#^I:3\//AW8:S\3O"NF&*P6?P)XK\?V/C'5+GP'<BP2^T6_4PV&
MB:I;63VWBGAG]COXJ^(_$7Q+\)O>^%= \2_#;Q%X;\+7&F:V?$DX\4ZSXOT7
MQ+XB\,KX9OM%\-ZOIB:9K.B^%+_4K/Q#XBO- \/?9Y]/F?54CNE(YS_AFGQ4
MND2N?&/PW7Q[;>!Y/B-=_"&36M83XAP>#X=,/B"?4'E;1!X*>^A\++_PE$_A
MJ'Q9+XGAT8,\FD+<QR6Z\-/#Y-&<(?VK5E*ER14H2JJ2=:,:L*M2O2I5'4A#
MVE.4)U9NAAW**:YJDH+Z2MF/'];#U*\N#<'2AC)3J2C6I4)491R^M/"5,)A\
M#BL33^K5\15I8JEB*6'A]?S"%*]*E[+"QK+[7A^+_P --2^(%]?^'/BQH_@G
MX+#QE\:KGXG>'=+>S\-^(/&S>*OB'XPU'0_%Z>'M8\ ^+].^(FD7OP[OO#&A
M:#X2U.Q9=*U/3;F&0^'(IFUBX\&_90^)_P )? '@WXVV'C6XTW3O%'B;7?AW
M;_"?Q!K.D_VW)X$\16D'CN*U^(<^D+:R6NIZ?X:N-1TEM6LF.;<7D6KV-E?W
M>D6UE+5N?V!OB[::KINFW'B3P+&E]X:\3>)YK]=.^*%VNGVGA2W\)76K6PTN
MS^'4_B77)3!XST-[34/">C:]H5XQO?L^J/\ 8+DI\::WI;Z'K.KZ+)/'=R:3
MJE]I3W4$&I6D-T]C/+:O<0VFKV.FZM;0SF/?';ZG866H0*P2[L[:9'A37 X/
M+,32Q.%PF9XG$1G&A*32M.E"CB:W+*565&#G.5?GC-3E4<J4(4G'V34EP\19
M[Q=D>+RG.,[X2RK+94*V8T*5.IRSHXJ>/RO TZE*.&AC:T\/0HX)T*]"5&DH
MQQM:MB%B)8ASI0_1#0_'WA:RL?#CW/Q@\"VOP0T;P5=:5\6?@S/:ZA>:_P"-
M_&=I;?9_%S0Z7'I=Q:^*]>^(?B$G7?!WQ DU(+X5T^YLDEU+0Y-'AM:IS?%7
M]FJ^TWQ(M]HUIH/B72/V8_A9X)T2\T/39;C2?B7J*> OAPOB_0_$.5F.@_$#
M0-<L/$-M!XFBC^PZU:+<65XUO>6MM<7_ .<ZXR.<#D8QEB/0$<@<X&TXQG)I
M0  >#C@94E1SZ\?>&0-PYSDY%=CX>HN:J?6L7&<(U(1]G*E1BU5Y;RJ1@I1J
MS24[3JQ=U*,;PC1@WX7_ !$_'0H5,/'),GJ0K5L-7G]9CB<7*,L*I*E3PM6J
MX5,)0<E3J2H4)\KJ0G*4I>VK1?Z%_';XB>%/%'@3XM0S_%'3O$>@:_XHT/5O
MV?? OA*\TU-(\(Z!:7<,-KH-_P"!-1\")?> 5\/^%YM1LM8OM'\7:2^MZXEC
M&VF^(K0RZLGYXX8=>I /TR2?RZ@YSC)/4"G@?Q$]@1L/(';?P"2>.>IP1[%
M.G'4 \\_3\/0^N37IX'!+ TY4XU)U(RJ2J.52,(OX5",5[-)6M%3FY.4IU'*
MJVG/D7Q_$G$$^(,50Q53!8;!NCAH8;DPSK24TJE6LYSG7G*3:E6E"G&,80I4
M8TZ44XPC(.N>O3C&.O/WL\X!QP.>H([4M%%=Q\T%%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "DQ_GC_)]<G///6EHH"[743'O[=O7/7&?QSG\:,?YX]0>#U'3L
M?Z86B@=WW8?C^& ?Y@TW:/\ .!_(#_/'0D%U% 7?=B8]<G_/M].W?GKS1CKR
M>>O0?R  Z=1@^]+10%WW8A&>Y_3^H/\ AWQGF@C..>GL/0#KC/;MZFEHH"[[
ML3'3MCT]_P#.!W X&!2T44"N^XF/<]<]OYXS^OIC&*",_P"1_4$4M% [ON]
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7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm216516d1_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex5-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  \ G,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_$LJC.2/
MQ_G\O/YTPRJ>CI]<$G\R<T30)<Q-#.I:.1=C*1M&#U PW7\_H<5X/_PS1\)1
MQ_PC*GW^WZD?_;K^7%7'DE\=K/7:_P"K_0XZ\\3"WU:A'$/K?%+"_GAI(]YW
MQ_WQ_P"._P#Q5&^/^^/_ !W_ .*KP;_AFGX2_P#0L+_X':E_\E4?\,T_"7_H
M6%_\#M2_^2JTY:/_ #^_!_YG-[?,_P#H783_ ,+G_P#,A[SOC_OC_P =_P#B
MJ-\?]\?^._\ Q5>#?\,T_"7_ *%A?_ [4O\ Y*H/[-/PE'_,LI]?MVI8_P#2
MJCEH_P#/[\'_ )C]OF?_ $+L)_X7/_YD/?-\7_/7_P >HWQ?\]?_ !ZOGUOV
M<?A"I^;PRN,]?M^I9/\ Y,G_ #Q34_9R^$,NY%\,\+Z7^I9Z]>;KZ@]Z7+1_
MY_+_ ,!?^8>VS3_H"PG_ (6R_P#F4^@=\?\ ?'_CO_Q5&^/^^/\ QW_XJO!/
M^&:_A+_T+$?_ (,-2_\ DF@?LU_"0_\ ,L)_X':E_6Y%*U+_ )_?U]X>VS/_
M *%V%_\ "U__ #(>^>8G]]?R3_&CS$_OK^2?XUX"?V;OA$K!3X83G'/V_4N?
M_)FF?\,V?"$C=_PC*[<??^WZEV^MSZ\?RI\D/^?S%[;-/^A=A/\ PL?_ ,RG
MT'OB_P">O_CU&^+_ )Z_^/5\_I^S9\(V5=OAE</]Q_M^I#H?^OG^7IQ36_9K
M^$"?>\,K_P"!VI?TNA1RT?\ G\O_  %_YC]KFG_0%@__  ME_P#,I]!;XO\
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M_@/_ -L/V^8_] >$_P#"U_\ S*>_>8G]]?R3_&CS$_OK^2?XUX&?V:/A$/\
MF5<_2_U(_P#MS2-^S5\(%Z^%AQU_T_4O_DFCDA_S^8O;YG_T+L)_X7/_ .9#
MWWS$_OK^2?XT>8G]]?R3_&OG_P#X9M^#_P#T*_\ Y/ZE_P#)-._X9H^$6?\
MD5E_\&6I8_+[3_2GRT?^?WX/_,/;YG_T+L)_X7/_ .9#W_S$_P">@_[[_P#L
M:/,3_GH/^^__ +&OGYOV;?@^G7PO],7^I?\ R338_P!F[X/R%MOA;I_T_P"I
M<_\ DS]/\:GV=/\ Y^_@A_6,Q_Z \)_X6O\ ^9CZ$WQ?\]?_ !ZC?%_SU_\
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MKU\+CIG_ (_]2_\ DFCV=/\ Y^_@A?6,Q_Z L'_X6R_^9#Z \Q/^>@_[[_\
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MT_LX?!T=/#7/H=3U/_Y*_I3?^&<O@X.GAC\K_4O_ )*%'LZ?_/W\$+ZQF/\
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M?R3_ !H\Q/[Z_DG^->"_\,S?"+_H5E_\&.H__)5'_#,WPB_Z%9?_  8ZC_\
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MFW?XBFQ^&_@C5?!WC&#^T!=W6GW/_"8:MKF@WW)^V7GAO4;[3^3S^AK?M$_
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M[>WT2VOA>;P[K/B.[(N+7[1Y]WX7O_%>E>&;4\7?COP<=$.!JUF1]+_\-%?
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M44C' S^5'/+O^"#V4.QS'_"+:-_T!]'_ /!;!_\ &*/^$6T;_H#Z/_X+8/\
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M+Z_,XL+/R(+HEKJ[6WG^RVL)DNF>"XL]OVT%"<\N_P""#V4.QW?_  BVC?\
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M/]KCX.^.;+4M1DURQ\*6=AJNH:3"_B?Q/X"\^[ETN]:ROIVT_P />+?$&I:
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M?TX2V.O"::";2)V^T&!=1M;B"XM+VV!)LKRWGM+PHP(!SR[_ ((/90[':?\
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M(/90['9?\(MHW_0'T?\ \%L'_P 8H_X1;1O^@/H__@M@_P#C%>>>-?CU\+O
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm216516d1_ex5-1img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex5-1img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  _ +,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]Z_$OB[2O
M!EE'<:QJ>GZ5;S2B".6\N4@1Y""0@+$ L0"<=>#Z5:.J6PNE@^T0><ZEUC\P
M;F48R0.N!N7/U'K7E/[;_P"S)9_M;?L]:SX0N+J6PN[F"=]-NXY&0V=XUM-#
M%*=O)"F7./:OSU'_  48^(&O?%+P'\8C;W=M\/?A=;Z7X.\?P-$=B7VIF1-4
MG8CK]DEMK$[>O[Y>SFNFCA_:*Z?]=#S,9F2P\^6:T_JY^K-EXFT[4M1N[2WU
M"RGN]/95NH(YU:2V++N4.H.5)4@C/4'-+-XDTZVUFWTZ2_LH]0O(I)X+5IU$
MT\<919'5,[F53+&&(& 9$S]X9^;/^":N@WGB+X,ZE\5-7%Y!KGQJU.7Q=-;W
M+$_V9:2?NK&V4'LEJD1SW:1SZ5\F?%W]M&QC_;AN?C+:^*7DTKX>^)(_ ,'A
M[;(J7FD,6BU74 <;#MNG1U.>5L>>"*(X=MM=@KYDJ5.%1KXMC]1=<\3:=X7T
MJ6_U+4++3[&W ,MQ<SK%%'D@#<S$ <D#D]ZH>$_B?X:\>SRQZ%XAT/6I(%#R
M)87\5RT:GH2$8X'UK.^(WPRT7XR_#>_\/^(K*'5-&U6(+=6[EE2< AARI!Z@
M'@U\S?\ !&#X-^&_"/[+-MXIT[2TMM<US5-;L+^[\Z222XBM-;OH(%.YB %C
MC4# ' K%17)?J=,J\O;*$5[K6Y]6^*_B1X>\"2VB:YKVBZ,^H.8K5;Z]BMS<
MN,95 [#<>1P/45K_ &B,+G>F/7=7Y]?\%/?A5:3?%_Q!\3KJRLOB5H?@CPO'
M%KWA,:J]G?>'84:6X;4[;:P7S/*)!W=E!Y KZ>^)WQ2GT7]B'7_&G@Z&:XEM
M?!<^LZ'&P+R.5L6EMP1U)P$SZG-4Z7NIKJ90QK=2I%KX3T:;XR>$;?Q2-#D\
M5>&TULN(QI[:G"+HL<8'E;MV>1QCO6]+?P01%WFB1%&2S.  /K7PM\+?V"/@
MS\2?V.=&\::_=W%_XA\0>&X]8U+QV=4F2^^TRPB66[#APJ$.SX7&% V]J]Z_
M8[^(&M_%W]ASP+XD\3K_ ,3_ %KPM;W=Z[#!N)&@!,I';>-KX[;JJ=)+6/>Q
M%'&SEI-*[5U;]3V:T\5:9?\ A^+5H-1L)M+GMQ=QWD=PC6\D)7>)!(#M*;>=
MV<8YJQ8ZE;ZG90W-M/#<6]PBRQ2Q.'25&&0RD<$$$$$5^2O[-/QP^(?[,G_!
M./PT/&&I7'BCX9_$7P?>VNE:KY96X\(WOV68103O_%#-)A8R.4(P>*_1W]BN
M5KK]CWX5/(2[MX/T@LS,2S'[%#DD]ZJKAW!<U^HL)F4:\N2UG8]-O]2M]*LY
M;BYGAM[>!#)++*X1(U R68G@ #DDUC>%_BSX5\;WSVVB^)O#^KW,<?FO%9:C
M#<.J9"[BJ,2!D@9]37'_ +93F#]DSXG2AF0Q>%-4<%201BSEZ$<U\R_\$C/@
MG?>#_ N@^*+WX::%X6.K>$; 1:_:ZQ)=W6LB6.*1S+&S$)N**YP.M9Q@G3YV
M;5,7RXF.'2W5S[AO]8M-*A$EU=6]M&TB1!I9 @+NP1%R3U9B% [D@#DU.)5;
M^)?SKX,_X*\?&1_$VJ^$OA#I7CNT\!WNJ17'B;5-4+L7LH[,9T]&" L/.OO*
M;CDK:R^E?0G_  3_ /VD&_:G_90\(>+[PQKK-W:?9]8C V&"]A)CG!7JA+J6
MVGD!UJG0:ASLBCF,)XF6'[=3U6\^)OAO3_$JZ-/X@T2#6),%;&2^B6Y;/(Q&
M6W?I6Q-=Q6T+2221HB LS,P 4#J2:_)K]O))/$O_  4@\9^&K#1KJ/Q'XB;P
MM::'XM?4FM;/PC<'[3([-\P#//%$0D>/WAMRO5N?TT^*LA'PF\1;-V5TNY*X
MSQB%P.?R_2G4H<O*^YGA,Q=9U+JW(=7H^N67B'3(;VPO+6^L[A=\5Q;RK+%*
MOJK*2"/I6-XH^,'A+P1?BUUKQ1X=TBZ,8F$-[J4-O(4/ ;:[ XX//3BO$?\
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M/I]C??:IAY,$VWS$\L/Y;9V+RRDC'!&3352/LW"VI-3"598I5U+1=/(^-O\
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:(=CPT_K*K]+'H5%%%9'<%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm216516d1_ex8-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex8-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !$ M8# 2(  A$! Q$!_\0
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M_9N^"K?\T[T+Z^7>?S%S2-^S?\% ?F^'>AC_ (!>?TNJ5J/_ #]7W![;-/\
MH"PG_A9+_P"9#VT7]CWNH/\ O[#_ /6H-_8]KJ#_ +^P_P#UZ\._X9P^"7_1
M/=$_[]WG_P DTJ_LZ?!-S_R3W0P>GW+W]1]IQ1RT?@]L_P ;_F+VN;_]"W!_
M^%O_ -Z'N'VZP_Y^H?\ O]%_\51]NL/^?J'_ +_1?_%5XB_[./P3'#?#W0O^
M^+W_ .20:0_LZ_!$?>^'NA?]^[S_ .231^Z_Y_?U]X_:YG_T!8+_ ,+'_P#,
M9[A]OL?^?J#_ +^0_P"-'V^Q_P"?J#_OY#_C7AP_9R^"1_YIYH/X)=_UN13?
M^&=?@> V?A_H.%^]\E[^?_'S[9_E3M2_Y_K[F+VN;_\ 0NP?_A;_ />9[E]N
ML/\ GZA_[_1?_%4?;K#_ )^H?^_T7_Q5>'C]G/X(D\?#W0?FQ_!>?_)52?\
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M:E_S^?X_YA[7,_\ H"P7_A8__F,]L^WV?_/W#_X$1_XT?;[/_G[A_P# B/\
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M'Z?:1[57)#_G\Q^VS/\ Z <%_P"%C_\ F0]M^WV?_/W#_P"!$?\ C1]OL_\
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M0_J(;S'_ *4FCDH_\_5^'^8>VS3_ * L)_X62_\ F0]S^WV/_/U!_P!_(?\
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M_C7AW_#./P3QC_A7NB8_W+S_ .2<?Y]:%_9R^";#CX=Z'[_NKS]/])IVI?\
M/]?<Q>US?_H78/\ \+?_ +S/<?M]C_S^1?\ ?^/_ .*H^WV/_/Y%_P!_X_\
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M ($1_P"->%I^SQ\#W/R_#W0?^^+S/_I0/\_A4P_9P^"I/_).]#^7I\EY[?\
M3S_G\C4^SI_\_?R'[?-/^@+!_P#A9+_YE/;_ +?8_P#/Y%_W_C_^*H^WV/\
MS^1?]_X__BJ\2_X9O^"W_1/-!_[]S_\ R13O^&;O@O\ ]$[T/_OB[_\ DJE:
MC_S]7W"]MFG_ $!83_PLE_\ ,A[3]ML?^?N#_O['_P#%T?;;'_G[@_[^Q_\
MQ=>*_P##.'P6_P"B>:%_WS=?_)='_#.'P6_Z)YH7_?-U_P#)=7RT?^?WX/\
MS#VV;?\ 0MP?_A:__F4]J^VV/_/W!_W]C_\ BZ/MMC_S]P?]_8__ (NO%?\
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MSJ_PHTY=<T=[CXF>#?BG\1_"_P ,_"OB3M_PB%R=8\5:7=WN@ZZ/MMI93\Y
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MECS9:AXR\4W-KV']NZF1Q=D#$E^ ?PEDO-!U ^"-)\_PQ!X8BT7R4EBL[?\
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M>%(-9\$>.]4T#Q NDZ[HO@'P?H20G4/'7Q?UR728/AS;WK$ W7A;2KB#5?\
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MUX)U7QG:?M'#PK#\0M3\?VL6A?$/Q#\6;5IH7\)>!XK_ %G1!\)O#6EV./\
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MS^T_"%_?M]MM2M??:^'M&&M3>(Q:6_\ ;-SI]MHUQJ(4"X?3+>[N+V&R,W>
M7-]<W&WDDS]../*+']G+X-V&F^,=$M?!MM#I'CZ#4[?Q?IQU+6'T[7(M5U&X
MU35A/8S:DUNIU2ZN)KB]N(%5[UI6^V[P,54<32Y%#V26FMEU3WN^W2_<YJV2
M9E*M[:&,=?\ VS&8O7%M?[)]3_V/!]O]LQC7UU],)A$L'9V.8_9?\1ZYXI\&
M^+]6FU?7/$7@F?X@:M%\)?$/B9FDU_7OAS9Z3X=M?[7OKBXM+.>ZMM3\7V_C
M"[T2ZN;53=>&YM$9@5(%>1OJOQ;U/X.?&#1O ?B2ZU+QQ8_M"ZCX*T'4-?\
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M-B^WY+_\54_69?RK_P )X_Y&?]ETO^?^,_\ "W$__)'S=_PAO[1'_1=O!_\
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M7TEL7V_)?_BJ-B^WY+_\51]9E_*O_">/^0?V72_Y_P",_P#"W$__ "1\V?\
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M_&?^%N)_^2/F[_A"_P!H=?\ FNW@_P#\,OS^OQ'_ )4?\(7^T.W_ #7;P?\
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M7Y_3XC_SKZ1V+[?DO_Q5&Q?;\E_^*H^LR_E7_A/'_(/[+I?\_P#&?^%N)_\
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MV+[?DO\ \52^LR_E7_A/'_(/[+I?\_\ &?\ A;B?_DCYN_X0W]HC_HNW@_\
M\,NO_P \BC_A"_VAO^B[^#?_  RP_P#GC5]([%]OR7_XJC8OM^2__%4_;R_D
MPG_A+#_(/[+I?\_\9_X6XG_Y(^;/^$+_ &A/^B[>$?\ PRH_^>33O^$-_:(_
MZ+MX/_\ #+K_ //(KZ1V+[?DO_Q5&Q?;\E_^*H]O+^3"?^$L/\@_LNE_S_QG
M_A;B?_DCYN_X0O\ :&_Z+OX-_P##+#_YXU'_  A?[0W_ $7?P;_X98?_ #QJ
M^D=B^WY+_P#%4;%]OR7_ .*I?69?RK_PGC_D']ETO^?^,_\ "W$__)'S7_PA
M?[0O_1=?"'_AEO\ \8]'_"%_M"_]%U\(?^&6_P#QCU]*;%]OR7_XJC8OM^2_
M_%4?69?RK_PGC_D']ETO^?\ C/\ PMQ/_P D?-W_  A?[0W_ $7?P;_X98?_
M #QJ/^$-_:(_Z+MX/_\ #+K_ //(KZ1V+[?DO_Q5&Q?;\E_^*I^WE_)A/_"6
M'^0?V72_Y_XS_P +<3_\D?-W_"&_M$?]%V\'_P#AEU_^>11_PAO[1'_1=O!_
M_AEU_P#GD5]([%]OR7_XJC8OM^2__%4OK,OY5_X3Q_R#^RZ7_/\ QG_A;B?_
M )(^;/\ A"_VA/\ HNWA'_PRH_\ GDTG_"%_M"G_ )KKX0_\,N!_/XD5]*;%
M]OR7_P"*HV+[?DO_ ,51]9E_*O\ PGC_ )!_9=+_ )_XS_PMQ/\ \D?-W_"%
M_M#M_P UV\'_ /AE^?T^(_\ .F_\(7^T)_T7;PC_ .&5'_SR:^D]B^WY+_\
M%4;%]OR7_P"*H^LR_E7_ (3Q_P @_LNE_P _\9_X6XG_ .2/FS_A"_VA/^B[
M>$?_  RH_P#GDT?\(7^T)_T7;PC_ .&5'_SR:^D]B^WY+_\ %4;%]OR7_P"*
MH^LR_E7_ (3Q_P @_LNE_P _\9_X6XG_ .2/F[_A"_VAO^B[^#?_  RP_P#G
MC4?\(;^T1_T7;P?_ .&77_YY%?2.Q?;\E_\ BJ-B^WY+_P#%4_;R_DPG_A+#
M_(/[+I?\_P#&?^%N)_\ DCYL_P"$+_:$_P"B[>$?_#*C_P">31_PA?[0G_1=
MO"/_ (94?_/)KZ3V+[?DO_Q5&Q?;\E_^*I?69?RK_P )X_Y!_9=+_G_C/_"W
M$_\ R1\U_P#"%_M"G_FNOA#_ ,,N!_/XD4[_ (0K]H/_ *+OX0_\,J?_ )Y%
M?2.P>B_FO^-&P>B_FO\ C1]9E_*O_">/^0?V91_Y_P"+_P#"W%?_ "1\W?\
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ME.0<E=*#GD45',^_X+_(].*Y8I=@HHHI%!1110 4444 %%%% !1110 5\_\
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MFLV<6O>$Q9ZW90Z#KEAI^HVNFZO:VMOXCUT67VRTNFM?[3NL$ J:Z?P)\(O
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MX;ET/3?%7B.QL]5G\/ZY=W0N-4\+>'/[<LKFTTF\T;%]INGW^M6>MW7V*H=
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M_P#:)T?Q#XFTSP9#X0\>6/BN[UW4]%U70M3LO"YN?#)TG0?"OBJ?4==O]/\
M$UWHQT^Y\/\ C'P[JEH-"U;6=7?[3=61T6TO[5K.TWX_CEHDWQ.F^&</A[Q;
M)<1>(9?!TWBK[-H2>$H?%D'@*#XG3Z"9SKG_  DAN;;P?>V%W]K/A[^R/M=\
M;#[<;ZUO;2TV_!7P5^&?P]BL8O"'A6QT0Z9/JMW:/;/>O*EUKMKI-AJDTT\]
MR]Q<M<Z;H>B:5BX9C;Z3I.FV "V=G:HCV^#/PV/Q!7XJ'PO9CX@+$8CXE1YX
MKL"71_\ A'99C"K_ &?[=<Z!MTIKO[*;QK*"WLC=JEM:[ #Y+\:?M?:G\,O$
M&L>&O%-E;:CJ'@?Q3X\N_B(^DQ&.31_A]?:=%<? B:'2O]+N3K/Q&\0^./ '
M@2P8YM+S6=%\7X(_LJ]^R<E=?&']KG2M=^)&H3/X6U?1?@F_PZ_X3G0=-^&T
MT>E:W:6/PV^$OQ&^,0T/QP?B1=ZE;^*/[.\5>,1X+T'_ (0C6+.\N['1,:UB
MZO,?>NI?"_X?ZQK6K>(M2\*Z->:WKUMX-L];U6>SB>\U*U^'.OWOBGP1!?SD
M#SX?#'B&_O=4TY<_Z->3D@D9K=L?"F@Z;+XEN+/3X()O%^IQZQXFFV<ZS?P:
M!HGA99[S(PV?#_AS2-+QT^R6-N,G% 'QS\*/VH/%/Q<^(VB^#M!T"&/3[74O
M''C;Q1KPB^T:7-\$K^R\_P" .O6,XN1<V^H_%"W\1Z'J=D?LEY:8\$?$BQXO
MK2S%>5?&_P#;@U;0+G]HWP]\-CIFIW?@3X>ZI:_#[6[ 6>J3WOQ4\':E8P?$
MVS^SZA<VFAW$'A?3_&7AW^QK7[7>7E[K/@?XI67V'5_^$4-E>?H?H'@3PCX6
M*-X<T*PT=ET'PWX44V,/E8\.>#HM3M_"VB]\V&@C5]4-C;=+7[=<=B*X'4?V
M=_@YJWA&U\"WW@71IO"ECJOB/7K;2!&?LRZSXPA\1P>)M3(SF>YUZ#QAXD75
MY[C>;HZK<EOO?* ?%R?M*_%;3OB,OA75M4UK26U3Q/?Z)H_AWQ1X5\$7%Q<Z
M7X.^)'[,G@?Q'KW_  E7@[Q;=Z;I_P!JM_BIJO\ Q*[KP]>?;-9US_B7WNCV
M/A[['>>I^'/VSM$O- TVUL]!\8?$+Q)8>&]"7Q-K>@:/X;\+>&X?'FK?!2?X
MXV7A6>#7_%OVK3]0U7P1!!JF;7^V?#FC_P!K:=8W_B?[<3GZ0U7X&?"S6-?L
M?%&J>$]/O->TVYUF\L-1G\U[BUN=<UWP1XDU66'YCS<Z_P##CP1JAX_X_/#F
MFD="#@Q?LS_ Z'7=$\31_#K1+?7] T2U\/:5?6J3VSVNF67AO4_!]C#Y,-RL
M%S/9^%M6U30+.\NUNKVUT>^N; 70M&"4 >->#/VV?!7B71;>:[\/^+[?7AX:
M\+7]SIUE8Z'>6]SXH\13> =*'@JQOAK@MK;6?^$H^(WAS0;*\U[^Q_#EZ9M0
MOK#6[VQT?5[NRI>(_CE\4KG]F_5?B#X8A_LSQ]<_'*Z^'6E6>K>&=.UV\TK3
M[W]J<?".QLI_#D'BWP_INL:OI?A>?[+BU\66=G>:Q9$G6LEB?>$_9Q^"T)U=
M8O NF1Q:[H2>&-1AA>]BMY-%@L]$L%L[>""Y6"PW0>%/"QO+RT6UO+R[\-^&
M[V\NWO?#^CO9Z!^ WPK/P\;X4KX4MX? (U8Z[_8%M<WMO&NLGQ5_PG,NKK?0
M72ZD=1/B_P#XJ W8NOM7]L;KPMF8F@#QC0?VC=8\+:%I^C>/O"OCWQ1XLTF?
MPEH/B_Q/IOAGP5X0T>#Q;XX.?"NF3>';CXD^(M2TY=4N+G2]*^T6EWXCLM'N
MK[3;S7M9L]/NKNZLN+\&_MCW,JZ#>^-/"NK6NC:MX<O_ !EXHUZU3PW9:7\,
MK'^S?@/JG]G:[Y_BVZN=9TCPOIWQHM]3\3^,[7[':6EE8W-[_8N+2\%G]2:;
M\$/ACI>D_P!BVOAM9=._M7PWK9BU*_U+6;A]5\'S6T_AR\FO]8NKS4;B?2KB
MS@-H;B[?'DCWSSOB']G?X9ZIX0UKP?I^AKH6GZ[X8UCP+?W&EB(SKX3\2:1X
M3\-^(M&A_M 7< M]6\/>"/"NAWA"?:5L=(MFLW6]M5) .6T7XT:WXF\-_$_7
M+&UN=.CL/AUHOQ1\"#5M-M+#4;?PUXI\-Z[#H7]JV7VK5;87-SK/@W6]?%M=
MW=K>?V/KFC6%_8Z1?6MY:5P2_MJ^%M&T*RM_$?@SXD7/CBR\+>)?$OB7PIIF
ME>$5UFVT'P#\/OASX_\ %_B^'[1XPM-#.BC1?BIX.N;2TMM6/B)K[51HG]B+
M?6=X+/Z=M/AYH\=[XPN+M);R'QI9Z9HVIV$\F+.+P[I6C'1+?0K>"WM[;&F_
MZ;KEX0>?M6KW)YLUM$M.+\7_ +,_P1\=Z<NE^+/A]HVMV(NQ>"&\CE)^T'PI
MI7@>X4S;OM M]4\':'I/AC6K7=]CUC1[&WLM0M+M>: +6A_&OP]J_B7XB^')
MK+7M%F^&5K:ZCK-YKUMING6^IZ7>V<U\NLZ'8#4KKQ'<>'Q]FGM1K]WH]GI%
MW>07-AI]]J][:7HM/,8/VN/#UWIUCJ%K\/OB>TNJW&F)HNC&P\%?VIJVF:Y\
M//%_Q3TC7K>>?QP-*M=-NO!W@S5KLKJ>IV>K6=\;;1;W1%O[L_9/=/#_ ,*/
M 'A3Q#XF\5Z!X?M-.\0>,7AD\3ZG#YV_53;F?!F4Y@M\F4F[-HMI]L('VW?W
MYCPO^SE\&?!4)A\+^!=,TA/[3&K)';-<2>1='PMJO@>'[/\ :;BZ\FWM?!VN
M:KX8LK48M;'1[@6%BEG9V=DMJ 1^*OCAHWA[2/!NH:7H7BCQM>>.M%O_ !1X
M>T?PM9:.=4F\,:5IMAJFK:_,/$^N>'=-%AIEMJNE7'V4:L-8O#?6]E86%Y?<
M'XN;]J;XF>(O%FO:SX?D\5:5\-8M!^+7C;P]KW_"/?#?6= F\.>#_"OP/G\+
M7E_8GQ;I/BVYT>[_ .%C:KK]]:DZ/XD-[JOANR/V.QTG6+.ON[Q=\$_AIXY\
M.:!X3\3>%K+4-"\+K#!X>T\-/!_9=I#IL^A?8X)X2MPMA<:/<3:;?VF3:WUA
M,UE?+=V9V@/P2^%S07=G_P (=I,=G>Z/KN@75G% 8K1M&\20>%K;7-+^S0E;
M<6.JP>!_"HN[? !&AZ>,#;R >0ZY^USX/\.>'[/Q3J?@SXCQZ%KFMW^C^#KR
M'3O"UQ<>.(M)TSQ%K6JZOH6DV_B[^V[;3K73O#=]=?9->TG1O$=Z9M-L]!T3
M6+_5[.SKK?B-\:8O 'B7PD+F/5M3TGQ%X5U"_M?#6CZ!:3ZWJFL7'Q!^$G@?
M0Q!JFKZWI-MI]Q::A\1H/MFEW=IB\M+BYOA>V7_"/7?VNS=_LQ? Z^CU.&Z\
M"6<UOJNKSZ]<VCW>HFS@O[X:[_:9TNP^U?9='M=5_P"$J\2?VUINEVUE8ZQ_
MPD6M_P!HV=T=6OA<^CZ[\._!WB2^T;4=:T2UO;SP^D,&C3/F,V$<'B3P?XPA
MBM_(V^0%\3> ?!VJ9!R;OP[IY&=N& /,-6_:&\*Z)\-;/XDZGI?B>RM+KQ;-
MX#_X1BZAT*/Q+_PF5EXRO? 5]H!(UL>&X)[;Q#I5Z&U0^(CHSV5N;ZSOFLKN
MTO#P^D_MC?#S5?L]Z= ^(%AX<?\ M6SUCQ)J.AZ18Z?X4\1:'\/M<^*NM>&]
M;L;C7/\ A))]1LO ^AS:H+O0?#^L>'+PSVMEIVMZM>W0%>Z:U\)? >O>&[KP
M=J/AZWG\.7OB"^\5S6"336_E^*+[Q7>>.+C7[*Y@87>GZPWBZ^NM>34[.XM;
MNSO9<V3J#M''Z;^S+\#-%UO0/$6G?#O1;;6?#.GRZ1HEZD<V+2UGT;7/#EPT
MT 8VVH7]UH'B+7=*O=3U:UO+[5;+5;JTU&\O%N22 >.R?M.Z[I_QLTO0-<\&
M>,-'\#Z[\._AQJ"Z;=6W@F\UOP]K_C_XM7OPYT/7M;FT?Q;> >']4N+W0[86
MNE7>L:Q9G^T[^_T6SL]*O2?6/B;^T/X2^%NNOHFNZ;XINH+"U\$7OB37M(L-
M(NM'\*P_$WQ9?^"? _\ ;<%SJEGKD_\ ;OBG2KW3$&A:3K L,?;==O-'L,78
MUM#_ &>/@]X;CBCTKP990Q6T7AN*U26XOKQK>+PAXDL_%7ANW@GN;FZG$&@:
M_8:?>:-;;B+'[#!8V82P4VM;WBGX-_#7QMXFT/Q=XJ\):9K7B#P_)8/I-_>0
M>88I=)O9M4T22Y@+"TU%M"U&>YU+0SJ=O>?V/?7%S>Z>+:\N7<@'R;JW[1OQ
M,\-_LN_#GXE7GAC5]3\=_$;P?XCU66YFD\%VUOX.OYOAOXW^(VE:G<6.G:Y=
M6VH^'[7^P[*TLK6UN[S5[S18H;V_SK;M9-W'B7]L?P=X$WV'C;PC\1M)\26E
MG+JEUX;ATCP[K&LOX;L=&LM<OO%]O!X?\3:K;7^GB"^M[8Z%I=W>^,#>RBQL
M?"]X0K77T!??"'X=:GX4T7P/J'AFQN_"GAO3!H^B:/-YKV>GZ9_PCE_X4\B
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm216516d1_ex8-1img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex8-1img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !# +8# 2(  A$! Q$!_\0
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M"?@SXR?$K4O$7Q?;Q/XOU?2-(TS0/"7[.ATGQ]8BXO=7N;:UTZ?QY\6#\./
M=G=W7 LM;ULG LKTV?W5^QK^T)IW[5/[-/P>^/6GPV]G+\1/"%AJVL:;93F>
MWTOQ1!Y^E>*M,@GR?M%OI?B>QU6TL[GO:06Q[XK6>"K0PWUJ?\%Z7MIW_&WW
M_(RPN?X'%9QC,E@W]9P'Q=4WY+IOW/JO<%(!8+DYV\Y/'ISZ=SQU':GG;ACQ
MC@G'7ZY)_P .,U_*5^W%XZ\01_\ !2'XL^ _AYXA^,$?[2>I67[*J?LM:/X5
M,/\ PK.SUK51XJF^+<WQ,FN+7^S8/#Q\(:5I>JWEM=W2ZS>65CXLOM!%W]D(
M7^E'XI7DEM\+?B'<6]S+'=6W@CQ1<VTT;_Z098/#>JD39]?M$'T/D]:=; U*
M/U2[TQ.RUV_-][F&6<0T,TGG"C1='^R'[SDT^;TMMHO/0]B(&W*\X QU'<Y]
MO\!S]6[E! ! <C(4_4CWY/X^W)%?GO\ \$N/$>J>)O\ @GO^REKOB#4;K6-<
MU+X1:+<ZKJ5X_F7EY=33WIGFGG@![CKV]B :_*/]N_09/B!_P47\5>!=>\ _
MM.?%OPUH/[)'PEUNV\,?LZ^(;/0[SPWK.J_$CXMZ5?Z]XCGN+:[N9]/U33[&
MQM;+/3^R;>HHX6=:M7HRLG0NV]^BT:TNKZO]#IQF<0PN783'TZ3KQQ.)P<%&
M+2M]<V=[=-OUU/Z9B0P! !'3DG(],G(X(]?>E('S +R,=C^8_P C/7FOFG4_
MA-HGQ'_9Z'P@U@>*-'T?Q#\,]+\(.+R_\OQKH,7]@P06\\^J_9_L_P#PE&E_
MZ%=&ZP1_;%N<G@@_E9^Q7!^TK\?/VA-,\$?M%6K:+X=_X)L/J'PNU+4=-ECC
M@^/?QNUR""^\&_$+58!\PTC2O@0WPQ\>BS'S?\)CXX^W*#96EI6<*'/"I-55
M:+NE:^G2W]:EXG-EAL1@L,\'BG]?TPS22OWYM7:RUW/WMHHHK$]DI7<7G1;?
MN@.&'R>F<^H_Q].E?GG%_P $VO@%_P *&_:?_9[CTXQ>"/VH/B1\0/B=XG9(
M(_MNA>*/'1TJ]MKW0Y?X3X-UC2+#5?#%LQ-K8W5E;[UN?],^U_HMLR/O$^GI
M^7_UZ9L0'@X^HS_^JJIU)TE[C_+]3DQ&"P>,7^TT56Z:ZHX'PQX T;P1\/O#
M_P //!-O:^&=#\)^$],\(>%+6SLS)9Z'I>A:7#I6A0Q61N1Y]MIEO;P VINE
M:Z\E0UR.2/B/0?\ @F)^S-IG[/5]\"]9\'>'?%>J:WX,\;Z%XI^,>O\ A#P[
M-\4->\6?$'^UKWQ/\0CXC-G_ &G8>('\0ZYJ>NZ+]EU,'1#]@L+&]-E9+O\
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MA2QCT#PKX9\)V'@OP]I=@@^SZ3H&F:1#HFG6=O#\H(M;""W1>Y\@$G)Y]!"
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M^,7[#7C'QU^T3JO[1WPP_:6\8_!#Q1KOPN\)_"C7M.T+P;H7B2TU+0/!^O\
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M/KF$Q>+:Z_5+;=[V1\M_\%)+F2VT']COR)FA$O\ P4'_ &0K:Y\M_+,UK/\
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M#$//:./A;V'U3E:OK?M;IZWN?6U%%%<I[P4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm216516d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm216516d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !I =0# 2(  A$! Q$!_\0
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M*HUG_GZL?^^F_P#B:/\ A5&L_P#/U8_]]-_\31RX3^KAS8O^K%S_ (6[<?\
M0)B_[_G_  H_X6[<?] F+_O^?\*I_P#"J-9_Y^K'_OIO_B:/^%4:S_S]6/\
MWTW_ ,31RX3^KAS8O^K%S_A;MQ_T"8O^_P"?\*/^%NW'_0)B_P"_Y_PJG_PJ
MC6?^?JQ_[Z;_ .)H_P"%4:S_ ,_5C_WTW_Q-'+A/ZN'-B_ZL7/\ A;MQ_P!
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M*HUG_GZL?^^F_P#B:/\ A5&L_P#/U8_]]-_\31RX3^KCYL7_ %8N?\+=N/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4@N+1YWDCF4KEFVL3@@9Y% 'HU%%>?>.0R>//"D4<LT<=Y.R7")*RK*!MP&
M.#0!Z#12 !0 .@KA?%WAJVTOPEK&HPW5^;Y8I)Q-]LE4!R<Y"AMH'/3% '=T
M5Q/A3PU;7_AO1-2>ZOQ>&.*X9S>2LKL,$@J6P0?I7:NHD1E895A@CVH 6BN
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M +_]*["'_D*W7_7./_V:@#BO!THLOB;XOTYB 9GCNE&>N1S_ .A"NPU[6(=
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M1P&4@\$&N!^),B+XB\&!F4'^T@>3V^7_ !KHO!G_ "+D/^\:YCQW_P A^/\
MZYK_ #H ]%K$\:.(_!6LLQ 'V.7DG_9-:&D_\@FU_P"N2_RK(\<_\BZW_71?
MZT 1_#=E;X>Z+M((%N!Q]3735R7P^_Y!US_UT']:ZF?_ (]Y/]P_RH \Q\)K
MH]SX\\9QZJ+"3-T-@N0AXRP.-WX9KT71WLWTJ!=-8-9Q+Y414Y!5#MX/<<=:
M\5UCH?JU>N^#?^1/TK_KW6@#E/C+*D6D:,TCA0-2C8DGL <UVUYKFF:?9F[N
MK^WC@"[MYD'(]O7\*Y#XC_\ 'S;?]<F_G7#> /\ D;K?_>_K0!N:9\-?^$L:
<]US5%DLWO[N2:&%QAA$3\I8=B>317K=% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
